FN Thomson Reuters Web of Science™
VR 1.0
PT J
AU Hass, U
   Christiansen, S
   Boberg, J
   Rasmussen, MG
   Mandrup, K
   Axelstad, M
AF Hass, U.
   Christiansen, S.
   Boberg, J.
   Rasmussen, M. G.
   Mandrup, K.
   Axelstad, M.
TI Low-dose effect of developmental bisphenol A exposure on sperm count and
   behaviour in rats
SO ANDROLOGY
LA English
DT Article
DE behaviour; bisphenol A; endocrine disruption; low dose; rat; sperm count
ID SPRAGUE-DAWLEY RATS; PERINATAL EXPOSURE; IN-UTERO; ENVIRONMENTAL
   ESTROGENS; LACTATIONAL EXPOSURE; SEXUAL DEVELOPMENT; ETHINYL ESTRADIOL;
   EPIDIDYMAL SPERM; PROSTATE-GLAND; MICE
AB Bisphenol A is widely used in food contact materials and other products and is detected in human urine and blood. Bisphenol A may affect reproductive and neurological development; however, opinion of the European Food Safety Authority (EFSA) on bisphenol A (EFSA J, 13, 2015 and 3978) concluded that none of the available studies were robust enough to provide a point of departure for setting a tolerable daily intake for bisphenol A. In the present study, pregnant Wistar rats (n = 17-21) were gavaged from gestation day 7 to pup day 22 with bisphenol A doses of 0, 25 mu g, 250 mu g, 5 mg or 50 mg/kg bw/day. In the offspring, growth, sexual maturation, weights and histopathology of reproductive organs, oestrus cyclicity and sperm counts were assessed. Neurobehavioural development was investigated using a behavioural testing battery including tests for motor activity, sweet preference, anxiety and spatial learning. Decreased sperm count was found at the lowest bisphenol A dose, that is 25 mu g/kg/day, but not at the higher doses. Reproductive organ weight and histology were not affected and no behavioural effects were seen in male offspring. In the female offspring, exposure to 25 mu g/kg bw/day bisphenol A dose resulted in increased body weight late in life and altered spatial learning in a Morris water maze, indicating masculinization of the brain. Decreased intake of sweetened water was seen in females from the highest bisphenol A dose group, also a possible sign of masculinization. The other investigated endpoints were not significantly affected. In conclusion, the present study using a robust experimental study design, has shown that developmental exposure to 25 mu g/kg bw/day bisphenol A can cause adverse effects on fertility (decreased sperm count), neurodevelopment (masculinization of spatial learning in females) and lead to increased female body weight late in life. These results suggest that the new EFSA temporary tolerable daily intake of 4 mu g/kg bw/day is not sufficiently protective with regard to endocrine disrupting effects of bisphenol A in humans.
C1 [Hass, U.; Christiansen, S.; Boberg, J.; Rasmussen, M. G.; Mandrup, K.; Axelstad, M.] Tech Univ Denmark, Div Diet Dis Prevent & Toxicol, Natl Food Inst, Morkhoj Bygade 19, DK-2860 Soborg, Denmark.
RP Hass, U (reprint author), Tech Univ Denmark, Div Diet Dis Prevent & Toxicol, Natl Food Inst, Morkhoj Bygade 19, DK-2860 Soborg, Denmark.
EM ulha@food.dtu.dk
FU Danish Environmental Protection Agency
FX The work presented here was supported by grants from the Danish
   Environmental Protection Agency.
CR alves CR, 2010, ENV TOXICOL PHARM, V30
   Anderson OS, 2013, FASEB J, V27, P1784, DOI 10.1096/fj.12-223545
   Ashby J, 1999, REGUL TOXICOL PHARM, V30, P156, DOI 10.1006/rtph.1999.1317
   Atanassova N, 2000, ENDOCRINOLOGY, V141, P3898, DOI 10.1210/en.141.10.3898
   Axelstad M, 2011, TOXICOL APPL PHARM, V250, P278, DOI 10.1016/j.taap.2010.10.031
   Axelstad M, 2008, TOXICOL APPL PHARM, V232, P1, DOI 10.1016/j.taap.2008.05.020
   Ayyanan A, 2011, MOL ENDOCRINOL, V25, P1915, DOI 10.1210/me.2011-1129
   Bernardo BD, 2015, FOOD CHEM TOXICOL, V84, P64, DOI 10.1016/j.fct.2015.07.011
   Boberg J, 2015, PROSTATE, V75, P126, DOI 10.1002/pros.22897
   Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368
   Chitra KC, 2003, TOXICOLOGY, V185, P119, DOI 10.1016/S0300-483X(02)00597-8
   Christiansen S, 2014, REPRODUCTION, V147, P477, DOI 10.1530/REP-13-0377
   Creasy DM, 2001, TOXICOL PATHOL, V29, P64, DOI 10.1080/019262301301418865
   Delclos KB, 2014, TOXICOL SCI, V139, P174, DOI 10.1093/toxsci/kfu022
   Della Seta D, 2005, BRAIN RES BULL, V65, P255, DOI 10.1016/j.brainresbull.2004.11.017
   EFSA, 2015, EFSA J, V13, P3978, DOI DOI 10.2903/J.EFSA.2015.3978
   Ferguson SA, 2012, NEUROTOXICOL TERATOL, V34, P598, DOI 10.1016/j.ntt.2012.09.006
   Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006
   Gioiosa L, 2013, HORM BEHAV, V63, P598, DOI 10.1016/j.yhbeh.2013.02.016
   Hass U, 1999, NEUROTOXICOL TERATOL, V21, P349, DOI 10.1016/S0892-0362(99)00013-6
   HASS U, 1995, NEUROTOXICOL TERATOL, V17, P341, DOI 10.1016/0892-0362(94)00093-S
   Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516
   Howdeshell KL, 2008, TOXICOL SCI, V102, P371, DOI 10.1093/toxsci/kfm306
   Isling LK, 2014, REPRODUCTION, V147, P465, DOI 10.1530/REP-13-0448
   Jarfelt K, 2005, REPROD TOXICOL, V19, P505, DOI 10.1016/j.reprotox.2004.11.005
   Jasarevic E, 2013, HORM BEHAV, V63, P180, DOI 10.1016/j.yhbeh.2012.09.009
   Johnson SA, 2016, HORM BEHAV, V80, P139, DOI 10.1016/j.yhbeh.2015.09.005
   Jones BA, 2012, HORM BEHAV, V61, P605, DOI 10.1016/j.yhbeh.2012.02.011
   Kato H, 2006, REPROD TOXICOL, V22, P20, DOI 10.1016/j.reprotox.2005.10.003
   Kuwahara R, 2013, J PHARMACOL SCI, V123, P132, DOI 10.1254/jphs.13093FP
   Liao CY, 2011, ENVIRON SCI TECHNOL, V45, P9372, DOI 10.1021/es202507f
   Maamar MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128051
   Mandrup K, 2016, ANDROLOGY-US, V4, P673, DOI 10.1111/andr.12193
   Miyawaki J, 2007, J ATHEROSCLER THROMB, V14, P245
   Munoz-de-Toro M, 2005, ENDOCRINOLOGY, V146, P4138, DOI 10.1210/en.2005-0340
   Paris F, 2002, MOL CELL ENDOCRINOL, V193, P43, DOI 10.1016/S0303-7207(02)00094-1
   Patisaul HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043890
   Prins GS, 2008, STEROIDS, V73, P233, DOI 10.1016/j.steroids.2007.10.013
   Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009
   Rebuli ME, 2015, TOXICOL SCI, V148, P341, DOI 10.1093/toxsci/kfv163
   Reif DM, 2010, ENVIRON HEALTH PERSP, V118, P1714, DOI 10.1289/ehp.1002180
   Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783
   Ryan BC, 2006, HORM BEHAV, V50, P85, DOI 10.1016/j.yhbeh.2006.01.007
   Ryan BC, 2010, TOXICOL SCI, V114, P133, DOI 10.1093/toxsci/kfp266
   Salian S, 2011, REPROD TOXICOL, V31, P359, DOI 10.1016/j.reprotox.2010.10.008
   Salian S, 2009, LIFE SCI, V85, P742, DOI 10.1016/j.lfs.2009.10.004
   Shelby MD, 2008, NTP CERHR MON, V22, P1
   Sik Kim H, 2005, J TOXICOL ENV HEAL A, V68, P2249
   Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342
   Stump DG, 2010, TOXICOL SCI, V115, P167, DOI 10.1093/toxsci/kfq025
   Timms BG, 2005, P NATL ACAD SCI USA, V102, P7014, DOI 10.1073/pnas.0502544102
   Tinwell H, 2002, TOXICOL SCI, V68, P339, DOI 10.1093/toxsci/68.2.339
   Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050
   Viberg H, 2011, TOXICOLOGY, V290, P187, DOI 10.1016/j.tox.2011.09.006
   Vinggaard AM, 2000, CHEM RES TOXICOL, V13, P1214, DOI 10.1021/tx000146b
   Vom Saal FS, 1998, TOXICOL IND HEALTH, V14, P239
   Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045
   Xu XH, 2010, HORM BEHAV, V58, P326, DOI 10.1016/j.yhbeh.2010.02.012
   Xu XB, 2011, NEUROTOXICOL TERATOL, V33, P458, DOI 10.1016/j.ntt.2011.06.002
   Xu XH, 2011, NEUROPHARMACOLOGY, V61, P565, DOI 10.1016/j.neuropharm.2011.04.027
   Yang YJ, 2016, HUM EXP TOXICOL, V35, P902, DOI 10.1177/0960327115608927
   Zhang XW, 2011, TOXICOL SCI, V121, P320, DOI 10.1093/toxsci/kfr061
NR 62
TC 2
Z9 2
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2047-2919
EI 2047-2927
J9 ANDROLOGY-US
JI Andrology
PD JUL
PY 2016
VL 4
IS 4
SI SI
BP 594
EP 607
DI 10.1111/andr.12176
PG 14
WC Andrology
SC Endocrinology & Metabolism
GA DV9VT
UT WOS:000383291000007
PM 27089241
ER

PT J
AU Lemmens, L
   Kos, S
   Beijer, C
   Brinkman, JW
   van der Horst, FAL
   van den Hoven, L
   Kieslinger, DC
   van Trooyen-van Vrouwerff, NJ
   Wolthuis, A
   Hendriks, JCM
   Wetzels, AMM
AF Lemmens, Louise
   Kos, Snjezana
   Beijer, Cornelis
   Brinkman, Jacoline W.
   van der Horst, Frans A. L.
   van den Hoven, Leonie
   Kieslinger, Dorit C.
   van Trooyen-van Vrouwerff, Netty J.
   Wolthuis, Albert
   Hendriks, Jan C. M.
   Wetzels, Alex M. M.
CA Semen Section Dutch Fdn Quality
TI Predictive value of sperm morphology and progressively motile sperm
   count for pregnancy outcomes in intrauterine insemination
SO FERTILITY AND STERILITY
LA English
DT Article
DE Intrauterine insemination; IUI; prognostic value; semen analysis
ID IN-VITRO FERTILIZATION; COST-EFFECTIVENESS; MALE SUBFERTILITY; STRICT
   CRITERIA; OVARIAN STIMULATION; ASSISTED CONCEPTION; SUCCESS; NUMBER;
   SEMEN; QUALITY
AB Objective: To investigate the value of sperm parameters to predict an ongoing pregnancy outcome in couples treated with intrauterine insemination (IUI), during a methodologically stable period of time.
   Design: Retrospective, observational study with logistic regression analyses.
   Setting: University hospital. Patient(s): A total of 1,166 couples visiting the fertility laboratory for their first IUI episode, including 4,251 IUI cycles.
   Intervention(s): None.
   Main Outcome Measure(s): Sperm morphology, total progressively motile sperm count (TPMSC), and number of inseminated progressively motile spermatozoa (NIPMS); odds ratios (ORs) of the sperm parameters after the first IUI cycle and the first finished IUI episode; discriminatory accuracy of the multivariable model.
   Result(s): None of the sperm parameters was of predictive value for pregnancy after the first IUI cycle. In the first finished IUI episode, a positive relationship was found for <= 4% of morphologically normal spermatozoa (OR 1.39) and a moderate NIPMS (5-10 million; OR 1.73). Low NIPMS showed a negative relation (<= 1 million; OR 0.42). The TPMSC had no predictive value. The multivariable model (i.e., sperm morphology, NIPMS, female age, male age, and the number of cycles in the episode) had a moderate discriminatory accuracy (area under the curve 0.73).
   Conclusion(s): Intrauterine insemination is especially relevant for couples with moderate male factor infertility (sperm morphology <= 4%, NIPMS 5-10 million). In the multivariable model, however, the predictive power of these sperm parameters is rather low. (C) 2016 by American Society for Reproductive Medicine.)
C1 [Lemmens, Louise; van den Hoven, Leonie; Wetzels, Alex M. M.] Radboud Univ Nijmegen, Fertil Lab, Dept Obstet & Gynaecol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.
   [Kos, Snjezana] Maasstad Hosp, Dept Clin Chem, Rotterdam, Netherlands.
   [Beijer, Cornelis] Atalmedial, Dept Clin Chem, Med Diagnost Ctr, Amsterdam, Netherlands.
   [Brinkman, Jacoline W.] Sint Jansdal Hosp, Dept Clin Chem, Harderwijk, Netherlands.
   [van der Horst, Frans A. L.] Reinier de Graaf Grp, Dept Clin Chem, Delft, Netherlands.
   [Kieslinger, Dorit C.] Vrije Univ Amsterdam, Dept Obstet & Gynecol, IVF Ctr, Med Ctr, Amsterdam, Netherlands.
   [van Trooyen-van Vrouwerff, Netty J.] St Antonius Hosp, Dept Clin Chem, Nieuwegein, Netherlands.
   [Wolthuis, Albert] Med Ctr Leeuwarden, Dept Clin Chem, Leeuwarden, Netherlands.
   [Hendriks, Jan C. M.] Radboud Univ Nijmegen, Dept Hlth Evidence, Med Ctr, NL-6525 ED Nijmegen, Netherlands.
RP Lemmens, L (reprint author), Radboud Univ Nijmegen, Dept Obstet & Gynaecol, Fertil Lab 791, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM louise.lemmens@radboudumc.nl
FU Dutch Foundation for Quality Assessment in Medical Laboratories (SKML),
   Nijmegen, the Netherlands
FX Supported by the Dutch Foundation for Quality Assessment in Medical
   Laboratories (SKML), Nijmegen, the Netherlands, a nonprofit organization
   for external quality control for medical laboratories. This foundation
   had no influence on the content of this study.
CR Ahinko-Hakamaa K, 2007, ACTA OBSTET GYN SCAN, V86, P855, DOI 10.1080/00016340701416895
   Ashrafi Mahnaz, 2013, Int J Fertil Steril, V7, P100
   Badawy A, 2009, FERTIL STERIL, V91, P777, DOI 10.1016/j.fertnstert.2007.12.010
   Burr RW, 1996, FERTIL STERIL, V65, P127
   Coetzee K, 1998, HUM REPROD UPDATE, V4, P73, DOI 10.1093/humupd/4.1.73
   Coppus SFPJ, 2009, HUM REPROD, V24, P1774, DOI 10.1093/humrep/dep109
   Deveneau NE, 2014, FERTIL STERIL, V102, P1584, DOI 10.1016/j.fertnstert.2014.09.016
   Dickey RP, 2002, FERTIL STERIL, V78, P1088, DOI 10.1016/S0015-0282(02)04212-7
   Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171
   Duran HE, 2002, HUM REPROD UPDATE, V8, P373, DOI 10.1093/humupd/8.4.373
   Gauci MM, 2001, ANDROLOGIA, V33, P135
   Goverde AJ, 2000, LANCET, V355, P13, DOI 10.1016/S0140-6736(99)04002-7
   Hamilton JAM, 2015, HUM REPROD, V30, P1110, DOI 10.1093/humrep/dev058
   Hauser R, 2001, ANDROLOGIA, V33, P13, DOI 10.1046/j.1439-0272.2001.00404.x
   Hox J., 2002, MULTILEVEL ANAL TECH
   Karabinus DS, 1997, FERTIL STERIL, V67, P536, DOI 10.1016/S0015-0282(97)80082-9
   Lee RKK, 2002, INT J ANDROL, V25, P277, DOI 10.1046/j.1365-2605.2002.00355.x
   Lindheim SR, 1996, J ASSIST REPROD GEN, V13, P569, DOI 10.1007/BF02066610
   Lockwood GM, 2015, ANDROLOGY-US, V3, P1088, DOI 10.1111/andr.12098
   Menkveld R, 2010, ASIAN J ANDROL, V12, P47, DOI 10.1038/aja.2009.14
   Merviel P, 2010, FERTIL STERIL, V93, P79, DOI 10.1016/j.fertnstert.2008.09.058
   Moolenaar LM, 2015, REPROD BIOMED ONLINE, V30, P659, DOI 10.1016/j.rbmo.2015.02.006
   Nederlands Huisartsen Genootschap (NHG) NVOG NVU KLEM NVKC, 2011, NETW SUBF
   Nikbakht R, 2011, INT J FERTIL STERIL, V5, P168
   Ombelet W, 1997, HUM REPROD, V12, P1458, DOI 10.1093/humrep/12.7.1458
   Ombelet W, 2014, REPROD BIOMED ONLINE, V28, P300, DOI 10.1016/j.rbmo.2013.10.023
   Papillon-Smith J, 2015, REPROD BIOMED ONLINE, V30, P392, DOI 10.1016/j.rbmo.2014.12.007
   Snijders T. A. B., 2012, MULTILEVEL ANAL INTR
   Steures P, 2004, FERTIL STERIL, V82, P45, DOI 10.1016/j.fertnstert.2003.12.028
   Sun Y, 2012, ANDROLOGIA, V44, P299, DOI 10.1111/j.1439-0272.2012.01280.x
   Tijani HA, 2010, HUM FERTIL, V13, P226, DOI 10.3109/14647273.2010.533811
   Tomlinson M, 2013, HUM FERTIL, V16, P175, DOI 10.3109/14647273.2013.807522
   Twisk JWR, 2005, J EPIDEMIOL COMMUN H, V59, P706, DOI 10.1136/jech.2004.030759
   van den Hoven L, 2015, FERTIL STERIL, V103, P53, DOI 10.1016/j.fertnstert.2014.09.036
   Van Voorhis BJ, 2001, FERTIL STERIL, V75, P661, DOI 10.1016/S0015-0282(00)01783-0
   Van Waart J, 2001, HUM REPROD UPDATE, V7, P495, DOI 10.1093/humupd/7.5.495
   van Weert JM, 2004, FERTIL STERIL, V82, P612, DOI 10.1016/j.fertnstert.2004.01.042
   WHO, 2010, LAB MAN EX PROC HUM
   WHO, 1999, LAB MAN EX HUM SEM S
   ZEGER SL, 1992, STAT MED, V11, P1825, DOI 10.1002/sim.4780111406
NR 40
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD JUN
PY 2016
VL 105
IS 6
BP 1462
EP 1468
DI 10.1016/j.fertnstert.2016.02.012
PG 7
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DN7WM
UT WOS:000377290900016
PM 26930619
ER

PT J
AU Ebrahimi, F
   Ibrahim, B
   Teh, CH
   Murugaiyah, V
   Chan, KL
AF Ebrahimi, Forough
   Ibrahim, Baharudin
   Teh, Chin-Hoe
   Murugaiyah, Vikneswaran
   Chan, Kit-Lam
TI Urinary NMR-based metabolomic analysis of rats possessing variable sperm
   count following orally administered Eurycoma longifolia extracts of
   different quassinoid levels
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Ewycoma longifolia; Quassinoids; NMR-based metabolomics; Rat sperm
   count; Urine
ID VOLATILE ORGANIC-COMPOUNDS; PITUITARY-GONADAL AXIS; SYSTEMS BIOLOGY;
   DRUG DISCOVERY; ETHYL-ALCOHOL; TONGKAT ALI; HUMAN-SEMEN; JACK; DISEASE;
   FERTILITY
AB Ethnopharmacological relevance: Eurycoma longifolia (Tongkat Ali, TA) roots have been ethnically used as a remedy to boost male sexual desire, libido, energy and fertility.
   Aim of the study: The study evaluated the effect of TA extracts with different quassinoid levels on rats sperm count and examined corresponding post-treatment urinary metabolic changes.
   Materials and methods: Twenty-four male Sprague-Dawley rats, categorized into 4 groups of 6 rats each, were orally administered for 48 days with water for the control (group 1), 125 mg/kg of TA water extract (TAW, group 2), 125 mg/kg of TA quassinoid-poor extract (TAQP, group 3) and 21 mg/kg of TA quassinoid-rich extract (TAQR, group 4). Upon completion of the 48-day treatment, the urine samples were analyzed by NMR and the animals were subsequently sacrificed for sperm count analysis. The urine profiles were categorized according to sperm count level.
   Results: The results showed that the sperm count in TAW- and TAQR-treated groups was significantly higher compared to the TAQP-administered and control groups. The orthogonal partial least squares discriminant analysis (OPLS-DA) model indicated a clear separation among the urine profiles with respect to sperm count level. Urine H-1-NMR profiles of the high-sperm count group contained higher concentrations of trigonelline, alanine, benzoic acid and higher intensity of a signal at 3.42 ppm, while ethanol was at higher concentration in the normal-sperm count group.
   Conclusions: The results proved the efficacy of quassinoids on sperm count increase in rats and provided quantitative markers in urine suitable for analysis of sperm profile and male fertility status. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Ebrahimi, Forough; Ibrahim, Baharudin; Murugaiyah, Vikneswaran; Chan, Kit-Lam] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town 11800, Malaysia.
   [Teh, Chin-Hoe] Bruker Malaysia Sdn Bhd, Selangor, Malaysia.
RP Chan, KL (reprint author), Univ Sains Malaysia, Sch Pharmaceut Sci, George Town 11800, Malaysia.
EM kitlamc@gmail.com
RI ibrahim, baharudin/H-4386-2016
FU NKEA Research Grant Scheme (NRGS) from the Ministry of Agriculture and
   Agro-Based Industry, Malaysia [NH0711S001]; Universiti Sains Malaysia
   (USM), Malaysia [1001/PFARMASI/811205]
FX This work was supported by a NKEA Research Grant Scheme of Project
   Number (NRGS)- NH0711S001 from the Ministry of Agriculture and
   Agro-Based Industry, Malaysia and a grant (1001/PFARMASI/811205) from
   Universiti Sains Malaysia (USM), Malaysia. The authors would like to
   thank Paul H. Dear, PhD. for his statistical advice. The authors also
   wish to thank Bruker Corporation (Fallanden, Switzerland) for providing
   the Topspin software.
CR AAFJES JH, 1985, ANDROLOGIA, V17, P87
   Ang HH, 1997, J EXP ANIM SCI, V46, P287
   Ang HH, 2001, PHYTOTHER RES, V15, P435, DOI 10.1002/ptr.968
   Asiah O, 2007, J TROP FOR SCI, V19, P61
   Aygen S, 2014, JIMD REP, V16, P101, DOI 10.1007/8904_2014_326
   Azmi M.M.I., 2004, EC ANAL E LONGIFOLIA, P91
   BADR FM, 1977, STEROIDS, V30, P647, DOI 10.1016/0039-128X(77)90054-X
   BADR FM, 1974, STEROIDS, V23, P921, DOI 10.1016/0039-128X(74)90064-6
   Basanta M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-72
   BUITRAGO JMG, 1981, ANDROLOGIA, V13, P335
   Carrola J, 2011, J PROTEOME RES, V10, P221, DOI 10.1021/pr100899x
   Carson C C, 1997, Tech Urol, V3, P135
   Cascante M, 2002, NAT BIOTECHNOL, V20, P243, DOI 10.1038/nbt0302-243
   Chan KL, 2009, NAT PROD COMMUN, V4, P1331
   Chan KL, 1986, PLANTA MED, V52, P105, DOI 10.1055/s-2007-969091
   CICERO TJ, 1981, ANNU REV MED, V32, P123, DOI 10.1146/annurev.me.32.020181.001011
   Cicero T.J., 1982, ADV ALCOHOL SUBST AB, V1, P87
   CICERO TJ, 1977, J PHARMACOL EXP THER, V201, P427
   DARISE M, 1982, PHYTOCHEMISTRY, V21, P2091, DOI 10.1016/0031-9422(82)83050-1
   Davidov EJ, 2003, DRUG DISCOV TODAY, V8, P175, DOI 10.1016/S1359-6446(03)02600-X
   Dohle G.R., 2004, EUR UROL, P7
   Eagon P.K., 1995, EFFECT ALCOHOL GROWT, P325
   Ebbels TMD, 2004, J PHARMACEUT BIOMED, V36, P823, DOI 10.1016/j.jpba.2004.08.016
   Emanuele M.A., 1995, ALCOHOL AND HORMONES, P97
   ERIKSSON CJP, 1983, BIOCHEM J, V210, P29
   Farouk AE, 2007, SAUDI MED J, V28, P1422
   GERSHBEIN LL, 1988, PROSTATE, V12, P263, DOI 10.1002/pros.2990120309
   Gibney MJ, 2005, AM J CLIN NUTR, V82, P497
   Griffin JL, 2011, NAT REV CARDIOL, V8, P630, DOI 10.1038/nrcardio.2011.138
   Gupta A, 2013, J ETHNOPHARMACOL, V149, P208, DOI 10.1016/j.jep.2013.06.024
   Hassan-Smith G, 2012, J NEUROIMMUNOL, V248, P48, DOI 10.1016/j.jneuroim.2012.01.009
   Holmes E, 2000, CHEM RES TOXICOL, V13, P471, DOI 10.1021/tx990210t
   Holmes E, 2001, CHEM RES TOXICOL, V14, P182, DOI 10.1021/tx000158x
   Ibrahim B, 2011, THORAX, V66, P804, DOI 10.1136/thx.2010.156695
   KLINEFELTER GR, 1991, REPROD TOXICOL, V5, P39, DOI 10.1016/0890-6238(91)90108-R
   Lachenmeier DW, 2009, J AGR FOOD CHEM, V57, P7194, DOI 10.1021/jf902038j
   Levine L.A., 2006, INDIAN J UROL, V22, P246
   Low BS, 2013, J ETHNOPHARMACOL, V145, P706, DOI 10.1016/j.jep.2012.11.013
   Low BS, 2014, PHYTOTHER RES, V28, P1022, DOI 10.1002/ptr.5094
   Low BS, 2013, J ETHNOPHARMACOL, V149, P201, DOI 10.1016/j.jep.2013.06.023
   Maclntyre DA, 2010, LEUKEMIA, V24, P788
   OECD, 2001, OECD GUID TEST CHEM
   OECD, 1995, OECD GUID TEST CHEM
   Primrose Sandy, 2011, Br J Nutr, V105, P1277, DOI 10.1017/S0007114510004812
   Ratnasooriya WD, 2000, ASIAN J ANDROL, V2, P213
   Remie R., 2000, EXPT SURG
   Sharma U, 2001, REPRODUCTION, V122, P431
   Talbott SM, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-28
   Tambi MIBM, 2012, ANDROLOGIA, V44, P226, DOI 10.1111/j.1439-0272.2011.01168.x
   Tambi MIM, 2005, INT J ANDROL, V28, P27
   Tambi M.I., 2002, P 3 WORLD C AG MAL F, V6
   Tambi M.I., 2003, P INT TRAD SHOW C SU
   Tambi MI, 2006, ASIAN J ANDROL S1, V8, P49
   Tambi M.I., 2006, P 5 WORLD C AG MAL F, V9
   Tambi MIB, 2010, ASIAN J ANDROL, V12, P376, DOI 10.1038/aja.2010.7
   Tee TT, 2007, ANTICANCER RES, V27, P3425
   Teh CH, 2011, J CHROMATOGR A, V1218, P1861, DOI 10.1016/j.chroma.2011.02.014
   van der Greef J, 2004, CURR OPIN CHEM BIOL, V8, P559, DOI 10.1016/j.cbpa.2004.08.013
   Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43
   Weidner W, 2005, EUR UROL, V47, P530, DOI 10.1016/j.eururo.2004.12.022
   WHO, 1999, WHO LAB MAN EX HUM S
   Cooper T.G., 2010, WHO LAB MANUAL EXAMI, P36
   WIDENIUS TV, 1989, ALCOHOL, V6, P241, DOI 10.1016/0741-8329(89)90025-6
   WIER PJ, 1995, REPROD TOXICOL, V9, P327, DOI 10.1016/0890-6238(95)00015-3
   Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9
   Yang YX, 2007, J PROTEOME RES, V6, P2605, DOI 10.1021/pr070063h
   Cormier M.J.N., 1997, United States Patent, Patent No. 5622944
   Sambandan TG, 2006, United States Patent, Patent No. [US 7,132,117 B2, 7132117]
NR 68
TC 0
Z9 0
U1 14
U2 14
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD APR 22
PY 2016
VL 182
BP 80
EP 89
DI 10.1016/j.jep.2016.02.015
PG 10
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA DI3PP
UT WOS:000373411100009
PM 26899442
ER

PT J
AU Shah, M
   Barthold, J
   Xie, L
   Bani-Hani, A
AF Shah, Mihir
   Barthold, Julia
   Xie, Li
   Bani-Hani, Ahmad
TI DOES VARICOCELE REPAIR IMPROVE TOTAL MOTILE SPERM COUNT (TMSC) IN
   ADOLESCENTS? A PILOT STUDY
SO JOURNAL OF UROLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Urological-Association (AUA)
CY MAY 06-10, 2016
CL San Diego, CA
SP Amer Urol Assoc
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
EI 1527-3792
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2016
VL 195
IS 4
SU S
MA MP43-18
BP E585
EP E586
PG 2
WC Urology & Nephrology
SC Urology & Nephrology
GA DL3MT
UT WOS:000375538600660
ER

PT J
AU Kohn, TP
   Louis, MR
   Pickett, SM
   Lindgren, MC
   Pastuszak, AW
   Lipshultz, LI
AF Kohn, Taylor P.
   Louis, Matthew R.
   Pickett, Stephen M.
   Lindgren, Mark C.
   Pastuszak, Alexander W.
   Lipshultz, Larry I.
TI DURATION OF TESTOSTERONE THERAPY AND MALE AGE PREDICT TIME TO RETURN OF
   NORMAL TOTAL MOTILE SPERM COUNT AFTER HUMAN CHORIONIC GONADOTROPIN
   THERAPY
SO JOURNAL OF UROLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Urological-Association (AUA)
CY MAY 06-10, 2016
CL San Diego, CA
SP Amer Urol Assoc
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
EI 1527-3792
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2016
VL 195
IS 4
SU S
MA PD07-11
BP E227
EP E227
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA DK9VB
UT WOS:000375278600506
ER

PT J
AU Centola, GM
   Blanchard, A
   Demick, J
   Li, S
   Eisenberg, ML
AF Centola, G. M.
   Blanchard, A.
   Demick, J.
   Li, S.
   Eisenberg, M. L.
TI Decline in sperm count and motility in young adult men from 2003 to
   2013: observations from a US sperm bank
SO ANDROLOGY
LA English
DT Article
DE semen analysis; sperm quality parameters; sperm count; sperm motility
ID MALE REPRODUCTIVE HEALTH; SEMEN QUALITY; GENERAL-POPULATION;
   MALE-FERTILITY; UNITED-STATES; PREGNANCY; METAANALYSIS; INFERTILITY;
   DISORDERS; CHEMICALS
AB Controversy exists regarding stability of semen quality over time with papers reporting decrease, increase or stable parameters in heterogeneous populations. The current study examined semen parameters of young adult men from 2003 to 2013 at an urban U.S. sperm bank. Semen parameters were analyzed before and after cryopreservation for a total of 9425 specimens from 489 individuals. Demographic information was obtained from a social and medical history questionnaire. Following 2-3days abstinence, the specimens were collected at the laboratory and assessed by uniform technicians and techniques. The data were analyzed using generalized linear regression after adjustment for age, days of abstinence, for repeated samples, as well as by the Cochran-Armitage trend test. The within variability was accounted for by the repeated measures model. All p values were two-sided with p<0.05 considered significant. There was a significant decline in sperm concentration (-3.55, 95% CI -4.87, -2.23; p<0.001), total motility (-1.23, 95% CI -1.65, -0.82; p<0.001), total count (-10.75, 95% CI -15.95, -5.54; p<0.001) and total motile count (-9.43, 95% CI -13.14, -5.73; p<0.001). There was no significant change in semen volume (0.03, 95% CI -0.02, 0.09; p=0.2). The post-thaw total motility significantly (-2.30, 95% CI -2.72, -1.87; p<0.001) decreased with time. Importantly, demographic and lifestyle factors were stable or improved over the study period. There was a decline in age (p(trend)=0.003) and alcohol use (p(trend)=0.005) and an increase in college GPA (Grade Point Average) (p(trend)=0.02). BMI (p(trend)=0.73), educational attainment (p(trend)=0.2), race/ethnicity (p(trend)=0.53), and lifestyle habits (weekly exercise, p(trend)=0.21; smoking, p(trend)=0.99; marital status, p(trend)=0.85) remained constant. Uniform technicians and techniques over the study period make measurement bias unlikely. This report demonstrates a decline in semen quality among young adult men in the Boston area who were attending or completed a college education during the past 10years, and requires further study.
C1 [Centola, G. M.; Blanchard, A.; Demick, J.] New England Cryogen Ctr, Brookline, MA USA.
   [Centola, G. M.; Blanchard, A.; Demick, J.] New England Cryogen Ctr, Marlborough, MA USA.
   [Li, S.; Eisenberg, M. L.] Stanford Univ, Sch Med, Dept Urol, Palo Alto, CA 94304 USA.
RP Centola, GM (reprint author), 500 Donald Lynch Blvd, Marlborough, MA USA.
EM gcentola@necryogenic.com
CR Agarwal A, 2008, FERTIL STERIL, V89, P124, DOI 10.1016/j.fertnstert.2007.01.166
   AUGER J, 1995, NEW ENGL J MED, V332, P281, DOI 10.1056/NEJM199502023320501
   Axelsson J, 2011, HUM REPROD, V26, P1012, DOI 10.1093/humrep/der045
   Benoff S, 2003, HUM REPROD, V18, P374, DOI 10.1093/humrep/deg020
   Benoff S, 2003, FERTIL STERIL, V80, P517, DOI 10.1016/S0015-0282(03)00981-6
   CARLSEN E, 1992, BRIT MED J, V305, P609
   Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048
   Fisch H, 2008, UROL CLIN N AM, V2, P137
   Fisch H, 1996, FERTIL STERIL, V65, P1009
   Gorpinchenko Igor, 2014, Cent European J Urol, V67, P65, DOI 10.5173/ceju.2014.01.art14
   Irvine S, 1996, BRIT MED J, V312, P467
   Jorgensen N, 2011, INT J ANDROL, V34, pE37, DOI 10.1111/j.1365-2605.2010.01133.x
   Jorgensen N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000990
   Jouannet P, 2001, APMIS, V109, P333, DOI 10.1034/j.1600-0463.2001.090502.x
   Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396
   Kristensen DM, 2011, ENVIRON HEALTH PERSP, V119, P534, DOI 10.1289/ehp.1002635
   Kristensen DM, 2012, MOL CELL ENDOCRINOL, V355, P221, DOI [10.1016/ j. mce. 2011.05.048., DOI 10.1016/J.MCE.2011.05.048]
   Liu K, 2014, ANDROLOGY-US, V2, P491, DOI 10.1111/j.2047-2927.2014.00205.x
   MAKLER A, 1980, FERTIL STERIL, V33, P337
   Mortimer D, 2013, HUM REPROD UPDATE, V1, pi1
   Multigner L, 2007, OCCUP ENVIRON MED, V64, P467, DOI 10.1136/oem.2005.023952
   Murray KS, 2012, FERTIL STERIL, V98, P1428, DOI 10.1016/j.fertnstert.2012.07.1130
   Nordkap L, 2012, MOL CELL ENDOCRINOL, V355, P221, DOI 10.1016/j.mce.2011.05.048
   Olea N, 2007, OCCUP ENVIRON MED, V64, P430, DOI 10.1136/oem.2007.033621
   Oliveira JBA, 2014, JBRA ASSIST REPROD, V18, P34
   Pastuszak AW, 2013, ASIAN J ANDROL, V15, P179, DOI 10.1038/aja.2012.105
   Ramasamy R, 2015, FERTIL STERIL, V103, P906, DOI 10.1016/j.fertnstert.2015.01.029
   Rider CV, 2010, INT J ANDROL, V2, P443
   Rolland M, 2013, HUM REPROD, V28, P462, DOI 10.1093/humrep/des415
   Saidi JA, 1999, J UROLOGY, V161, P460, DOI 10.1016/S0022-5347(01)61923-2
   Sermondade N, 2013, HUM REPROD UPDATE, V19, P221, DOI 10.1093/humupd/dms050
   Sharpe RM, 2010, PHILOS T R SOC B, V365, P1697, DOI 10.1098/rstb.2009.0206
   SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E
   SHERINS RJ, 1995, NEW ENGL J MED, V332, P327, DOI 10.1056/NEJM199502023320510
   Slama R, 2004, EPIDEMIOLOGY, V15, P458, DOI 10.1097/01.ede.0000129520.84568.87
   Splingart C, 2012, INT J ANDROL, V35, P467, DOI 10.1111/j.1365-2605.2011.01229.x
   Swan SH, 2007, HUM REPROD, V22, P1497, DOI 10.1093/humrep/dem068
   Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055
   Toft G, 2004, REPROD TOXICOL, V19, P5, DOI 10.1016/j.reprotox.2004.05.006
   Vinggaard AM, 2008, CHEM RES TOXICOL, V21, P813, DOI 10.1021/tx7002382
   World Health Organization, 2010, WHO MAN EX PROC HUM
   Zhu QX, 2011, FERTIL STERIL, V96, P572, DOI 10.1016/j.fertnstert.2011.06.058
   Zou ZK, 2011, FERTIL STERIL, V95, P2018, DOI 10.1016/j.fertnstert.2011.02.052
NR 43
TC 0
Z9 0
U1 11
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2047-2919
EI 2047-2927
J9 ANDROLOGY-US
JI Andrology
PD MAR
PY 2016
VL 4
IS 2
BP 270
EP 276
DI 10.1111/andr.12149
PG 7
WC Andrology
SC Endocrinology & Metabolism
GA DG9PT
UT WOS:000372417000010
PM 26789272
ER

PT J
AU Bakay, K
   Guven, D
   Batioglu, AS
   Cakiroglu, H
   Ayas, B
AF Bakay, Kadir
   Guven, Davut
   Batioglu, A. Sertac
   Cakiroglu, Hasan
   Ayas, Bulent
TI There is No Effect of Total Sperm Count on Pregnancy Rates in ICSI
   Cycles
SO JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE
LA English
DT Article
DE Total Sperm Count; ICSI; Pregnancy Rate
ID INJECTION ICSI; OUTCOMES; FERTILIZATION; MORPHOLOGY
AB Aim: To determine whether the total sperm count has any effect on pregnancy rates in ICSI cycles. Material and Method : This retrospective cohort study was performed on single ICSI cycles of 661 couples in two separate Assisted Reproduction Technology Centers between January 2010 and December 2012. Total sperm count and pregnancy rates were compared. Results: Pregnancy rates showed difference among total sperm count groups but there was no statistically significant difference between them. Discussion: It is shown that there are no statistically significant effect of total sperm count on pregnancy rates in ICSI cycles.
C1 [Guven, Davut; Batioglu, A. Sertac; Cakiroglu, Hasan; Ayas, Bulent] Ondokuz Mayis Univ, Fac Med, Dept Obstet & Gynecol, Samsun, Turkey.
   [Bakay, Kadir] Baskent Univ, Fac Med, Dept Obstet & Gynecol, Alanya Hosp, Antalya, Turkey.
RP Bakay, K (reprint author), Baskent Univ, Fac Med, Dept Obstet & Gynecol, Antalya, Turkey.
EM drkadirbakay@gmail.com
CR Arikan II, 2012, CLIN EXP OBSTET GYN, V39, P280
   Bakay K, 2016, J CLIN ANAL MED, V7, P94, DOI 10.4328/JCAM.4071
   Bartoov B, 2002, J ANDROL, V23, P1
   Bartoov B, 2003, FERTIL STERIL, V80, P1413, DOI 10.1016/j.fertnstert.2003.05.016
   Berkovitz A, 2006, REPROD BIOMED ONLINE, V12, P634
   Bonduelle M, 2007, HUM REPROD UPDATE, V13, P515, DOI 10.1093/humupd/dmm024
   De Jonge C, 2012, FERTIL STERIL, V97, P260, DOI 10.1016/j.fertnstert.2011.12.045
   Gul U, 2016, J CLIN ANAL MED, V7, P55, DOI 10.4328/JCAM.3332
   Kim HH, 2007, FERTIL STERIL, V88, P622, DOI 10.1016/j.fertnstert.2006.12.013
   Klement AH, 2012, INT J MOL EPIDEMIOL, V3, P205
   Schmitt W, 1993, GAMETOGENESIS FERTIL, P15
   Nagyl ZP, 1998, HUM REP VOLUME, V13, P1
   Nyboe Andersen Anders, 2008, Hum Reprod Update, V14, P593, DOI 10.1093/humupd/dmn032
   Penn HA, 2011, FERTIL STERIL, V95, P2320, DOI 10.1016/j.fertnstert.2011.03.004
   Repping S, 2002, FERTIL STERIL, V78, P22, DOI 10.1016/S0015-0282(02)03178-3
   Setti AS, 2012, J ASSIST REPROD GEN, V29, P1241, DOI 10.1007/s10815-012-9868-x
   TOURNAYE H, 1995, REPROD FERT DEVELOP, V7, P269, DOI 10.1071/RD9950269
   Van Rumste MM, 2000, COCHRANE DB SYST REV
   VANSTEIRTEGHEM AC, 1993, HUM REPROD, V8, P1061
NR 19
TC 1
Z9 1
U1 0
U2 0
PU DERMAN MEDICAL PUBL
PI ANKARA
PA KARTALTEPE MAHALLESI, ATATURK BULVARI, ANKARA, 00000, TURKEY
SN 1309-0720
EI 1309-2014
J9 J CLIN ANAL MED
JI J. Clin. Anal. Med.
PD JAN
PY 2016
VL 7
IS 1
BP 94
EP 96
DI 10.4328/JCAM.4071
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM7UU
UT WOS:000376566300022
ER

PT J
AU Xiao, CW
   Agbo, C
   Dahan, MH
AF Xiao, Cheng Wei
   Agbo, Chioma
   Dahan, Michael H.
TI Comparison of pregnancy rates in pre-treatment male infertility and low
   total motile sperm count at insemination
SO ARCHIVES OF GYNECOLOGY AND OBSTETRICS
LA English
DT Article
DE Intrauterine insemination; Total motile sperm count; Male factor
   infertility; Sperm analysis; Pregnancy; Controlled ovarian
   hyper-stimulation
ID INTRAUTERINE INSEMINATION; SEMEN PARAMETERS; QUALITY; CYCLES; MEN;
   SUBFERTILITY; POPULATION; MORPHOLOGY; COUPLES; EUROPE
AB In intrauterine insemination (IUI), total motile sperm count (TMSC) is an important predictor of pregnancy. However, the clinical significance of a poor TMSC on the day of IUI in a patient with prior normal semen analysis (SA) is unclear. We performed this study to determine if these patients perform as poorly as those who had male factor infertility diagnosed prior to commencing treatment.
   147 males with two abnormal SA based on the 2010 World Health Organization criteria underwent 356 IUI with controlled ovarian hyper-stimulation (COH). Their pregnancy rates were compared to 120 males who had abnormal TMSC at the time of 265 IUI with COH, in a retrospective university-based study.
   The two groups were comparable in female age (p = 0.11), duration of infertility (p = 0.17), previous pregnancies (p = 0.13), female basal serum FSH level (p = 0.54) and number of mature follicles on the day of ovulation trigger (p = 0.27). Despite better semen parameters on the day of IUI in the pre-treatment male factor infertility group (TMSC mean +/- A SD: 61 +/- A 30 million vs. 3.5 +/- A 2 million, p < 0.001), pregnancy rates were much higher in the group with low TMSC on the day of IUI (5 % vs. 17 %, p < 0.001).
   A patient with a recent (within 6 months) normal pre-treatment SA but low TMSC on the day of IUI likely has a reasonable chance to achieve pregnancy, and does not perform as poorly as subjects previously diagnosed with male factor infertility. More studies should be performed to confirm these findings.
C1 [Xiao, Cheng Wei; Dahan, Michael H.] McGill Univ, Reprod Ctr, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada.
   [Agbo, Chioma] Stanford Univ, Palo Alto, CA 94304 USA.
RP Dahan, MH (reprint author), McGill Univ, Reprod Ctr, Royal Victoria Hosp, 687 Pins West,F6-58, Montreal, PQ H3A 1A1, Canada.
EM dahanhaim@hotmail.com
CR Caserta D, 2013, ARCH GYNECOL OBSTET, V287, P813, DOI 10.1007/s00404-012-2643-5
   Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048
   Daris B, 2010, ARCH GYNECOL OBSTET, V281, P363, DOI 10.1007/s00404-009-1140-y
   Dickey RP, 2002, FERTIL STERIL, V78, P1088, DOI 10.1016/S0015-0282(02)04212-7
   Dickey RP, 1999, FERTIL STERIL, V71, P684, DOI 10.1016/S0015-0282(98)00519-6
   Dinelli L, 2014, FERTIL STERIL, V101, P994, DOI 10.1016/j.fertnstert.2014.01.009
   Dong FL, 2011, SYST BIOL REPROD MED, V57, P251, DOI 10.3109/19396368.2011.603792
   Dorjpurev Uranchimeg, 2011, J Med Invest, V58, P127, DOI 10.2152/jmi.58.127
   Ferraretti AP, 2013, HUM REPROD, V28, P2318, DOI 10.1093/humrep/det278
   FRANCAVILLA F, 1990, FERTIL STERIL, V53, P892
   Francavilla F, 2007, INT J ANDROL, V30, P174, DOI 10.1111/j.1365-2605.2006.00727.x
   Ghaleno LR, 2014, ARCH GYNECOL OBSTET, V289, P173, DOI 10.1007/s00404-013-2946-1
   Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005
   Hammadeh ME, 1997, ARCH GYNECOL OBSTET, V259, P125
   Jarow JP, 2013, J UROLOGY, V189, P1825, DOI 10.1016/j.juro.2012.11.077
   Jorgensen N, 2001, HUM REPROD, V16, P1012, DOI 10.1093/humrep/16.5.1012
   Kleppe M, 2014, ANDROLOGIA, V46, P1183, DOI 10.1111/and.12212
   Leushuis E, 2010, FERTIL STERIL, V94, P2631, DOI 10.1016/j.fertnstert.2010.03.021
   Luco SM, 2014, EUR J OBSTET GYN R B, V179, P159, DOI 10.1016/j.ejogrb.2014.05.003
   Merviel P, 2010, FERTIL STERIL, V93, P79, DOI 10.1016/j.fertnstert.2008.09.058
   Ombelet W, 2014, REPROD BIOMED ONLINE, V28, P300, DOI 10.1016/j.rbmo.2013.10.023
   Papillon-Smith J, 2015, REPROD BIOMED ONLINE, V30, P392, DOI 10.1016/j.rbmo.2014.12.007
   SMALL DRJ, 1987, CAN MED ASSOC J, V136, P829
   Soria Macizo, 2012, J Reprod Infertil, V13, P158
   Steures P, 2004, HUM REPROD, V19, P2263, DOI 10.1093/humrep/deh435
   Stone BA, 1999, AM J OBSTET GYNECOL, V180, P1522, DOI 10.1016/S0002-9378(99)70048-7
   van der Merwe FH, 2005, GYNECOL OBSTET INVES, V59, P86, DOI 10.1159/000082368
   Van Voorhis BJ, 2001, FERTIL STERIL, V75, P661, DOI 10.1016/S0015-0282(00)01783-0
   World Health Organization, 1987, WHO LAB MAN EX HUM S
   World Health Organization, 1992, WHO LAB MAN EX HUM S
   WHO, 1999, WHO LAB MAN EX HUM S
NR 31
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0932-0067
EI 1432-0711
J9 ARCH GYNECOL OBSTET
JI Arch. Gynecol. Obstet.
PD JAN
PY 2016
VL 293
IS 1
BP 211
EP 217
DI 10.1007/s00404-015-3850-7
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DA2CW
UT WOS:000367603900028
PM 26288981
ER

PT J
AU Campos-Pereira, FD
   Franco, LS
   Alves, GA
   Goncalves, L
   Curtolo, RF
   Hara, RV
   Dolder, MAH
   Marin-Morales, MA
   Severi-Aguiar, GDD
AF Campos-Pereira, F. D.
   Souza Franco, L.
   Alves, G. A.
   Goncalves, L.
   Ferraz Curtolo, R.
   Vaz Hara, R.
   Heidi Dolder, M. A.
   Marin-Morales, M. A.
   Severi-Aguiar, G. D. D.
TI Evaluation of diamine putrescine effects on epididymal sperm count and
   transit in Wistar rats
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 51st Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 13-16, 2015
CL Portuguese Soc Pharmacol, Sect Toxicol, Porto, PORTUGAL
SP European Soc Toxicol
HO Portuguese Soc Pharmacol, Sect Toxicol
C1 [Campos-Pereira, F. D.; Vaz Hara, R.; Marin-Morales, M. A.] UNESP Rio Claro, Dept Biol, Rio Claro, Brazil.
   [Souza Franco, L.; Alves, G. A.; Goncalves, L.; Ferraz Curtolo, R.; Severi-Aguiar, G. D. D.] UNIARARAS, Programa Posgrad Ciencias Biomed, Araras, Brazil.
   [Heidi Dolder, M. A.] Univ Estadual Campinas, Dept Struct & Funct Biol, Campinas, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD OCT 16
PY 2015
VL 238
IS 2
SU S
MA P03-101
BP S121
EP S121
DI 10.1016/j.toxlet.2015.08.387
PG 1
WC Toxicology
SC Toxicology
GA DE5SY
UT WOS:000370693801224
ER

PT J
AU Shetty, SD
   Bairy, LK
AF Shetty, Surekha Devadasa
   Bairy, Laxminarayana Kurady
TI Effect of sorafenib on sperm count and sperm motility in male Swiss
   albino mice
SO JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH
LA English
DT Article
DE Anticancer drug; cauda epididymis; fertility; spermatogenesis
ID SEMEN QUALITY; SPERMATOGENESIS; FERTILIZATION; MOUSE; TESTOSTERONE;
   INFERTILITY; TOXICITY; DURATION; PROGRAM; MAMMALS
AB The issue of male germ line mutagenesis and the effects on developmental defects in the next generation has become increasingly high profile over recent years. Mutagenic substance affects germinal cells in the testis. Since the cells are undergoing different phases of cell division and maturation, it is an ideal system to study the effect of chemotherapeutic agents. There are lacunae in the literature on the effect of sorafenib on gonadal function. With background, a study was planned to evaluate the effects of sorafenib on sperm count and sperm motility in male Swiss albino mice. Male Swiss albino mice were used for the study. The animals were segregated into control, positive control (PC) and three treatment groups. PC received oral imatinib (100 mg/kg body weight) and treatment groups received 25, 50, and 100 mg/kg body weight of sorafenib orally for 7 consecutive days at intervals of 24 h between two administrations. The control group remained in the home cage for an equal duration of time to match their corresponding treatment groups. The animals were sacrificed at the end of 1 (st) , 2 (nd) , 4 (th) , 5 (th) , 7 (th) , and 10 (th) weeks after the last exposure to drug, respectively. Sperm suspensions were prepared and introduced into a counting chamber. Total sperm count and motility were recorded. There was a significant decrease in sperm count and sperm motility by sorafenib which was comparable with the effect of PC imatinib. Sorafenib adversely affects sperm count and sperm motility which are reversible after discontinuation of treatment.
C1 [Shetty, Surekha Devadasa] Manipal Univ, Melaka Manipal Med Coll, Dept Anat, Manipal, Karnataka, India.
   [Bairy, Laxminarayana Kurady] Manipal Univ, Dept Pharmacol, Kasturba Med Coll, Manipal, Karnataka, India.
RP Bairy, LK (reprint author), Manipal Univ, Dept Pharmacol, Kasturba Med Coll, Udupi, Karnataka, India.
EM kl.bairy@manipal.edu
CR Adler ID, 1996, MUTAT RES-FUND MOL M, V352, P169, DOI 10.1016/0027-5107(95)00223-5
   Arnon J, 2001, HUM REPROD UPDATE, V7, P394, DOI 10.1093/humupd/7.4.394
   Bahadur G, 2005, HUM REPROD, V20, P774, DOI 10.1093/humrep/deh671
   Bebb RA, 1996, J CLIN ENDOCR METAB, V81, P757, DOI 10.1210/jc.81.2.757
   CHECK JH, 1990, ARCH ANDROLOGY, V24, P229
   Chen KF, 2010, J HEPATOL, V52, P88, DOI 10.1016/j.jhep.2009.10.011
   Choudhury RC, 2000, ENVIRON TOXICOL PHAR, V8, P191, DOI 10.1016/S1382-6689(00)00041-7
   Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055
   Eddy E. M., 1994, P29
   Huang WS, 2009, WORLD J GASTROENTERO, V15, P4464, DOI 10.3748/wjg.15.4464
   Isojarvi JIT, 2004, NEUROLOGY, V62, P247
   Kumar PK, 2011, HYGEIA J MED, V3, P20
   Kumar SG, 2006, MUTAT RES-GEN TOX EN, V607, P240, DOI 10.1016/j.mrgentox.2006.04.019
   LIU DY, 1991, J ANDROL, V12, P231
   MEISTRICH ML, 1983, FERTIL STERIL, V40, P220
   Narayana K, 2009, EXP TOXICOL PATHOL, V61, P553, DOI 10.1016/j.etp.2008.12.001
   OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307
   ORTH JM, 1988, ENDOCRINOLOGY, V122, P787
   Poon R, 2004, TOXICOL SCI, V77, P142, DOI 10.1093/toxsci/kfg251
   Prasad AM, 2010, PHARM ONLINE, V1, P469
   Robaire B, 2007, ASIAN J ANDROL, V9, P545, DOI 10.1111/j.1745-7262.2007.00316.x
   RUSSELL LD, 1984, J REPROD FERTIL, V70, P635
   SAACKE RG, 1994, THERIOGENOLOGY, V41, P45, DOI 10.1016/S0093-691X(05)80047-0
   Shivabasavaiah KR, 2011, J PHARM RES, V4, P323
   Turk G, 2008, FERTIL STERIL, V89, P1474, DOI 10.1016/j.fertnstert.2007.04.059
   van der Spoel AC, 2002, P NATL ACAD SCI USA, V99, P17173, DOI 10.1073/pnas.262586099
   VEGA SG, 1988, MUTAT RES, V204, P269, DOI 10.1016/0165-1218(88)90099-7
   WYROBEK AJ, 1983, MUTAT RES, V115, P1, DOI 10.1016/0165-1110(83)90014-3
NR 28
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 2231-4040
EI 0976-2094
J9 J ADV PHARM TECHNOL
JI J. Adv. Pharm. Technol. Res.
PD OCT-DEC
PY 2015
VL 6
IS 4
BP 165
EP 169
DI 10.4103/2231-4040.165012
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DE1FU
UT WOS:000370372900005
ER

PT J
AU Mahmoudi, R
   Mortazavi, SMJ
   Safari, S
   Nikseresht, M
   Mozdarani, H
   Jafari, M
   Zamani, A
   Haghani, M
   Davari, M
   Tabatabaie, A
   Soleimani, A
AF Mahmoudi, R.
   Mortazavi, S. M. J.
   Safari, S.
   Nikseresht, M.
   Mozdarani, H.
   Jafari, M.
   Zamani, A.
   Haghani, M.
   Davari, M.
   Tabatabaie, A.
   Soleimani, A.
TI Effects of microwave electromagnetic radiations emitted from common
   Wi-Fi routers on rats' sperm count and motility
SO INTERNATIONAL JOURNAL OF RADIATION RESEARCH
LA English
DT Article
DE Electromagnetic fields; microwave; wi-fi router; sperm count; sperm
   motility
ID VISUAL REACTION-TIME; MOBILE PHONE; IN-VITRO; INCREASED RADIORESISTANCE;
   HUMAN SPERMATOZOA; GAMMA-RAYS; EXPOSURE; SEMEN; FIELDS
AB Background: Wi-Fi allows electronic devices such as laptops to exchange data or connect to a network resource. The main goal of this study was to assess the bioeffects of short term exposure to 2.4 GHz microwave radiation emitted from a common Wi-Fi router on sperm quality. Materials and Methods: Male Wistar rats were divided into 7 groups; I, sham exposed 4 h/day for 7days at 30 cm from the router. II, exposed for 2 h/day for 7days at 30 cm and sacrificed a 0 er 53 days. The exposure protocols for groups III to VII were 2h - 30 cm, 2h - 60 cm, 4 h - 30 cm, 4 h- 60 cm, 4 h - 30 cm (no data exchange) respectively. Rats in all the groups except group II, were sacrificed immediately a 0 er exposure and basic parameters of testicles weight, sperm motility, morphology, count, and DNA fragmentation were studied. Nonparametric tests were used to detect statistically significant differences between different groups. Results: Findings of this study showed statistically significant differences between the relative frequency of progressive and rapid progressive sperms in sham exposed rats compared to those of exposure groups. The testicles weight, DNA fragmentation of sperms and the frequency of sperms with normal morphology were not affected by Wi-Fi radiation. However, statistically significant differences between sperm count of the sham exposed rats compared to those of exposure group were observed. Conclusion: Exposure to microwave radiation emitted from Wi-Fi routers affects sperm parameters such as count and motility which are among the key parameters determining the chance of conceiving.
C1 [Mahmoudi, R.; Safari, S.; Nikseresht, M.; Jafari, M.] Yasuj Univ Med Sci, Sch Med, Cellular & Mol Res Ctr, Yasuj, Iran.
   [Mortazavi, S. M. J.; Haghani, M.] Shiraz Univ Med Sci, INIRPRC, Shiraz, Iran.
   [Mortazavi, S. M. J.; Zamani, A.] Shiraz Univ Med Sci, Sch Med, Dept Med Phys & Med Engn, Shiraz, Iran.
   [Mozdarani, H.] Tarbiat Modares Univ, Fac Med Sci, Dept Med Genet, Tehran, Iran.
   [Davari, M.] Shiraz Univ Med Sci, IVF Ctr, Shiraz, Iran.
   [Tabatabaie, A.] Shiraz Univ Med Sci, Vice Chancellery Hlth, Shiraz, Iran.
   [Soleimani, A.] Shiraz Univ Med Sci, Sch Hlth, Dept Epidemiol, Shiraz, Iran.
RP Mortazavi, SMJ (reprint author), Shiraz Univ Med Sci, INIRPRC, Shiraz, Iran.
EM mmortazavi@sums.ac.ir
FU Ionizing and Non-ionizing Radiation Protection Research Center
   (INIRPRC), Shiraz University of Medical Sciences (SUMS), Shiraz, Iran
FX This study was supported by the Ionizing and Non-ionizing Radiation
   Protection Research Center (INIRPRC), Shiraz University of Medical
   Sciences (SUMS), Shiraz, Iran.
CR Agarwal A, 2008, FERTIL STERIL, V89, P124, DOI 10.1016/j.fertnstert.2007.01.166
   Agarwal A, 2009, FERTIL STERIL, V92, P1318, DOI 10.1016/j.fertnstert.2008.08.022
   Avendano C, 2012, FERTIL STERIL, V97, P39, DOI 10.1016/j.fertnstert.2011.10.012
   De Iuliis GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006446
   Erogul O, 2006, ARCH MED RES, V37, P840, DOI 10.1016/j.arcmed.2006.05.003
   Falzone N, 2008, BIOELECTROMAGNETICS, V29, P268, DOI 10.1002/bem.20390
   FCC, 2011, DOC ENF BUR STEPS ED
   Johnson M T, 2001, Biomed Sci Instrum, V37, P215
   La Vignera S, 2012, J ANDROL, V33, P350, DOI 10.2164/jandrol.111.014373
   Mailankot M, 2008, CLINICS, V64, P561
   Mortavazi Seyed, 2009, Oman Med J, V24, P274, DOI 10.5001/omj.2009.56
   Mortazavi SMJ, 2014, DOSE-RESPONSE, V12, P233, DOI 10.2203/dose-response.12-055.Mortazavi
   Mortazavi S M J, 2008, Pak J Biol Sci, V11, P1142
   Mortazavi S M J, 2014, Int J Occup Environ Med, V5, P101
   Mortazavi SMJ, 2012, ACTA NEUROL BELG, V112, P171, DOI 10.1007/s13760-012-0044-y
   Mortazavi SMJ, 2007, BIOELECTROMAGNETICS, V28, P326, DOI 10.1002/bem.20305
   Mortazavi S M J, 2012, J Nat Sci Biol Med, V3, P60, DOI 10.4103/0976-9668.95958
   Mortazavi SMJ, 2011, IRAN J RADIAT RES, V9, P9
   Mortazavi SMJ, 2013, DOSE-RESPONSE, V11, P281, DOI 10.2203/dose-response.12-010.Mortazavi
   Mortazavi SMJ, 2011, TECHNOL HEALTH CARE, V19, P435, DOI 10.3233/THC-2011-0641
   Mortazavi SMJ, 2013, IRAN J PUBLIC HEALTH, V42, P428
   Mortazavi SMJ, 2013, J MED HYPOTHESES IDE, V7, P8
   Mortazavi SMJ, 2010, J REPROD INFERTIL, V11, P251
   Mortazavi Smj, 2013, J Hum Reprod Sci, V6, P124, DOI 10.4103/0974-1208.117178
   Mortazavi SMJ, 2013, J BIOMED PHYS ENG, V3, P1
   Mortazavi SMJ, 2011, J REPROD INFERTILITY, V11, P251
   Salama N, 2009, SYST BIOL REPROD MED, V55, P181, DOI 10.3109/19396360903013126
   Salama N, 2010, INT J ANDROL, V33, P88, DOI 10.1111/j.1365-2605.2008.00940.x
   Turk Z, 2001, WIEN KLIN WOCHENSCHR, V113, P47
NR 29
TC 0
Z9 0
U1 3
U2 3
PU IJRR-IRANIAN JOURNAL RADIATION RES
PI TEHRAN
PA NO 29, 4TH FL, CHAMRAN MEDICAL BLDG, PARVANEH ST, ALE-AHMAD HWY, TEHRAN,
   00000, IRAN
SN 2322-3243
J9 INT J RADIAT RES
JI Int. J. Radiat. Res.
PD OCT
PY 2015
VL 13
IS 4
BP 363
EP 368
DI 10.7508/ijrr.2015.04.010
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA DC3VQ
UT WOS:000369147400010
ER

PT J
AU Centola, GM
   Blanchard, A
   Demick, JL
   Li, S
   Eisenberg, ML
AF Centola, G. M.
   Blanchard, A.
   Demick, J. L.
   Li, S.
   Eisenberg, M. L.
TI A CASE FOR BANKING SPERM DUE TO INCREASED AGE: DECLINE IN SPERM COUNT
   AND MOTILITY IN YOUNG ADULT MEN
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 71st Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 17-21, 2015
CL Baltimore, MD
SP Amer Soc Reprod Med
C1 [Centola, G. M.] New England Cryogen Ctr, Newton, MA USA.
   [Blanchard, A.] New England Cryogen Ctr, Brookline, MA USA.
   [Demick, J. L.] New England Cryogen Ctr, Lab, Brookline, MA USA.
   [Li, S.; Eisenberg, M. L.] Stanford Univ, Sch Med, Urol, Stanford, CA 94305 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2015
VL 104
IS 3
SU S
MA O-203
BP E78
EP E79
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DR6NP
UT WOS:000380018900202
ER

PT J
AU Libby, V
   Reed, B
   Babayev, SN
   Ezzati, M
   Ha, TK
   Tan, O
   McIntire, DD
   Carr, B
   Doody, K
AF Libby, V.
   Reed, B.
   Babayev, S. N.
   Ezzati, M.
   Ha, T. K.
   Tan, O.
   McIntire, D. D.
   Carr, B.
   Doody, K.
TI PREDICTIVE VALUE OF POSTWASHED TOTAL PROGRESSIVELY MOTILE SPERM COUNT
   USING CASA ESTIMATES IN 1524 DONOR AND 6871 NON-DONOR INTRAUTERINE
   INSEMINATION CYCLES.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 71st Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 17-21, 2015
CL Baltimore, MD
SP Amer Soc Reprod Med
C1 [Libby, V.; Reed, B.; Babayev, S. N.; Ezzati, M.; Ha, T. K.; Tan, O.; McIntire, D. D.; Carr, B.] UT Southwestern Med Ctr, Dallas, TX USA.
   [Doody, K.] Ctr Assisted Reprod, Bedford, TX USA.
CR BYRD W, 1990, FERTIL STERIL, V53, P521
   Freour T, 2009, INT J ANDROL, V32, P498, DOI 10.1111/j.1365-2605.2008.00886.x
   MARSHBURN PB, 1992, FERTIL STERIL, V58, P179
   Tan O, 2014, J ASSIST REPROD GEN, V31, P1147, DOI 10.1007/s10815-014-0306-0
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2015
VL 104
IS 3
SU S
MA P-400
BP E241
EP E242
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DR6NP
UT WOS:000380018900656
ER

PT J
AU Patounakis, G
   Richter, KS
   DeCherney, A
   Devine, K
AF Patounakis, G.
   Richter, K. S.
   DeCherney, A.
   Devine, K.
TI PRE-WASH SPERM MORPHOLOGY PREDICTS IUI OUTCOMES BY PREDICTING POST-WASH
   TOTAL MOTILE SPERM COUNT (TMSC): AN ANALYSIS OF 26,373 IUI CYCLES.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 71st Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 17-21, 2015
CL Baltimore, MD
SP Amer Soc Reprod Med
C1 [Patounakis, G.; DeCherney, A.] NIH, Bethesda, MD 20892 USA.
   [Richter, K. S.; Devine, K.] Shady Grove Fertil, Rockville, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2015
VL 104
IS 3
SU S
MA P-394
BP E239
EP E240
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DR6NP
UT WOS:000380018900651
ER

PT J
AU Almabhouh, FA
   Osman, K
   Fatimah, IS
   Sergey, G
   Gnanou, J
   Singh, HJ
AF Almabhouh, F. A.
   Osman, K.
   Fatimah, I. Siti
   Sergey, G.
   Gnanou, J.
   Singh, H. J.
TI Effects of leptin on sperm count and morphology in Sprague-Dawley rats
   and their reversibility following a 6-week recovery period
SO ANDROLOGIA
LA English
DT Article
DE 8-OHdG; DNA fragmentation; leptin; sperm count; sperm morphology
ID OXIDATIVE STRESS; SEMEN QUALITY; DNA FRAGMENTATION; MALE-INFERTILITY;
   ADULT-RAT; REPRODUCTION; RECEPTOR; HORMONE; LOCALIZATION; SPERMATOZOA
AB Altered epididymal sperm count and morphology following leptin treatment has been reported recently. This study examined the effects of 42days of leptin treatment on sperm count and morphology and their reversibility during a subsequent 56-day recovery period. Twelve-week-old male Sprague-Dawley rats were randomised into four leptin and four saline-treated control groups (n=6). Intraperitoneal injections of leptin were given daily (60gKg(-1) body weight) for 42days. Controls received 0.1ml of 0.9% saline. Leptin-treated animals and their respective age-matched controls were euthanised on either day 1, 21, 42 or 56 of recovery for collection of epididymal spermatozoa. Sperm concentration was determined using a Makler counting chamber. Spermatozoa were analysed for 8-hydroxy-2-deoxyguanosine and DNA fragmentation (Comet assay). Data were analysed using anova. Sperm concentration was significantly lower but fraction of abnormal spermatozoa, and levels of 8-hydroxy-2-deoxyguanosine were significantly higher in leptin-treated rats on day 1 of recovery. Comet assays revealed significant DNA fragmentation in leptin-treated rats. These differences were reduced by day 56 of recovery. It appears that 42days of leptin treatment to Sprague-Dawley rats has significant adverse effects on sperm count and morphology that reverse following discontinuation of leptin treatment.
C1 [Almabhouh, F. A.; Sergey, G.; Singh, H. J.] Univ Teknol MARA, Fac Med, Selangor 47000, Malaysia.
   [Osman, K.; Fatimah, I. Siti] Univ Kebangsaan Malaysia, Fac Allied Hlth Sci, Kuala Lumpur, Malaysia.
   [Gnanou, J.] Natl Def Univ Malaysia, Fac Med & Def Hlth, Selangor, Malaysia.
RP Singh, HJ (reprint author), Univ Teknol MARA, Fac Med, Sg Buloh Campus, Sg Buloh 47000, Selangor, Malaysia.
EM hjsingh@salam.uitm.edu.my
FU Fundamental Research Grant Scheme from the Ministry of Higher Education
   [(600-RMI/ST/FRGS5/3Fst) (60/2010)]
FX This study was funded under the Fundamental Research Grant Scheme from
   the Ministry of Higher Education (600-RMI/ST/FRGS5/3Fst) (60/2010).
CR Abbasihormozi S, 2013, ARCH GYNECOL OBSTET, V287, P1241, DOI 10.1007/s00404-012-2675-x
   Agarwal A, 2005, J ANDROL, V26, P654, DOI 10.2164/jandrol.05016
   Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)004948-8
   Aquila S, 2005, J CLIN ENDOCR METAB, V90, P4753, DOI 10.1210/jc.2004-2233
   Barash IA, 1996, ENDOCRINOLOGY, V137, P3144, DOI 10.1210/en.137.7.3144
   Barratt CLR, 2010, HUM REPROD, V25, P824, DOI 10.1093/humrep/dep465
   Chatterjee S, 2013, J HEPATOL, V58, P778, DOI 10.1016/j.jhep.2012.11.035
   Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100
   El-Hefnawy T, 2000, ENDOCRINOLOGY, V141, P2624, DOI 10.1210/en.141.7.2624
   Eskenazi B, 2003, HUM REPROD, V18, P447, DOI 10.1093/humrep/deg107
   Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437
   Ferretti G, 2014, J MATERN-FETAL NEO M, V27, P1353, DOI 10.3109/14767058.2013.858319
   Garcia-Peiro A, 2011, FERTIL STERIL, V95, P105, DOI 10.1016/j.fertnstert.2010.06.053
   Gomez E, 1998, INT J ANDROL, V21, P81
   Haluzik M, 2000, Cas Lek Cesk, V139, P259
   Haron MN, 2013, NOVUS INT J MED SCI, V2, P1
   Haron MN, 2010, FERTIL STERIL, V93, P322, DOI 10.1016/j.fertnstert.2009.07.995
   Kidd SA, 2001, FERTIL STERIL, V75, P237, DOI 10.1016/S0015-0282(00)01679-4
   Kumar MV, 2002, P NATL ACAD SCI USA, V99, P1921, DOI 10.1073/pnas.042683699
   Lampiao F, 2008, ASIAN J ANDROL, V10, P799, DOI 10.1111/j.1745-7262.2008.00421.x
   Makker K, 2009, INDIAN J MED RES, V129, P357
   Mantzoros CS, 2000, ANN NY ACAD SCI, V900, P174
   Mounzih K, 1997, ENDOCRINOLOGY, V138, P1190, DOI 10.1210/en.138.3.1190
   Narayana K, 2002, MUTAT RES-GEN TOX EN, V513, P193, DOI 10.1016/S1383-5718(01)00308-4
   Nguyen RHN, 2007, HUM REPROD, V22, P2488, DOI 10.1093/humrep/dem139
   Oliva R, 2006, HUM REPROD UPDATE, V12, P417, DOI 10.1093/humupd/dml009
   Palmer NO, 2012, SPERMATOGENESIS, V2, P253, DOI DOI 10.4161/SPMG.21362)
   Quennell JH, 2009, ENDOCRINOLOGY, V150, P2805, DOI 10.1210/en.2008-1693
   Sayed-Ahmed A, 2012, ACTA HISTOCHEM, V114, P185, DOI 10.1016/j.acthis.2011.04.008
   Shimizu H, 1997, INT J OBESITY, V21, P536, DOI 10.1038/sj.ijo.0800437
   Simon L, 2011, REPROD BIOMED ONLINE, V23, P724, DOI 10.1016/j.rbmo.2011.08.010
   Tripathi DN, 2008, TOXICOLOGY, V248, P96, DOI 10.1016/j.tox.2008.03.015
   Waelput W, 2006, CURR MED CHEM, V13, P465, DOI 10.2174/092986706775527929
   Zamorano PL, 1997, NEUROENDOCRINOLOGY, V65, P223, DOI 10.1159/000127276
   Zeng JB, 1997, AM J PHYSIOL-ENDOC M, V273, pE1102
NR 35
TC 0
Z9 0
U1 3
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-4569
EI 1439-0272
J9 ANDROLOGIA
JI Andrologia
PD SEP
PY 2015
VL 47
IS 7
BP 751
EP 758
DI 10.1111/and.12325
PG 8
WC Andrology
SC Endocrinology & Metabolism
GA CO0TJ
UT WOS:000358865400005
PM 25269426
ER

PT J
AU Afzalzadeh, MR
   Ahangarpour, A
   Amirzargar, A
   Varnamkhasti, MK
   Ganjalidarani, H
AF Afzalzadeh, Mohammad Reza
   Ahangarpour, Akram
   Amirzargar, Ashraf
   Varnamkhasti, Mohammad Kazemi
   Ganjalidarani, Hadi
TI The Effect of Vitis vinifera L. Juice on Serum Levels of Inhibin B,
   Sperm Count in Adult Male Rats
SO WORLD JOURNAL OF MENS HEALTH
LA English
DT Article
DE Inhibin B; Male rat; Sperm count
ID GRAPE POLYPHENOLS; AQUEOUS EXTRACT; SPERMATOGENESIS; ANTIOXIDANT
AB Purpose: Vitis vinifera is a species of Vitis that is native to the Mediterranean region, central Europe, and southwestern Asia, and has been used as a drug in traditional medicine. Traditional medicinal plants have been used for medical purposes with increasing effectiveness. It is important to identify drugs that inhibit spermatogenesis. Therefore, the present study aimed to investigate the effect of grape juice (GJ) on serum levels of inhibin B and sperm count in normal male rats.
   Materials and Methods: Thirty-five adult male rats were randomly divided into five groups, each containing seven rats. Rats in the control group received 1 mL of normal saline over the course of the study. The experimental groups received GJ (100, 200, 400, and 1,600 mg/kg, orally, for 35 days consecutively). At the end of the treatment period, fertility indices were measured, including body weight difference, sex organ weight, sperm motility and count, epididymal sperm reserve, daily sperm production (DSP), and serum inhibin B levels.
   Results: We found that GJ reduces body weight difference, was associated with decreased sperm motility and count in all treatment groups (p=0.05 and p=0.001, respectively). Moreover, DSP was significantly decreased in all treatment groups compared to the control group (p=0.05), except in the group receiving 100 mg/kg of GJ. Inhibin B levels were significantly decreased in all treatment groups (p=0.05).
   Conclusions: The results of our study suggest that GJ in all doses, but especially in higher doses, may decrease fertility in male rats.
C1 [Afzalzadeh, Mohammad Reza; Varnamkhasti, Mohammad Kazemi; Ganjalidarani, Hadi] Shahid Chamran Univ Ahvaz, Sch Vet Med, Dept Vet, Ahwaz, Iran.
   [Ahangarpour, Akram] Ahvaz Jundishapur Univ Med Sci, Hlth Res Inst, Diabet Res Ctr, Dept Physiol, Ahwaz 61335189, Iran.
   [Amirzargar, Ashraf] Jundishapur Univ Med Sci, Sch Med, Physiol Res Ctr, Dept Physiol, Ahwaz, Iran.
RP Ahangarpour, A (reprint author), Ahvaz Jundishapur Univ Med Sci, Hlth Res Inst, Diabet Res Ctr, Dept Physiol, Ahwaz 61335189, Iran.
EM akramahangarpour@gmail.com
CR Afzalzadeh MR, 2013, J PHYS PHARM ADV, V6, P159
   Ahangarpour Akram, 2014, World J Mens Health, V32, P151, DOI 10.5534/wjmh.2014.32.3.151
   Ahangarpour Akram, 2014, World J Mens Health, V32, P176, DOI 10.5534/wjmh.2014.32.3.176
   Al-Daraji HJ, 2012, AM J PHARM TECH RES, V2, P308
   Andersen ML, 2006, BRAIN RES REV, V51, P136, DOI 10.1016/j.brainresrev.2005.10.005
   Anderson RA, 2000, INT J ANDROL, V23, P136, DOI 10.1046/j.1365-2605.2000.00229.x
   Bazrafkan M, 2010, INT J PHARMACOL, V6, P926, DOI 10.3923/ijp.2010.926.929
   Boque N, 2013, J SCI FOOD AGR, V93, P1226, DOI 10.1002/jsfa.5884
   Bullock G, 2000, HDB EXPT ANIMALS LAB, P150
   Buzzard JJ, 2004, ENDOCRINOLOGY, V145, P3532, DOI 10.1210/en.2003-1036
   Castilla P, 2006, AM J CLIN NUTR, V84, P252
   Dadfar M, 2010, UROL J, V7, P110
   Favaron F, 2009, J PLANT PATHOL, V91, P579
   Gilber SF., 1997, DEV BIOL, P755
   Govand AA, 2012, IJBAS IJENS, V12, P59
   Hogan S, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-71
   Illingworth PJ, 1996, J CLIN ENDOCR METAB, V81, P1321, DOI 10.1210/jc.81.4.1321
   Kaushik MC, 2010, ANDROLOGIA, V42, P193, DOI 10.1111/j.1439-0272.2009.00979.x
   Krause W, 2002, HAUTARZT, V53, P5, DOI 10.1007/s105-002-8040-3
   Leifert WR, 2008, NUTR RES, V28, P729, DOI [10.1016/j.nutres.2008.08.007, 10.1016/j.nutres.2008.09.001]
   Mennen LI, 2005, AM J CLIN NUTR, V81, p326S
   Nikkhah R, 2010, HORTIC ENVIRON BIOTE, V51, P39
   Ola M, 2013, JORDAN J PHARM SCI, V6, P30
   Parandin R, 2009, ZUMS J, V16, P23
   Piyachaturawat R, 1998, PHARM BIOL, V36, P44
   Ramaswamy S, 2003, ENDOCRINOLOGY, V144, P1175, DOI 10.1210/en.2002-221078
   Razie S, 2011, ASIAN J BIOL SCI, V4, P70
   Srivastav A, 2010, REPROD TOXICOL, V29, P214, DOI 10.1016/j.reprotox.2009.11.001
   World Health Organization (WHO), 1983, APFIP9914E WHO
   Yakubu MT, 2007, ANDROLOGIA, V39, P235, DOI 10.1111/j.1439-0272.2007.00792.x
NR 30
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC SEXUAL MEDICINE & ANDROLOGY
PI GWANGJU
PA DEPT UROLOGY, CHONNAM NATL UNIV MEDICAL SCH, 671 JEBONG-RO, DONG-GU,
   GWANGJU, 501-757, SOUTH KOREA
SN 2287-4208
EI 2287-4690
J9 WORLD J MENS HEALTH
JI World J. Mens Health
PD AUG
PY 2015
VL 33
IS 2
BP 109
EP 115
DI 10.5534/wjmh.2015.33.2.109
PG 7
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA DI6SR
UT WOS:000373631000009
ER

PT J
AU Lee, WK
AF Lee, Won Ki
TI The Effect of Vitis vinifera L. Juice on Serum Levels of Inhibin B,
   Sperm Count in Adult Male Rats COMMENTS
SO WORLD JOURNAL OF MENS HEALTH
LA English
DT Editorial Material
ID TRANS-RESVERATROL; BOTRYTIS-CINEREA; GRAPE; EXTRACTS
C1 [Lee, Won Ki] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Urol, Chunchon, South Korea.
RP Lee, WK (reprint author), Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Urol, Chunchon, South Korea.
CR Favaron F, 2009, J PLANT PATHOL, V91, P579
   Mullen W, 2007, J AGR FOOD CHEM, V55, P3148, DOI 10.1021/jf062970x
   Murthy KNC, 2002, J AGR FOOD CHEM, V50, P5909, DOI 10.1021/jf0257042
   Sapanidou VG, 2014, J BIOL RES-THESSALON, V21, P1, DOI 10.1186/2241-5793-21-19
   Soleas GJ, 1997, J CLIN LAB ANAL, V11, P287, DOI 10.1002/(SICI)1098-2825(1997)11:5<287::AID-JCLA6>3.0.CO;2-4
   Stagos D, 2006, MUTAT RES-GEN TOX EN, V609, P165, DOI 10.1016/j.mrgentox.2006.06.032
   Timperio AM, 2012, PLANT PHYSIOL BIOCH, V50, P65, DOI 10.1016/j.plaphy.2011.07.008
NR 7
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC SEXUAL MEDICINE & ANDROLOGY
PI GWANGJU
PA DEPT UROLOGY, CHONNAM NATL UNIV MEDICAL SCH, 671 JEBONG-RO, DONG-GU,
   GWANGJU, 501-757, SOUTH KOREA
SN 2287-4208
EI 2287-4690
J9 WORLD J MENS HEALTH
JI World J. Mens Health
PD AUG
PY 2015
VL 33
IS 2
BP 115
EP 116
PG 2
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA DI6SR
UT WOS:000373631000010
ER

PT J
AU Hamilton, JAM
   Cissen, M
   Brandes, M
   Smeenk, JMJ
   de Bruin, JP
   Kremer, JAM
   Nelen, WLDM
   Hamilton, CJCM
AF Hamilton, J. A. M.
   Cissen, M.
   Brandes, M.
   Smeenk, J. M. J.
   de Bruin, J. P.
   Kremer, J. A. M.
   Nelen, W. L. D. M.
   Hamilton, C. J. C. M.
TI Total motile sperm count: a better indicator for the severity of male
   factor infertility than the WHO sperm classification system
SO HUMAN REPRODUCTION
LA English
DT Article
DE semen analysis; total motile sperm count; World health organization
   criteria; spontaneous ongoing pregnancy rate; male subfertility
ID HUMAN SEMEN CHARACTERISTICS; INTRAUTERINE INSEMINATION; SUBFERTILE
   COUPLES; SPONTANEOUS PREGNANCY; REFERENCE VALUES; PREDICTION;
   POPULATION; PARAMETERS; MORPHOLOGY; FERTILITY
AB STUDY QUESTION: Does the prewash total motile sperm count (TMSC) have a better predictive value for spontaneous ongoing pregnancy (SOP) than the World Health Organization (WHO) classification system?
   SUMMARY ANSWER: The prewash TMSC shows a better correlation with the spontaneous ongoing pregnancy rate (SOPR) than the WHO 2010 classification system.
   WHAT IS KNOWN ALREADY: According to the WHO classification system, an abnormal semen analysis can be diagnosed as oligozoospermia, astenozoospermia, teratozoospermia or combinations of these and azoospermia. This classification is based on the fifth percentile cut-off values of a cohort of 1953 men with proven fertility. Although this classification suggests accuracy, the relevance for the prognosis of an infertile couple and the choice of treatment is questionable. The TMSC is obtained by multiplying the sample volume by the density and the percentage of A and B motility spermatozoa.
   STUDY DESIGN, SIZE, DURATION: We analyzed data from a longitudinal cohort study among unselected infertile couples who were referred to three Dutch hospitals between January 2002 and December 2006. Of the total cohort of 2476 infertile couples, only the couples with either male infertility as a single diagnosis or unexplained infertility were included (n = 1177) with a follow-up period of 3 years.
   PARTICIPANTS/MATERIALS, SETTING, METHODS: In all couples a semen analysis was performed. Based on the best semen analysis if more tests were performed, couples were grouped according to the WHO classification system and the TMSC range, as described in the Dutch national guidelines for male infertility. The primary outcome measure was the SOPR, which occurred before, during or after treatments, including expectant management, intrauterine insemination, in vitro fertilization or intracytoplasmic sperm injection. After adjustment for the confounding factors (female and male age, duration and type of infertility and result of the postcoital test) the odd ratios (ORs) for risk of SOP for each WHO and TMSC group were calculated. The couples with unexplained infertility were used as reference.
   MAIN RESULTS AND THE ROLE OF CHANCE: A total of 514 couples did and 663 couples did not achieve a SOP. All WHO groups have a lower SOPR compared with the unexplained group (ORs varying from 0.136 to 0.397). Comparing the couples within the abnormal WHO groups, there are no significant differences in SOPR, except when oligoasthenoteratozoospermia is compared with asthenozoospermia [OR 0.501 (95% CI 0.311-0.809)] and teratozoospermia [OR 0.499 (95% CI: 0.252-0.988)], and oligoasthenozoospermia is compared with asthenozoospermia [OR 0.572 (95% CI: 0.373-0.877)]. All TMSC groups have a significantly lower SOPR compared with the unexplained group (ORs varying from 0.171 to 0.461). Couples with a TMSC of <1 x 10(6) and 1-5 x 10(6) have significantly lower SOPR compared with couples with a TMSC of 5-10 x 10(6) [respectively, OR 0.371 (95% CI: 0.215-0.64) and OR 0.505 (95% CI: 0.307-0.832)].
   LIMITATIONS, REASON FOR CAUTION: To include all SOPs during the follow-up period of 3 years, couples were not censured at the start of treatment.
   WIDER IMPLICATIONS OF THE FINDINGS: Roughly, three prognostic groups can be discerned: couples with a TMSC<5, couples with a TMSC between 5 and 20 and couples with a TMSC of more than 20 x 10(6) spermatozoa. We suggest using TMSC as the method of choice to express severity of male infertility.
C1 [Hamilton, J. A. M.; Cissen, M.; de Bruin, J. P.; Hamilton, C. J. C. M.] Jeroen Bosch Hosp, Shertogenbosch, Netherlands.
   [Smeenk, J. M. J.] St Elizabeth Hosp, Tilburg, Netherlands.
   [Brandes, M.; Kremer, J. A. M.; Nelen, W. L. D. M.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.
RP Hamilton, JAM (reprint author), Jeroen Bosch Hosp, Shertogenbosch, Netherlands.
EM jozefienhamilton@gmail.com
RI Nelen, Willianne/N-4239-2013; Kremer, J.A.M./H-8063-2014
CR American Fertility Society, 1985, FERTIL STERIL, V43, P351
   Ayala C, 1996, J ANDROL, V17, P718
   Badawy A, 2009, FERTIL STERIL, V91, P777, DOI 10.1016/j.fertnstert.2007.12.010
   Bensdorp AJ, 2013, HUM REPROD, V28, pi71
   Brandes M, 2011, INT J ANDROL, V34, P614, DOI 10.1111/j.1365-2605.2010.01128.x
   Brandes M, 2011, REPROD BIOMED ONLINE, V22, P192, DOI 10.1016/j.rbmo.2010.10.013
   Brandes M, 2011, HUM REPROD, V26, P360, DOI 10.1093/humrep/deq349
   Cissen M, 2004, MALE SUBFERTILITY TR
   Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048
   Deveneau NE, 2014, FERTIL STERIL, V102, P1584, DOI 10.1016/j.fertnstert.2014.09.016
   EIMERS JM, 1994, FERTIL STERIL, V61, P44
   Esteves SC, 2012, UROLOGY, V79, P16, DOI 10.1016/j.urology.2011.08.003
   HULL MGR, 1985, BRIT MED J, V291, P1693
   Hunault CC, 2004, HUM REPROD, V19, P2019, DOI 10.1093/humrep/deh365
   Kurger TF, 1988, FERTIL STERIL, V49, P112
   Nederlands Huisartsen Genootschap (NHG) NVOG NVU KLEM NVKC, 2011, NETW SUBF
   NVOG, 2004, RICHTL OR FERT
   Ombelet W, 1997, HUM REPROD, V12, P987
   Opsahl MS, 1996, J REPROD MED, V41, P313
   POLANSKY FF, 1988, FERTIL STERIL, V49, P1059
   SMITH KD, 1977, FERTIL STERIL, V28, P1314
   van der Steeg JW, 2007, HUM REPROD, V22, P536, DOI 10.1093/humrep/del378
   van der Steeg JW, 2011, FERTIL STERIL, V95, P1013, DOI 10.1016/j.fertnstert.2010.02.024
   van Rumste MME, 2014, REPROD BIOMED ONLINE, V28, P336, DOI 10.1016/j.rbmo.2013.10.021
   van Weert JM, 2004, FERTIL STERIL, V82, P612, DOI 10.1016/j.fertnstert.2004.01.042
   WHO, 1999, WHO LAB MAN EX HUM S, P128
   WHO, 2010, WHO LAB MAN EX PROC, P223
   [Anonymous], 2013, ASS TREATM PEOPL FER
NR 28
TC 5
Z9 5
U1 1
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD MAY
PY 2015
VL 30
IS 5
BP 1110
EP 1121
DI 10.1093/humrep/dev058
PG 12
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA CI5JQ
UT WOS:000354792100012
PM 25788568
ER

PT J
AU Ahangarpour, A
   Oroojan, AA
   Heidari, H
   Ghaedi, E
   Taherkhani, R
AF Ahangarpour, Akram
   Oroojan, Ali Akbar
   Heidari, Hamid
   Ghaedi, Ehsan
   Taherkhani, Reza
TI Effects of Hydro-alcoholic Extract from Arctium lappa L. (Burdock) Root
   on Gonadotropins, Testosterone, and Sperm Count and Viability in Male
   Mice with Nicotinamide/ Streptozotocin-Induced Type 2 Diabetes
SO MALAYSIAN JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE Arctium lappa; diabetes; gonadotropin; testosterone; sperm
ID RATS; SPERMATOGENESIS; PARAMETERS; MELLITUS; TESTIS; MOUSE
AB Background: Reproductive dysfunction is a complication of diabetes. Arctium lappa (burdock) root has hypoglycemic and antioxidative properties, which are traditionally used for treatment of impotence and sterility. Therefore, the aim of this study is to investigate the effects of its hydro alcoholic extract on gonadotropin, testosterone, and sperm parameters in nicotinamide/streptozotocin-induced diabetic mice.
   Methods: In this experimental study, 56 adult male Naval Medical Research Institute (NMRI) mice (30-35 g) were randomly divided into seven groups: control, diabetes, diabetes + glibenclamide (0.25 mg/kg), diabetes + extract (200 or 300 mg/kg), and extract (200 or 300 mg/kg). Diabetes was induced with intraperitoneal injection of nicotinamide (NA) and streptozotocin (STZ). Twenty-four hours after the last extract and drug administration, serum samples, testes, and cauda epididymis were removed immediately for experimental assessment.
   Results: Body weight, serum luteinizing hormone (LH), follicle stimulating hormone (FSH), and testosterone levels, and sperm count (P < 0.05) and viability (P < 0.01) decreased in diabetic mice. Administration of glibenclamide significantly improved these reductions in diabetic animals (P < 0.05). However, the hydro alcoholic extract (300 mg/kg) enhanced sperm viability only in diabetic mice (P < 0.01). In addition, this dose of extract increased sperm count, LH, FSH, and testosterone in nondiabetic animals compared with the control group (P < 0.05).
   Conclusion: The results indicate that applied burdock root extract has anti-infertility effects in nondiabetic mice. Hence, this part of the A. lappa plant has an effect on the health of the reproductive system in order to improve diabetic conditions.
C1 [Ahangarpour, Akram] Ahvaz Jundishapur Univ Med Sci, Dept Physiol, Diabet Res Ctr, Hlth Res Inst, Ahwaz 61335189, Iran.
   [Heidari, Hamid] Qom Univ Med Sci, Sch Med, Dept Physiol, Qom 3715835155, Iran.
   [Taherkhani, Reza] Bushehr Univ Med Sci, Dept Microbiol & Parasitol, Fac Med, Bushehr 7514633341, Iran.
EM aliakbar_oroojan@yahoo.com
CR Adaramoye Oluwatosin, 2012, Niger J Physiol Sci, V27, P137
   Agarwal A, 2012, STUDIES MENS HLTH FE, V1st
   Ahangarpour A, 2014, ACTA ENDOCRINOL-BUCH, V10, P588, DOI 10.4183/aeb.2014.588
   Ahangarpour A, 2013, ZUMS J, V21, P22
   Ahangarpour Akram, 2012, Iran J Med Sci, V37, P181
   Ahangarpour Akram, 2014, Iran J Reprod Med, V12, P65
   Ahangarpour Akram, 2014, Malays J Med Sci, V21, P12
   Ahangarpour Akram, 2014, World J Mens Health, V32, P151, DOI 10.5534/wjmh.2014.32.3.151
   Ahangarpour Akram, 2014, World J Mens Health, V32, P176, DOI 10.5534/wjmh.2014.32.3.176
   Aitken RJ, 2009, ADV EXP MED BIOL, V636, P154, DOI [10.1007/978-0-387-09597-4_9, DOI 10.1007/978-0-387-09597-4_]
   Altay B, 2003, FERTIL STERIL, V80, P828, DOI 10.1016/S0015-0282(03)00984-1
   Amaral S, 2006, THERIOGENOLOGY, V66, P2056, DOI 10.1016/j.theriogenology.2006.06.006
   Cao JianFeng, 2012, African Journal of Biotechnology, V11, P9079
   Jian Feng C, 2012, BMC COMPLEM ALTERN M, V12, P8, DOI [10.1186/1472-6882-12-8, DOI 10.1186/1472-6882-12-8]
   Ferracane R, 2010, J PHARMACEUT BIOMED, V51, P399, DOI 10.1016/j.jpba.2009.03.018
   Gauthaman K, 2008, PHYTOMEDICINE, V15, P44, DOI 10.1016/j.phymed.2007.11.011
   Goycheva P, 2006, TRAKIA J SCI, V4, P1
   Guyton A, 2006, TXB MED PHYSL, P974
   Kalyani Rita R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P226, DOI 10.1097/MED.0b013e32814db856
   La Vignera S, 2012, J ANDROL, V33, P145, DOI 10.2164/jandrol.111.013193
   Perez-Gutierrez RM, 2012, BIOL PHARM BULL, V35, P1516
   Martinez-Pastor F, 2009, REPRODUCTION, V137, P225, DOI 10.1530/REP-08-0357
   Padee P, 2010, J ETHNOPHARMACOL, V132, P491, DOI 10.1016/j.jep.2010.07.056
   Rabbani SI, 2010, PAK J PHARM SCI, V23, P326
   Rabbani Syed Imam, 2010, J Pharmacol Pharmacother, V1, P18, DOI 10.4103/0976-500X.64531
   Ratnasooriya WD, 2008, J ETHNOPHARMACOL, V118, P373, DOI 10.1016/j.jep.2008.04.023
   Shrilatha B, 2007, REPROD TOXICOL, V23, P578, DOI 10.1016/j.reprotox.2007.02.001
   Singh A, 2009, CONTRACEPTION, V79, P71, DOI 10.1016/j.contraception.2008.07.023
   Talebi AR, 2013, J ASSIST REPROD GEN, V30, P1203, DOI 10.1007/s10815-013-0078-y
   Tiwari AK, 2002, CURR SCI INDIA, V83, P30
   Tomar R, 2006, DIABETES CARE, V29, P1120, DOI 10.2337/dc06-0197
NR 31
TC 1
Z9 1
U1 1
U2 1
PU UNIV SAINS MALAYSIA, SCH MEDICAL SCIENCES
PI KELANTAN
PA HEALTH CAMPUS, 16150 KUBANG KERIAN, KELANTAN, 00000, MALAYSIA
SN 1394-195X
EI 2180-4303
J9 MALAYS J MED SCI
JI Malays. J. Med. Sci.
PD MAR-APR
PY 2015
VL 22
IS 2
BP 25
EP 32
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CR3GY
UT WOS:000361221000004
PM 26023292
ER

PT J
AU Zhang, HG
   Wang, RX
   Li, LL
   Sun, WT
   Zhang, HY
   Liu, RZ
AF Zhang, H. G.
   Wang, R. X.
   Li, L. L.
   Sun, W. T.
   Zhang, H. Y.
   Liu, R. Z.
TI Male carriers of balanced reciprocal translocations in Northeast China:
   sperm count, reproductive performance, and genetic counseling
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Sperm count; Balanced translocation; Genetic counseling; Reproductive
   performance
ID MALE-INFERTILITY; CHROMOSOMAL TRANSLOCATIONS; MEIOTIC SEGREGATION;
   COUPLES; ABNORMALITIES; BREAKPOINTS; SPERMATOZOA
AB Balanced chromosomal translocations in men can cause failure of spermatogenesis owing to meiotic impairment. Male carriers may exhibit normozoospermia, although clinical manifestations can include oligozoospermia or azoospermia, oligozoospermia or normozoospermia. Here, we reported the characteristics of balanced reciprocal translocations in men from northeastern China, and explored the relationship between sperm count and reproductive performance, to enable informed genetic counseling. The frequency of balanced reciprocal translocations was found to be 1.62%. Semen analysis showed that 5.9% of male carriers had azoospermia, 43.1% had oligozoospermia, and 51.0% had normozoospermia. Of the 25 men with a balanced reciprocal translocation and azoospermia or oligozoospermia, chromosome 1 was the most commonly often involved in the translocation. However, in the 26 normozoospermic men with a balanced reciprocal translocation and normozoospermia, chromosome 3 was most commonly implicated. Fifty percent of men with a balanced reciprocal translocation conceived a pregnancy that went to term. Our data suggest that of all chromosomes, chromosomes 1 and 3 are the most commonly involved chromosomes in balanced reciprocal such translocations in northeastern Chinese men. Karyotype analysis should be performed for men with azoospermia, oligozoospermia, and those in couples having suffered recurrent miscarriages. Natural conception should be discussed during genetic counseling for male carriers of balanced chromosomal translocations with normozoospermia.
C1 [Zhang, H. G.; Wang, R. X.; Li, L. L.; Sun, W. T.; Zhang, H. Y.; Liu, R. Z.] Jilin Univ, Hosp 1, Ctr Prenatal Diag, Ctr Reprod Med, Changchun 130023, Jilin, Peoples R China.
RP Liu, RZ (reprint author), Jilin Univ, Hosp 1, Ctr Prenatal Diag, Ctr Reprod Med, Changchun 130023, Jilin, Peoples R China.
EM lrz410@126.com
FU National Natural Science Fund [81471515]
FX We express our sincere gratitude to all the staff of the Genetics
   Laboratory, Center for Prenatal Diagnosis, First Hospital, Jilin
   University, for their excellent work. This work was supported by the
   National Natural Science Fund (#81471515).
CR Akbari Mohammad T, 2012, Indian J Hum Genet, V18, P198, DOI 10.4103/0971-6866.100764
   Ananthapur V, 2014, ANDROLOGIA, V46, P453, DOI 10.1111/and.12120
   Bache I, 2004, EUR J HUM GENET, V12, P993, DOI 10.1038/sj.ejhg.5201263
   Bianco B, 2011, ANDROLOGIA, V43, P145, DOI 10.1111/j.1439-0272.2009.01020.x
   Braun-Falco M, 2007, J ANDROL, V28, P647, DOI 10.2164/jandrol.106.002030
   Chang EM, 2012, J ASSIST REPROD GEN, V29, P67, DOI 10.1007/s10815-011-9654-1
   Ching Christina B, 2012, Curr Urol, V6, P37, DOI 10.1159/000338868
   Flynn H, 2014, J OBSTET GYNAECOL RE, V40, P109, DOI 10.1111/jog.12133
   Godo A, 2013, HUM REPROD, V28, P840, DOI 10.1093/humrep/des431
   Kara Murat, 2014, Eurasian J Med, V46, P220, DOI 10.5152/eajm.2014.33
   Keify F, 2012, ARCH IRAN MED, V15, P249, DOI 012154/AIM.0016
   Kim JW, 2011, FERTIL STERIL, V95, P349, DOI 10.1016/j.fertnstert.2010.08.014
   Kochhar PK, 2013, J OBSTET GYNAECOL RE, V39, P113, DOI 10.1111/j.1447-0756.2012.01905.x
   Li L, 2014, GENE, V547, P43, DOI 10.1016/j.gene.2014.06.007
   Olesen C, 2001, MOL HUM REPROD, V7, P11, DOI 10.1093/molehr/7.1.11
   Ozawa N, 2008, FERTIL STERIL, V90, P1301, DOI 10.1016/j.fertnstert.2007.09.051
   Pernice F, 2002, FERTIL STERIL, V78, P192, DOI 10.1016/S0015-0282(02)03180-1
   Resim S, 2013, BALK MED J, V30, P250, DOI 10.5152/balkanmedj.2012.107
   Venkateshwari A, 2011, ANDROLOGIA, V43, P428, DOI 10.1111/j.1439-0272.2010.01069.x
   Vozdova M, 2012, HUM REPROD, V27, P930, DOI 10.1093/humrep/der445
   Vozdova M, 2011, FERTIL STERIL, V96, pE66, DOI 10.1016/j.fertnstert.2011.04.042
   Vozdova M, 2008, HUM REPROD, V23, P581, DOI 10.1093/humrep/dem345
   Vozdova M, 2013, J ASSIST REPROD GEN, V30, P391, DOI 10.1007/s10815-012-9921-9
   Zhang HG, 2015, GENET MOL RES, V14, P2809, DOI 10.4238/2015.March.31.11
NR 24
TC 1
Z9 1
U1 0
U2 0
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2015
VL 14
IS 4
BP 18792
EP 18798
DI 10.4238/2015.December.28.28
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DF8DN
UT WOS:000371587400157
PM 26782529
ER

PT J
AU Pereira, MC
   Vieira, MM
   Pereira, JS
AF Pereira, Maria Conceicao
   Vieira, Margarida M.
   Pereira, Joana Simoes
TI Sperm Count Improvement in a Cancer-Surviving Patient
SO CASE REPORTS IN ONCOLOGY
LA English
DT Article
DE Aromatase inhibitors; Testosterone; Gonadotropins; Oligospermia;
   Oncological diseases
ID AROMATASE INHIBITION; ELDERLY-MEN; TESTOSTERONE; FERTILITY; OBESITY
AB Objective: To describe the case of a cancer-surviving patient who was treated with an aromatase inhibitor for fertility reasons with successful results. Clinical Case: A 30-year-old patient from our institute who had been submitted to bone marrow transplantation in the past as part of treatment for Hodgkin's disease had revealed oligospermia several times. His sperm count mean value was 33,500 cells/ml. He was treated with an aromatase inhibitor (letrozole, 2 mg/day) for 8 months. After this period, his sperm count had increased significantly to 1,000,000 cells/ml. Conclusion: A large number of cancer survivors express a wish for having babies. After their cure, a lot of them have a low count of spermatozoids, and we think that our results show an easy way of helping them. (C) 2015 S. Karger AG, Basel
C1 [Pereira, Maria Conceicao; Vieira, Margarida M.; Pereira, Joana Simoes] Portuguese Canc Inst, Dept Endocrinol, P-1099023 Lisbon, Portugal.
RP Pereira, MC (reprint author), Portuguese Canc Inst, Dept Endocrinol, Rua Prof Lima Basto, P-1099023 Lisbon, Portugal.
EM mcmspereira@hotmail.com
CR Cohen PG, 1999, MED HYPOTHESES, V52, P49, DOI 10.1054/mehy.1997.0624
   Gillam MP, 2002, J CLIN ENDOCR METAB, V87, P4447, DOI 10.1210/jc.2002-020426
   Gudeloglu A, 2014, SEMIN REPROD MED, V32, P313, DOI 10.1055/s-0034-1375184
   Harden C, 2004, EPILEPSY BEHAV, V5, P260, DOI 10.1016/j.yebeh.2003.12.001
   Jung Jae Hung, 2014, Clin Exp Reprod Med, V41, P108, DOI 10.5653/cerm.2014.41.3.108
   Leder BZ, 2004, J CLIN ENDOCR METAB, V89, P1174, DOI 10.1210/jc.2003-031467
   Raman LD, 2002, J UROL 1, V167, P624
   Stephens SM, 2013, SEMIN REPROD MED, V31, P251, DOI 10.1055/s-0033-1345272
   Stokes VJ, 2015, CLIN ENDOCRINOL, V82, P633, DOI 10.1111/cen.12591
   T'Sjoen GG, 2005, J CLIN ENDOCR METAB, V90, P5717, DOI 10.1210/jc.2005-0982
   Zumoff B, 2003, METABOLISM, V52, P1126, DOI 10.1016/S0026-0495(03)00186-0
NR 11
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1662-6575
J9 CASE REP ONCOL
JI Case Rep. Oncol.
PY 2015
VL 8
IS 2
BP 301
EP 307
DI 10.1159/000438668
PG 7
GA CU2TB
UT WOS:000363375300016
PM 26351438
ER

PT J
AU Si, JL
   Li, P
   Xin, QB
   Li, XW
   An, LH
   Li, J
AF Si, Jiliang
   Li, Peng
   Xin, Quanbing
   Li, Xuewen
   An, Lihong
   Li, Jie
TI Perinatal Exposure to Low Doses of Tributyltin Chloride Reduces Sperm
   Count and Quality in Mice
SO ENVIRONMENTAL TOXICOLOGY
LA English
DT Article
DE organotin; mouse; low dose; spermatogenesis; endocrine disruptor
ID ENDOCRINE-DISRUPTING CHEMICALS; 2-GENERATION REPRODUCTIVE TOXICITY;
   TRI-N-BUTYLTIN; ORGANOTIN COMPOUNDS; BISPHENOL-A; SWISS MICE; MALE RATS;
   IN-UTERO; NEURONS; SPERMATOGENESIS
AB Exposure to endocrine disruptors (EDs) during early development might lead to adverse health outcomes later in life. Tributyltin (TBT), a proven ED, is widely used in consumer goods and industrial products. Herein we demonstrate the effects of low doses of tributyltin chloride (TBTCl) on reproduction of male KM mice. Pregnant mice were administered by gavage with 0, 1, 10, or 100 g TBTCl/kg body weight/day from day 6 of pregnancy through the period of lactation. TBTCl dramatically decreased sperm counts and motility on postnatal days (PNDs) 49 and 152. Meanwhile, a significant increase in sperm abnormality was observed in exposed mice on PND 49, but comparable to that in the control on PND 152. The histopathological analysis of testes of treated animals showed a dose-dependent increase in sloughing of germ cells in seminiferous tubules. Mice treated with 10 g TBTCl/kg exhibited decreased intratesticular 17-estradiol (E2) levels on PND 49, and then followed by an obvious recovery on PND 152. While, no significant differences in serum E2, testosterone (T) levels and intratesticular T levels were detectable between control and TBTCl-exposed offspring at the sacrifice. These results suggest that perinatal TBTCl exposure is implicated in causing long lasting alterations in male reproductive system and these changes may persist far into adulthood. (c) 2013 Wiley Periodicals, Inc. Environ Toxicol 30: 44-52, 2015.
C1 [Si, Jiliang; Xin, Quanbing; Li, Xuewen; An, Lihong; Li, Jie] Shandong Univ, Dept Environm Hlth, Sch Publ Hlth, Jinan 250100, Peoples R China.
   [Li, Peng] Shandong Univ, Dept OB GYN Qilu Hosp, Jinan 250100, Peoples R China.
RP Si, JL (reprint author), Shandong Univ, Dept Environm Hlth, Sch Publ Hlth, Jinan 250100, Peoples R China.
EM sjlsdu@sdu.edu.cn
FU Science Foundation for the Excellent Youth Scholars of Shandong Province
   of China [BS2010SF014]
FX Contract grant sponsor: Science Foundation for the Excellent Youth
   Scholars of Shandong Province of China. Contract grant number:
   BS2010SF014
CR Adeeko A, 2003, TOXICOL SCI, V74, P407, DOI 10.1093/toxsci/kfg131
   Barker D.J.P., 2004, J AM COLL NUTR, V23, P588
   CARLSEN E, 1992, BRIT MED J, V305, P609
   Chamorro-Garcia R, 2013, ENVIRON HEALTH PERSP, V121, P359, DOI 10.1289/ehp.1205701
   Chapin RE, 1997, FUND APPL TOXICOL, V38, P129, DOI 10.1006/faat.1997.2341
   Chen YF, 2008, TOXICOLOGY, V251, P21, DOI 10.1016/j.tox.2008.06.015
   Cheng CY, 2011, SPERMATOGENESIS, V1, P2, DOI DOI 10.4161/SPMG.1.1.13971
   Chung JY, 2011, ENVIRON HEALTH PERSP, V119, P1569, DOI 10.1289/ehp.1003391
   Cooke GM, 2004, FOOD CHEM TOXICOL, V42, P211, DOI 10.1016/j.fct.2003.09.003
   Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002
   Foster WG, 2010, ENVIRON HEALTH PERSP, V118, P458, DOI 10.1289/ehp.0901084
   Fritz WA, 2003, J NUTR, V133, P2287
   GARNER DL, 1995, BIOL REPROD, V53, P276, DOI 10.1095/biolreprod53.2.276
   Graceli JB, 2013, REPROD TOXICOL, V36, P40, DOI 10.1016/j.reprotox.2012.11.008
   Grote K, 2004, TOXICOLOGY, V202, P145, DOI 10.1016/j.tox.2004.05.003
   Grun F, 2006, MOL ENDOCRINOL, V20, P2141, DOI 10.1210/me.2005-0367
   Kaiser J, 2003, SCIENCE, V302, P376, DOI 10.1126/science.302.5644.376
   Kanemoto Y, 2002, BRIT J PHARMACOL, V136, P201, DOI 10.1038/sj.bjp.0704707
   Kishimoto K, 2001, J PHARMACOL EXP THER, V299, P171
   Kuriyama SN, 2005, ENVIRON HEALTH PERSP, V113, P149, DOI 10.1289/ehp.7421
   Merzenich H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-24
   Myers JP, 2009, ENVIRON HEALTH PERSP, V117, P1652, DOI 10.1289/ehp.0900887
   Nakanishi T, 2008, J TOXICOL SCI, V33, P269, DOI 10.2131/jts.33.269
   Nakatsu Y, 2009, TOXICOL APPL PHARM, V240, P292, DOI 10.1016/j.taap.2009.06.024
   Narayana K, 2005, MUTAT RES-GEN TOX EN, V588, P28, DOI 10.1016/j.mrgentox.2005.08.012
   O'Donnell L, 2001, ENDOCR REV, V22, P289, DOI 10.1210/er.22.3.289
   Oetken M, 2004, INT REV CYTOL, V236, P1, DOI 10.1016/S0074-7696(04)36001-8
   Omura M, 2001, TOXICOL SCI, V64, P224, DOI 10.1093/toxsci/64.2.224
   Penza M, 2011, TOXICOL APPL PHARM, V255, P65, DOI 10.1016/j.taap.2011.05.017
   Saunders PTK, 1997, ADV EXP MED BIOL, V424, P99
   Shi GQ, 2009, ENVIRON HEALTH PERSP, V117, P379, DOI 10.1289/ehp.11865
   Si JL, 2011, ENVIRON TOXICOL, V26, P307, DOI 10.1002/tox.20560
   Si JL, 2012, ENVIRON TOXICOL, V27, P662, DOI 10.1002/tox.21756
   Si JL, 2012, ENVIRON TOXICOL, V27, P605, DOI 10.1002/tox.20753
   Smith BS, 1971, J MOLLUS STUD, V39, P377
   Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87
   Svechnikov K, 2010, J BIOMED BIOTECHNOL, V2010, DOI [DOI 10.1155/2010/684504, 10.1155/2010/68450420862379]
   Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055
   Tyl RW, 2008, TOXICOL SCI, V104, P362, DOI 10.1093/toxsci/kfn084
   Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021
   Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050
   Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494
   Wysocki P, 2006, THERIOGENOLOGY, V66, P2152, DOI 10.1016/j.theriogenology.2006.07.002
   Yamada J, 2010, TOXICOL LETT, V198, P282, DOI 10.1016/j.toxlet.2010.07.011
   Yan FH, 2009, ENVIRON TOXICOL PHAR, V28, P19, DOI 10.1016/j.etap.2009.01.011
   Yu WJ, 2003, J VET MED SCI, V65, P1331, DOI 10.1292/jvms.65.1331
NR 46
TC 1
Z9 2
U1 3
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1520-4081
EI 1522-7278
J9 ENVIRON TOXICOL
JI Environ. Toxicol.
PD JAN
PY 2015
VL 30
IS 1
BP 44
EP 52
DI 10.1002/tox.21892
PG 9
WC Environmental Sciences; Toxicology; Water Resources
SC Environmental Sciences & Ecology; Toxicology; Water Resources
GA AX2LI
UT WOS:000346775000004
PM 23913619
ER

PT J
AU Kleppe, M
   van Hooff, MH
   Rhemrev, JP
AF Kleppe, M.
   van Hooff, M. H.
   Rhemrev, J. P.
TI Effect of total motile sperm count in intra-uterine insemination on
   ongoing pregnancy rate
SO ANDROLOGIA
LA English
DT Article
DE Intra-uterine insemination; pregnancy rate; semen quality
ID SUCCESS; MORPHOLOGY
AB In a descriptive retrospective cohort study, we determined the cumulative pregnancy rate for couples undergoing intra-uterine insemination (IUI) with at least one total motile sperm count (TMC) <1million compared to couples with a TMC consistently >1million. Eight hundred and ninety-five cycles in 273 couples were studied from 2006 to 2009. In 895 cycles, ovarian stimulation was performed through recFSH injections. IUI was scheduled 38 +/- 2h after the administration of HCG when at least one follicle measured >18mm. The cumulative pregnancy rate according to the TMC was calculated. The cumulative pregnancy rate after four cycles of IUI was 17.3% in couples with at least one TMC <1million and 25.5% in couples with a TMC consistently >1million. It is concluded that the TMC does not significantly influence cumulative pregnancy rates after 4 IUI cycles. Couples with a low TMC could benefit from IUI. This could be considered before IVF.
C1 [Kleppe, M.] Maastricht Univ, Med Ctr, Dept Obstet & Gynaecol, NL-6202 AZ Maastricht, Netherlands.
   [Kleppe, M.; Rhemrev, J. P.] Bronovo Hosp, Dept Obstet & Gynaecol, The Hague, Netherlands.
   [van Hooff, M. H.] St Franciscus Gasthuis, Dept Obstet & Gynaecol, Rotterdam, Netherlands.
RP Kleppe, M (reprint author), Maastricht Univ, Med Ctr, Dept Obstet & Gynaecol, POB 5800, NL-6202 AZ Maastricht, Netherlands.
EM marjolein.kleppe@mumc.nl
CR Badawy A, 2009, FERTIL STERIL, V91, P777, DOI 10.1016/j.fertnstert.2007.12.010
   Cantineau AE, 2010, COCHRANE DB SYST REV, P1
   Claman P, 2004, FERTIL STERIL, V82, P13, DOI 10.1016/j.fertnstert.2003.09.081
   Daya S, 2005, HUM REPROD, V20, P1135, DOI 10.1093/humrep/deh889
   Dickey RP, 1999, FERTIL STERIL, V71, P684, DOI 10.1016/S0015-0282(98)00519-6
   Huang HY, 1996, J ASSIST REPROD GEN, V13, P56, DOI 10.1007/BF02068871
   Hunault CC, 2004, HUM REPROD, V19, P2019, DOI 10.1093/humrep/deh365
   Jarvela IY, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-18
   Merviel P, 2010, FERTIL STERIL, V93, P79, DOI 10.1016/j.fertnstert.2008.09.058
   Miller DC, 2002, UROLOGY, V60, P497, DOI 10.1016/S0090-4295(02)01773-9
   Ombelet W, 1997, HUM REPROD, V12, P1458, DOI 10.1093/humrep/12.7.1458
   Rhemrev JPT, 2001, FERTIL STERIL, V76, P884, DOI 10.1016/S0015-0282(01)02826-6
   Saleh A, 2000, FERTIL STERIL, V74, P509, DOI 10.1016/S0015-0282(00)00702-0
   VansVoorhis BJ, 2001, FERTIL STERIL, V75, P661
   VansWeert JM, 2004, FERTIL STERIL, V82, P612
NR 15
TC 1
Z9 2
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-4569
EI 1439-0272
J9 ANDROLOGIA
JI Andrologia
PD DEC
PY 2014
VL 46
IS 10
BP 1183
EP 1188
DI 10.1111/and.12212
PG 6
WC Andrology
SC Endocrinology & Metabolism
GA AT4MQ
UT WOS:000344913900015
PM 24386953
ER

PT J
AU Dobrzynska, MM
   Jankowska-Steifer, EA
   Tyrkiel, EJ
   Gajowik, A
   Radzikowska, J
   Pachocki, KA
AF Dobrzynska, Malgorzata M.
   Jankowska-Steifer, Ewa A.
   Tyrkiel, Ewa J.
   Gajowik, Aneta
   Radzikowska, Joanna
   Pachocki, Krzysztof A.
TI Comparison of the Effects of Bisphenol A Alone and in a Combination with
   X-irradiation on Sperm Count and Quality in Male Adult and Pubescent
   Mice
SO ENVIRONMENTAL TOXICOLOGY
LA English
DT Article
DE bisphenol A; combined exposure; sperm count and morphology; comet assay;
   histology
ID ENDOCRINE-DISRUPTING CHEMICALS; MALE REPRODUCTIVE-TRACT; SPRAGUE-DAWLEY
   RATS; DNA-DAMAGE; URINARY CONCENTRATIONS; SERTOLI-CELLS; COMET ASSAY;
   GERM-CELLS; EXPOSURE; TOXICITY
AB Bisphenol A (BPA) is employed in the manufacturing of epoxy, polyester-styrene, and polycarbonate resins, which are used for the production of baby and water bottles and reusable containers, food and beverage packing, dental fillings and sealants. The study was designed to examine the effects of 8-week exposure (a full cycle of spermatogenesis) to BPA alone and in a combination with X-irradiation on the reproductive organs and germ cells of adult and pubescent male mice. Pzh:Sfis male mice were exposed to BPA (5, 10, and 20 mg/kg) or X-rays (0.05 Gy) or to a combination of both (0.05 Gy 1 5 mg/kg bw BPA). The following parameters were examined: sperm count, sperm motility, sperm morphology, and DNA damage in male gametes. Both BPA and X-rays alone diminished sperm quality. BPA exposure significantly reduced sperm count in pubescent males compared to adult mice, with degenerative changes detected in seminiferous epithelium. This may suggest a higher susceptibility of germ cells of younger males to BPA action. Combined BPA with X-ray treatment enhanced the harmful effect induced by BPA alone in male germ cells of adult males, whereas low-dose irradiation showed sometimes protective or additive effects in pubescent mice. (C) 2013 Wiley Periodicals, Inc.
C1 [Dobrzynska, Malgorzata M.; Tyrkiel, Ewa J.; Gajowik, Aneta; Radzikowska, Joanna; Pachocki, Krzysztof A.] Natl Inst Hyg, Natl Inst Publ Hlth, Dept Radiat Hyg & Radiobiol, PL-00791 Warsaw, Poland.
   [Jankowska-Steifer, Ewa A.] Med Univ Warsaw, Dept Histol & Embryol, Warsaw, Poland.
RP Dobrzynska, MM (reprint author), Natl Inst Hyg, Natl Inst Publ Hlth, Dept Radiat Hyg & Radiobiol, PL-00791 Warsaw, Poland.
EM mdobrzynska@pzh.gov.pl
FU Polish Ministry of Science and Higher Education [N N404 029535]
FX Contract grant sponsor: Polish Ministry of Science and Higher Education,
   2008-2011, project No. N N404 029535
CR Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a
   Akingbemi BT, 2004, ENDOCRINOLOGY, V145, P592, DOI 10.1210/en.2003-1174
   Allard P, 2011, REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, P673, DOI 10.1016/B978-0-12-382032-7.10050-5
   ANDERSON D, 1994, MUTAT RES, V307, P261, DOI 10.1016/0027-5107(94)90300-X
   Anjum S, 2011, FOOD CHEM TOXICOL, V49, P2849, DOI 10.1016/j.fct.2011.07.062
   Ashby J, 2003, TOXICOL SCI, V74, P129, DOI 10.1093/toxsci/kfg093
   Bonde JP, 1995, REPROD MED REV, V4, P59
   Brehm R, 2007, AM J PATHOL, V171, P19, DOI 10.2353/ajpath.2007.061171
   Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391
   Cao XL, 2011, FOOD ADDIT CONTAM A, V28, P791, DOI 10.1080/19440049.2010.513015
   CARLSEN E, 1992, BRIT MED J, V305, P609
   Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002
   Dobrzynska MM, 2013, DRUG CHEM TOXICOL, V36, P19, DOI 10.3109/01480545.2011.644561
   Dobrzynska M. M., 2003, HUMAN MONITORING GEN, P309
   EFSA, 2006, EFSA J, V428, P1
   HARRISON A, 1980, HEALTH PHYS, V39, P219, DOI 10.1097/00004032-198008000-00007
   HAWKINS MM, 1989, INT J CANCER, V43, P975, DOI 10.1002/ijc.2910430604
   Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516
   Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839
   Kabuto H, 2004, LIFE SCI, V74, P2931, DOI 10.1016/j.lfs.2003.07.060
   Kavlock RJ, 1996, ENVIRON HEALTH PERSP, V104, P715, DOI 10.2307/3432708
   Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6
   Lee HJ, 2003, TOXICOL SCI, V75, P40, DOI 10.1093/toxsci/kfg150
   Liu GW, 2006, RADIAT RES, V165, P379, DOI 10.1667/RR3528.1
   Lyons G., 2000, BISPHENOL KNOWN ENDO
   Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P252, DOI 10.1289/ehp.1002238
   O'Donnell L, 2001, ENDOCR REV, V22, P289, DOI 10.1210/er.22.3.289
   Pacchierotti F, 2008, MUTAT RES-GEN TOX EN, V651, P64, DOI 10.1016/j.mrgentox.2007.10.009
   PILGRIM C, 1994, NEUROSCIENCE, V60, P843, DOI 10.1016/0306-4522(94)90267-4
   Pollycove M, 1998, ENVIRON HEALTH PERSP, V106, P363, DOI 10.2307/3433939
   Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004
   ROWLEY MJ, 1974, RADIAT RES, V59, P665, DOI 10.2307/3574084
   Roy JR, 2009, MED SCI MONITOR, V15, pRA137
   Sakue M, 2001, J OCCUP HEALTH, V43, P185
   Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703
   Searle A. G., 1974, MUTAT RES, V22, P69
   Sharpe RM, 1998, TRENDS ENDOCRIN MET, V9, P371, DOI 10.1016/S1043-2760(98)00089-7
   Sharpe RM, 1998, BIOL REPROD, V59, P1084, DOI 10.1095/biolreprod59.5.1084
   Sharpe RM, 2006, BEST PRACT RES CL EN, V20, P91, DOI 10.1016/j.beem.2005.09.005
   SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E
   Sikka SC, 1999, ENDOCRINE AND HORMONAL TOXICOLOGY, P91
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   SJOBERG P, 1985, ARCH TOXICOL, V58, P78, DOI 10.1007/BF00348313
   Sridharan S, 2007, BIOL REPROD, V76, P804, DOI 10.1095/biolreprod.106.059212
   Staples CA, 1998, CHEMOSPHERE, V36, P2149, DOI 10.1016/S0045-6535(97)10133-3
   Sun Y, 2004, BIOMED CHROMATOGR, V18, P501, DOI 10.1002/bmc.345
   Takao T, 1999, LIFE SCI, V65, P2351, DOI 10.1016/S0024-3205(99)00502-0
   Tan BLL, 2003, TOXICOL LETT, V143, P261, DOI 10.1016/S0378-4274(03)00172-3
   Toyama Y, 2004, ARCH HISTOL CYTOL, V67, P373, DOI 10.1679/aohc.67.373
   Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121
   UNSCEAR (United Nations Scientific Committee on the Effect of Atomic Radiation), 2008, SOURC EFF ION RAD
   US EPA, 2008, BISPH INT RISK INF S
   Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021
   Volkel Wolfgang, 2002, Chem Res Toxicol, V15, P1281, DOI 10.1021/tx025548t
   Vom Saal FS, 1998, TOXICOL IND HEALTH, V14, P239
   Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010
   Wong EWP, 2011, TRENDS PHARMACOL SCI, V32, P290, DOI 10.1016/j.tips.2011.01.001
   WORKING PK, 1985, TOXICOL APPL PHARM, V77, P144, DOI 10.1016/0041-008X(85)90275-3
   WYROBEK AJ, 1975, P NATL ACAD SCI USA, V72, P4425, DOI 10.1073/pnas.72.11.4425
NR 59
TC 2
Z9 2
U1 5
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1520-4081
EI 1522-7278
J9 ENVIRON TOXICOL
JI Environ. Toxicol.
PD NOV
PY 2014
VL 29
IS 11
BP 1301
EP 1313
DI 10.1002/tox.21861
PG 13
WC Environmental Sciences; Toxicology; Water Resources
SC Environmental Sciences & Ecology; Toxicology; Water Resources
GA AS6NP
UT WOS:000344380400008
PM 23619965
ER

PT J
AU Feyles, F
   Peiretti, V
   Mussa, A
   Manenti, M
   Canavese, F
   Cortese, MG
   Lala, R
AF Feyles, Francesca
   Peiretti, Valentina
   Mussa, Alessandro
   Manenti, Marco
   Canavese, Ferdinando
   Cortese, Maria Grazia
   Lala, Roberto
TI Improved Sperm Count and Motility in Young Men Surgically Treated for
   Cryptorchidism in the First Year of Life
SO EUROPEAN JOURNAL OF PEDIATRIC SURGERY
LA English
DT Article
DE cryptorchidism; orchiopexy; sperm analysis; testicular volume
ID HUMAN CHORIONIC-GONADOTROPIN; GERM-CELL DEVELOPMENT; UNDESCENDED TESTES;
   TESTICULAR FUNCTION; EARLY ORCHIOPEXY; ORCHIDOPEXY; FERTILITY; BOYS;
   SPERMATOGENESIS; INFERTILITY
AB Introduction The timing of surgery in cryptorchidism has been debated for a long time. Reports on histology suggest better fertility outcomes with early surgery, whereas evidence of long-term improved fertility still lacks sound data. The aim of this study is to analyze sperm count and motility in a cohort of young men operated on during the first 2 years of life for cryptorchidism.
   Patients and Methods A total of 78 young men (age, 18-26 years) surgically treated for cryptorchidism in the second year of life were recalled to evaluate testicular volume and sperm count and motility. Of the 78 young men, 51 accepted to participate to clinical and sperm evaluation. Relationship between total sperm count (TSC), sperm motility (SM), and age at surgery was investigated by Student t-test and Fisher test. Patients were divided into two groups: those patients who were submitted to surgery in their first year of life (Group A) and those patients who were submitted to surgery in their first and the second year of life (Group B). We investigated the ratio of those patients with normal sperm count to those patients with abnormal sperm count (we defined as normal TSC > 15 million and SM > 15%) and compared the mean TSC and SM in the two groups.
   Results TSC were slightly but not significantly higher in the first group (45.5 +/- 15.5 million/mL vs. 36.5 +/- 23.6 million/mL, p = 0.107) and SM (30.5% +/- 11.3% vs. 26.5% +/- 15.4%, p = 0.341). The percentage of patients with normal sperm count and motility were significantly higher in the first group: normal TSC was found in 26 of 27 patients (96.3%) in Group Aversus 18 of 24 patients (75.0%) in Group B (p = 0.042), normal SM was found in 26 of 27 patients (96.3%) versus 16 of 24 patients (66.7%), respectively (p = 0.008). In the two groups, no statistically significant difference was found neither in the proportion of patients with bilateral cryptorchidism, in the position of the testes, nor in the ratio of subjects treated with hormonal therapy before being operated on.
   Conclusions In formerly cryptorchid subjects submitted to surgery in the first 2 years of life, the percentage of patients with normal sperm count and motility is higher than 95%, with even better fertility prognosis if orchiopexy is performed in the first year of life.
C1 [Feyles, Francesca; Peiretti, Valentina; Mussa, Alessandro; Lala, Roberto] Regina Margherita Childrens Hosp, Dept Endocrinol & Diabetol, Turin, Italy.
   [Manenti, Marco] St Anna Hosp, Dept Androl, Turin, Italy.
   [Canavese, Ferdinando; Cortese, Maria Grazia] Regina Margherita Childrens Hosp, Dept Pediat Surg, Turin, Italy.
RP Feyles, F (reprint author), Regina Margherita Childrens Hosp, Dept Endocrinol & Diabetol, Turin, Italy.
EM francesca.feyles@gmail.com
RI Mussa, Alessandro/H-1162-2013
OI Mussa, Alessandro/0000-0003-2795-6013
CR Canavese F, 2009, EUR J PEDIATR SURG, V19, P388, DOI 10.1055/s-0029-1241171
   Cortes D, 2000, J UROLOGY, V163, P1290, DOI 10.1016/S0022-5347(05)67763-4
   Dunkel L, 1997, J CLIN INVEST, V100, P2341, DOI 10.1172/JCI119773
   Gracia J, 2000, BJU INT, V85, P1100, DOI 10.1046/j.1464-410x.2000.00662.x
   Hadziselimovic F, 2001, LANCET, V358, P1156, DOI 10.1016/S0140-6736(01)06274-2
   Hadziselimovic F, 1977, Adv Anat Embryol Cell Biol, V53, P3
   Hadziselimovic F., 2008, INT BRAZ J UROL, V34, P327
   Hadziselimovic F, 2008, INT BRAZ J UROL, V34, P319, DOI 10.1590/S1677-55382008000300009
   Hadziselimovic F, 2007, HORM RES, V68, P46, DOI 10.1159/000100874
   Huff DS, 2001, HORM RES, V55, P11, DOI 10.1159/000049957
   HUFF DS, 1989, J UROLOGY, V142, P546
   Kim SO, 2011, UROLOGY, V78, P886, DOI 10.1016/j.urology.2011.04.057
   Kollin C, 2012, J CLIN ENDOCR METAB, V97, P4588, DOI 10.1210/jc.2012-2325
   Lala R, 1997, J UROLOGY, V157, P1898, DOI 10.1016/S0022-5347(01)64897-3
   Ritzen EM, 2007, ACTA PAEDIATR, V96, P638, DOI 10.1111/j.1651-2227.2006.00159.x
   MENGEL W, 1974, J PEDIATR SURG, V9, P445, DOI 10.1016/S0022-3468(74)80003-5
   Mizuno K, 2008, J UROLOGY, V179, P1195, DOI 10.1016/j.juro.2007.10.029
   Murphy F, 2007, PEDIATR SURG INT, V23, P625, DOI 10.1007/s00383-007-1900-3
   Rey RA, 2012, J CLIN ENDOCR METAB, V97, P4358, DOI 10.1210/jc.2012-3662
   Trsinar B, 2009, WORLD J UROL, V27, P513, DOI 10.1007/s00345-009-0406-0
   Vilar O., 1970, HUMAN TESTIS, P95
   Vinardi S, 2001, J PEDIATR SURG, V36, P385, DOI 10.1053/jpsu.2001.20723
   Virtanen HE, 2008, HUM REPROD UPDATE, V14, P49, DOI 10.1093/humupd/dmm027
   WHO, 1999, WHO LAB MAN EX HUM S
   Zhou BY, 2002, J PEDIATR SURG, V37, P1751, DOI 10.1053/jpsu.2002.36713
NR 25
TC 5
Z9 7
U1 0
U2 6
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0939-7248
EI 1439-359X
J9 EUR J PEDIATR SURG
JI Eur. J. Pediatr. Surg.
PD OCT
PY 2014
VL 24
IS 5
BP 376
EP 380
DI 10.1055/s-0033-1349715
PG 5
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA AQ7PY
UT WOS:000343012700002
PM 23852722
ER

PT J
AU Ahangarpour, A
   Oroojan, AA
   Aliakbari, FR
AF Ahangarpour, A.
   Oroojan, A. A.
   Aliakbari, F. Ramezani
TI EFFECTS OF C-PEPTIDE AND NICOTINAMIDE ON SERUM LH, FSH, TESTOSTERONE
   LEVELS AND SPERM COUNT IN NICOTINAMIDE/STREPTOZOTOCIN-INDUCED-DIABETES
   IN MICE
SO ACTA ENDOCRINOLOGICA-BUCHAREST
LA English
DT Article
DE diabetes; C-peptide; nicotinamide; sperm; mice
ID MALE-INFERTILITY; RATS; MELLITUS
AB Introduction. One of the diabetes complications in men is infertility. C-peptide and Nicotinamide have antidiabetic and antioxidant activity. So, the aim of this study was to investigate the effects of these drugs on male infertility caused by diabetes.
   Methods. In this experimental study 40 adult male NMRI mice (20-25g) were obtained and randomly divided into 5groups:. controls, diabetes model, diabetes+C-peptide, diabetes+Nicotinamide, diabetes+C-peptide+Nicotinamide. Diabetes induced was confirmed 3 days after administration of a single dose of streptozotocin (STZ) (65mg/kg) 15 min after an intraperitoneal injection of Nicotinamide (120mg/kg). Then C-peptide (25nmol/kg) and Nicotinamide (100mg/kg) were injected for 28 days. 24h after the last drugs injection serum samples, testes and cauda epididymis of animals were removed for hormonal, testis morphology and sperm count assessment.
   Results. Diabetes induced could decrease serum testosterone level and sperm count significantly (p<0.001, p<0.05 respectively). Serum LH, testosterone levels and sperm count increased in Diabetes+Cpeptide+Nicotinamide versus diabetes group (p<0.05, p<0.001, p<0.01 respectively). Also administration of Nicotinamide alone showed an increase in serum testosterone (p<0.001).
   Conclusion. The results of this study demonstrated that combined administration of Nicotinamide and C-peptide improved diabetes induced male reproductive disorders by enhanced serum LH, testosterone levels and sperm count in diabetic mice.
C1 [Ahangarpour, A.] Ahvaz Jundishapur Univ Med Sci, Diabet Res Ctr, Dept Physiol, Hlth Res Inst, Ahwaz 0611, Iran.
RP Oroojan, AA (reprint author), Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Physiol, Ahwaz 0611, Iran.
EM aliakbar_oroojan@yahoo.com
FU Student Research Committee of Ahvaz Jundishapur Medical Sciences
   University, Ahvaz, Iran [93.S.1]
FX This paper is No. 93.S.1 of a student research project, financially
   supported by the Student Research Committee of Ahvaz Jundishapur Medical
   Sciences University, Ahvaz, Iran.
CR Abedinzadeh M, 2009, J GUILAN U MED SCI, V71, P7
   Agarwal A., 2005, Iranian Journal of Reproductive Medicine, V3, P1
   Ahangarpour A, 2014, MALAYS J ME IN PRESS
   Ahangarpour A, 2013, ZUMS J, V21, P22
   Ahangarpour Akram, 2014, Iran J Reprod Med, V12, P65
   Aitken RJ, 2008, ADV EXP MED BIOL, V636, P154, DOI 10.1007/978-0-387-09597-4_9
   Alenzi FQ, 2009, IRAN J ALLERGY ASTHM, V8, P11, DOI 08.01/ijaai.1118
   Alves MG, 2013, BBA-MOL BASIS DIS, V1832, P626, DOI 10.1016/j.bbadis.2013.01.011
   Amaral Sandra, 2008, Curr Diabetes Rev, V4, P46
   Bhatt MP, 2013, DIABETES, V62, P3851, DOI 10.2337/db13-0039
   Fox JG, 2007, MOUSE BIOMEDICAL RES, V3, P644
   Husain GM, 2011, PHYTOTHER RES, V25, P1806, DOI 10.1002/ptr.3491
   Ibrahim SS, 2008, AFR J BIOCH RES, V2, P174
   Jelodar G, 2009, J PHYSIOL SCI, V59, P377, DOI 10.1007/s12576-009-0045-7
   Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536
   La Vignera S, 2012, J ANDROL, V33, P145, DOI 10.2164/jandrol.111.013193
   Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446
   Nejatbakhsh F, 2012, IRAN J REPROD MED, V10, P511
   Punitha I. S. R., 2005, DIABETOLOGIA CROATIC, V34, P117
   Rabbani SI, 2010, PAK J PHARM SCI, V23, P326
   Rabbani Syed Imam, 2010, J Pharmacol Pharmacother, V1, P18, DOI 10.4103/0976-500X.64531
   Sato Y, 2004, CELL MOL LIFE SCI, V61, P727, DOI 10.1007/s00018-003-3460-6
   Tiwari AK, 2002, CURR SCI INDIA, V83, P30
   Turk G, 2008, CLIN NUTR, V27, P289, DOI 10.1016/j.clnu.2007.12.006
   Vasic D, 2012, INT J INFLAM, V2012, DOI [DOI 10.1155/2012/932725, 10.1155/2012/932725]
   Wahren J, 2007, DIABETOLOGIA, V50, P503, DOI 10.1007/s00125-006-0559-y
NR 26
TC 1
Z9 1
U1 2
U2 5
PU EDITURA ACAD ROMANE
PI BUCURESTI
PA CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCURESTI 050711, ROMANIA
SN 1841-0987
EI 1843-066X
J9 ACTA ENDOCRINOL-BUCH
JI Acta Endocrinol.
PD OCT-DEC
PY 2014
VL 10
IS 4
BP 588
EP 594
DI 10.4183/aeb.2014.588
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AP9IZ
UT WOS:000342394800006
ER

PT J
AU Tan, O
   Ha, T
   Carr, BR
   Nakonezny, P
   Doody, KM
   Doody, KJ
AF Tan, Orkun
   Ha, Thoa
   Carr, Bruce R.
   Nakonezny, Paul
   Doody, Kathleen M.
   Doody, Kevin J.
TI Predictive value of postwashed total progressively motile sperm count
   using CASA estimates in 6871 non-donor intrauterine insemination cycles
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Article
DE Intrauterine insemination; Computer assisted sperm analysis; Pregnancy;
   Semen analysis
ID IN-VITRO FERTILIZATION; PREGNANCY RATES; SEMEN ANALYSIS; SUCCESS;
   INFERTILITY; MORPHOLOGY; SPERMATOZOA; NUMBER; IMPACT; METAANALYSIS
AB To determine whether postwashed total progressively motile sperm count (TPMSC) obtained by CASA estimates could predict positive pregnancy test result in non-donor IUI cycles.
   Six thousand eight hundred and seventy one (6,871) IUI cycles with non-donor semen were retrospectively analyzed. Patient, cycle characteristics and prewashed and postwashed semen parameters were included in analysis. The main outcome measure was the positive pregnancy test result.
   The pregnancy rate per cycle (PR/cycle) when postwashed TPMSC is between 0-0.5 million, 0.51-1 million, 1.01-5 million, 5.01-10 million and greater than 10 million were 8.1 % (42/520), 14.4 % (41/285), 16.1 % (237/1,469), 18.4 % (193/1,046) and 18.8 % (668/3,551) respectively. The predicted odd of positive pregnancy result is statistically significantly higher when TPMSC is > 0.51 million compared to the TPMSC of < 0.51 million (OR = 1.68, 95 % CI: 1.04-2.71). The predicted odd of positive pregnancy result is greatest when TPMSC is at least 5 million (OR = 2, 95 % CI: 1.38 to 2.9).
   TPMSC is an independent predictor of pregnancy test result and TPMSC of half million or greater is adequate to achieve statistically similar pregnancy test results after non-donor IUI cycles.
C1 [Tan, Orkun; Ha, Thoa; Carr, Bruce R.; Doody, Kevin J.] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Dallas, TX 75390 USA.
   [Tan, Orkun] ReproMed Fertil Ctr, Dallas, TX 75240 USA.
   [Nakonezny, Paul] Univ Texas SW Med Ctr Dallas, Div Biostat, Dept Clin Sci, Dallas, TX 75390 USA.
   [Doody, Kathleen M.; Doody, Kevin J.] Ctr Assisted Reprod, Bedford, TX 76022 USA.
RP Tan, O (reprint author), ReproMed Fertil Ctr, 3800 San Jacinto, Dallas, TX 75240 USA.
EM drorkuntan@gmail.com
CR Badawy A, 2009, FERTIL STERIL, V91, P777, DOI 10.1016/j.fertnstert.2007.12.010
   Berg U, 1997, FERTIL STERIL, V67, P747, DOI 10.1016/S0015-0282(97)81377-5
   Berker B, 2011, ARCH GYNECOL OBSTET, V284, P1561, DOI 10.1007/s00404-011-1997-4
   Bollendorf A, 1996, J ANDROL, V17, P550
   Branigan EF, 1999, FERTIL STERIL, V71, P547, DOI 10.1016/S0015-0282(98)00503-2
   BRASCH JG, 1994, FERTIL STERIL, V62, P150
   Brazil C, 2004, J ANDROL, V25, P635
   Campana A, 1996, HUM REPROD, V11, P732
   Costello MF, 2004, AUST NZ J OBSTET GYN, V44, P93, DOI 10.1111/j.1479-828X.2004.00192.x
   Dinelli L, 2014, FERTIL STERIL, V101, P994, DOI 10.1016/j.fertnstert.2014.01.009
   DODSON WC, 1991, FERTIL STERIL, V55, P457
   Dodson WC, 1998, FERTIL STERIL, V70, P574, DOI 10.1016/S0015-0282(98)00210-6
   Duran HE, 2002, HUM REPROD UPDATE, V8, P373, DOI 10.1093/humupd/8.4.373
   Farhi J, 2010, GYNECOL ENDOCRINOL, V26, P500, DOI 10.3109/09513590903367036
   Freour T, 2010, EUR J OBSTET GYN R B, V149, P186, DOI 10.1016/j.ejogrb.2009.12.029
   HORVATH PM, 1989, FERTIL STERIL, V52, P288
   Huang HY, 1996, J ASSIST REPROD GEN, V13, P56, DOI 10.1007/BF02068871
   Hughes EG, 1997, HUM REPROD, V12, P1865, DOI 10.1093/humrep/12.9.1865
   Jorgensen N, 1997, INT J ANDROL, V20, P201, DOI 10.1046/j.1365-2605.1997.00052.x
   Khalil MR, 2001, ACTA OBSTET GYN SCAN, V80, P74, DOI 10.1080/791201839
   Kleppe M., 2014, ANDROLOGIA
   LELANNOU D, 1994, CONTRACEPT FERTIL S, V22, P361
   Miller DC, 2002, UROLOGY, V60, P497, DOI 10.1016/S0090-4295(02)01773-9
   Nicopoullos JDM, 2010, HUM REPROD, V25, P1869, DOI 10.1093/humrep/deq134
   Nikbakht R, 2011, INT J FERTIL STERIL, V5, P168
   NULSEN JC, 1993, OBSTET GYNECOL, V82, P780
   Ok Elvan Koyun, 2013, J Turk Ger Gynecol Assoc, V14, P142, DOI 10.5152/jtgga.2013.52280
   Rhemrev JPT, 2001, FERTIL STERIL, V76, P884, DOI 10.1016/S0015-0282(01)02826-6
   Strandell A, 2003, ACTA OBSTET GYN SCAN, V82, P1023, DOI 10.1034/j.1600-0412.2003.00324.x
   Streda R, 2007, Ceska Gynekol, V72, P397
   Sun Y, 2012, ANDROLOGIA, V44, P299, DOI 10.1111/j.1439-0272.2012.01280.x
   Tijani HA, 2010, HUM FERTIL, V13, P226, DOI 10.3109/14647273.2010.533811
   Van Voorhis BJ, 2001, FERTIL STERIL, V75, P661, DOI 10.1016/S0015-0282(00)01783-0
   van Weert JM, 2004, FERTIL STERIL, V82, P612, DOI 10.1016/j.fertnstert.2004.01.042
   Wainer R, 1996, CONTRACEPT FERTIL S, V24, P897
   Wainer R, 2004, HUM REPROD, V19, P2060, DOI 10.1093/humrep/deh390
   Zhao YL, 2004, J ASSIST REPROD GEN, V21, P143, DOI 10.1023/B:JARG.0000031246.76666.f6
NR 37
TC 1
Z9 1
U1 1
U2 1
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD SEP
PY 2014
VL 31
IS 9
BP 1147
EP 1153
DI 10.1007/s10815-014-0306-0
PG 7
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA AP1KW
UT WOS:000341829700004
PM 25106939
ER

PT J
AU Chavarro, JE
   Minguez-Alarcon, L
   Mendiola, J
   Cutillas-Tolin, A
   Lopez-Espin, JJ
   Torres-Cantero, AM
AF Chavarro, Jorge E.
   Minguez-Alarcon, Lidia
   Mendiola, Jamie
   Cutillas-Tolin, Ana
   Lopez-Espin, Jose J.
   Torres-Cantero, Alberto M.
TI Trans fatty acid intake is inversely related to total sperm count in
   young healthy men (vol 29, pg 429, 2014)
SO HUMAN REPRODUCTION
LA English
DT Correction
CR Chavarro JE, 2014, HUM REPROD, V29, P429, DOI 10.1093/humrep/det464
NR 1
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD JUN
PY 2014
VL 29
IS 6
BP 1346
EP 1347
DI 10.1093/humrep/deu059
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AH9SV
UT WOS:000336483400029
ER

PT J
AU Chavarro, JE
   Minguez-Alarcon, L
   Mendiola, J
   Cutillas-Tolin, A
   Lopez-Espin, JJ
   Torres-Cantero, AM
AF Chavarro, Jorge E.
   Minguez-Alarcon, Lidia
   Mendiola, Jaime
   Cutillas-Tolin, Ana
   Lopez-Espin, Jose J.
   Torres-Cantero, Alberto M.
TI Trans fatty acid intake is inversely related to total sperm count in
   young healthy men
SO HUMAN REPRODUCTION
LA English
DT Article
DE trans fatty acids; fat intake; semen quality; young healthy men
ID FOOD FREQUENCY QUESTIONNAIRE; SEMEN QUALITY; DIETARY-INTAKE; EPIDIDYMAL
   MATURATION; UNIVERSITY-STUDENTS; HUMAN SPERMATOZOA; TESTICULAR CELLS;
   ADIPOSE-TISSUE; UNITED-STATES; DANISH MEN
AB STUDY QUESTION: Is intake of fatty acids related to semen quality among young men?
   SUMMARY ANSWER: The intake of trans fatty acids is inversely related to total sperm count in healthy young men.
   WHAT IS KNOWN ALREADY: Spain has seen an increase in the proportion of calories consumed as fat over the same period that a downward trend in semen quality has been observed. In addition, rodent models suggest that trans fat intake may severely affect testicular function.
   STUDY DESIGN, SIZE, DURATION: Cross-sectional study of 209 men recruited between October 2010 and November 2011.
   PARTICIPANTS/MATERIALS, setting, methods: A group of 209 healthy young university students 18-23 years of age provided a semen sample and completed a previously validated food frequency questionnaire. The association between intake of fatty acids with semen quality parameters (sperm concentration, motility, morphology and total count) was assessed using multivariate linear regression.
   MAIN RESULTS AND THE ROLE OF THE CHANCE: Trans fatty acid intake was inversely related to total sperm count after adjusting for potential confounders (P, trend = 0.03). The multivariate adjusted mean (95% confidence interval) total sperm count in increasing quartiles of trans fat intake was 144 (110-190), 113 (87-148), 100 (18-130) and 89 (69-117). There also was an inverse association between cholesterol intake and ejaculate volume (P, trend = 0.04). No other statistically significant relations were observed.
   LIMITATIONS, REASONS FOR CAUTION: The cross-sectional design of the study limits causal inference, we cannot exclude the possibility of unmeasured confounding and there was insufficient statistical power to identify modest associations.
   WIDER IMPLICATIONS OF THE FINDINGS: The results of this study, together with previous experimental work in rodents and biomarker studies among infertility patients, suggest that intake of trans fatty acids may be related to lower semen quality. Although the data provide further evidence that diet is a modifiable factor that could impact male fertility, it is not known whether the observed differences in sperm count translate into differences in fertility.
C1 [Chavarro, Jorge E.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Chavarro, Jorge E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Chavarro, Jorge E.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA.
   [Chavarro, Jorge E.] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Minguez-Alarcon, Lidia; Mendiola, Jaime; Cutillas-Tolin, Ana; Torres-Cantero, Alberto M.] Univ Murcia, Sch Med, Div Prevent Med & Publ Hlth, Dept Hlth & Social Sci, Espinardo 30100, Murcia, Spain.
   [Lopez-Espin, Jose J.] Miguel Hernandez Univ, Ctr Operat Res, Elche 03202, Spain.
   [Torres-Cantero, Alberto M.] Univ Murcia, Murcia 30003, Spain.
RP Chavarro, JE (reprint author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Bldg 2 3rd Floor,655 Huntington Ave, Boston, MA 02115 USA.
EM jchavarr@hsph.harvard.edu; minguez@um.es
FU Seneca Foundation; Regional Agency of Science and Technology
   [00694/PI/04]; Ministerio de Ciencia e Innovacion, Instituto de Salud
   Carlos III (FIS) [PI10/00985]; National Institutes of Health [P30
   DK46200]
FX This work was supported by The Seneca Foundation, Regional Agency of
   Science and Technology, grant no 00694/PI/04, Ministerio de Ciencia e
   Innovacion, Instituto de Salud Carlos III (FIS), grant no PI10/00985,
   and grant P30 DK46200 from the National Institutes of Health.
CR Attaman JA, 2012, HUM REPROD, V27, P1466, DOI 10.1093/humrep/des065
   Baylin A, 2002, AM J CLIN NUTR, V76, P750
   Baylin A, 2005, AM J EPIDEMIOL, V162, P373, DOI 10.1093/aje/kwi213
   BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B
   Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349
   Carlsen E, 2005, HUM REPROD, V20, P942, DOI 10.1093/humrep/deh704
   CARLSEN E, 1992, BRIT MED J, V305, P609
   Chavarro JE, 2011, FERTIL STERIL, V95, P1794, DOI 10.1016/j.fertnstert.2010.10.039
   CHRISTOPHERSEN BO, 1986, SCAND J CLIN LAB INV, V46, P55
   Eskenazi B, 2005, HUM REPROD, V20, P1006, DOI 10.1093/humrep/deh725
   Fisch H, 1996, FERTIL STERIL, V65, P1009
   Gaskins AJ, 2012, HUM REPROD, V27, P2899, DOI 10.1093/humrep/des298
   Haidl G, 1997, HUM REPROD, V12, P2720, DOI 10.1093/humrep/12.12.2720
   HALL JC, 1991, J ANDROL, V12, P76
   Handelsman DJ, 1997, HUM REPROD, V12, P2701, DOI 10.1093/humrep/12.12.2701
   HANIS T, 1989, BRIT J NUTR, V61, P519, DOI 10.1079/BJN19890140
   HILL EG, 1982, P NATL ACAD SCI-BIOL, V79, P953, DOI 10.1073/pnas.79.4.953
   Hulshof KFAM, 1999, EUR J CLIN NUTR, V53, P143, DOI 10.1038/sj.ejcn.1600692
   JENSEN B, 1976, LIPIDS, V11, P179, DOI 10.1007/BF02532855
   Jensen TK, 2013, AM J CLIN NUTR, V97, P411, DOI 10.3945/ajcn.112.042432
   Larque E, 2003, J NUTR, V133, P2526
   Lenzi A, 2000, MOL HUM REPROD, V6, P226, DOI 10.1093/molehr/6.3.226
   Leonard AE, 2000, BIOCHEM J, V350, P765, DOI 10.1042/0264-6021:3500765
   Mandal MNA, 2004, GENOMICS, V83, P626, DOI 10.1016/i.ygeno.2003.09.020
   Mendiola J, 2009, FERTIL STERIL, V91, P812, DOI 10.1016/j.fertnstert.2008.01.020
   Mendiola J, 2013, ANDROLOGY-US, V1, P408, DOI 10.1111/j.2047-2927.2012.00058.x
   MENKVELD R, 1990, HUM REPROD, V5, P586
   Minguez-Alarcon L, 2012, HUM REPROD, V27, P2807, DOI 10.1093/humrep/des247
   Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005
   Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49
   Ollero Mario, 2000, Molecular Reproduction and Development, V55, P326, DOI 10.1002/(SICI)1098-2795(200003)55:3<326::AID-MRD11>3.0.CO;2-A
   Palma I., 2008, TABLAS COMPOSICION A
   Paulsen CA, 1996, FERTIL STERIL, V65, P1015
   PRIVETT OS, 1977, AM J CLIN NUTR, V30, P1009
   Putnam J., 2002, FoodReview, V25, P2
   RANA APS, 1991, BIOCHIM BIOPHYS ACTA, V1061, P185, DOI 10.1016/0005-2736(91)90284-F
   Retterstol K, 1998, BBA-LIPID LIPID MET, V1392, P59, DOI 10.1016/S0005-2760(98)00021-6
   Retterstol K, 2000, BBA-MOL CELL BIOL L, V1483, P119, DOI 10.1016/S1388-1981(99)00166-3
   Saether T, 2003, BIOL REPROD, V69, P117, DOI 10.1095/biolreprod.102.014035
   Lancellotti TES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013457
   Skakkebaek NE, 2006, INT J ANDROL, V29, P2, DOI 10.1111/j.1365-2605.2005.00573.x
   Stokes-Riner A, 2007, J ANDROL, V28, P638, DOI 10.2164/jandrol.107.002741
   Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200
   Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089
   Sun Q, 2007, AM J CLIN NUTR, V86, P74
   Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228
   Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055
   Tvrdik P, 2000, J CELL BIOL, V149, P707, DOI 10.1083/jcb.149.3.707
   U.S. Department of Agriculture, 2010, AGR RES SERV 2010 NA
   Varela-Moreiras G., 2010, EUR J CLIN NUTR, V64, P37
   Veaute C, 2007, AM J REPROD IMMUNOL, V58, P487, DOI 10.1111/j.1600-0897.2007.00530.x
   Vierula M, 1996, INT J ANDROL, V19, P11, DOI 10.1111/j.1365-2605.1996.tb00427.x
   Vioque J, 1991, EUR J CANCER PREV, V1, P19, DOI 10.1097/00008469-199110001-00029
   Vioque J., 1995, NUTR SALUD PUBLICA M
   Vioque J, 2007, BRIT J NUTR, V97, P977, DOI 10.1017/S0007114507659017
   Vioque J, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-26
   Vujkovic M, 2009, HUM REPROD, V24, P1304, DOI 10.1093/humrep/dep024
   Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035
   Cooper TG, 2010, WHO LAB MAN EX PROC
   Willett W, 2013, NUTR EPIDEMIOLOGY
   Willett WC, 1998, NUTR EPIDEMIOLOGY
   WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51
   Zhang K, 2001, NAT GENET, V27, P89
NR 63
TC 11
Z9 12
U1 3
U2 16
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD MAR
PY 2014
VL 29
IS 3
BP 429
EP 440
DI 10.1093/humrep/det464
PG 12
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AB5IM
UT WOS:000331822100008
PM 24419496
ER

PT J
AU Storer, B
   Peck, J
   Hansen, KR
   Weedin, E
   Craig, L
AF Storer, Brooke
   Peck, Jennifer
   Hansen, Karl R.
   Weedin, Elizabeth
   Craig, LaTasha
TI The Effects of Male Tobacco Use on Both Total Motile Sperm Count and
   Pregnancy Rates in Intrauterine Insemination
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 62nd Annual Meeting of the Pacific-Coast-Reproductive-Society (PCRS)
CY MAR 19-23, 2014
CL Indian Wells, CA
SP Pacific Coast Reprod Soc
C1 [Storer, Brooke; Weedin, Elizabeth] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA.
   [Peck, Jennifer] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK 73190 USA.
   [Hansen, Karl R.; Craig, LaTasha] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Sect Reprod Endocrinol & Infertil, Oklahoma City, OK 73190 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD FEB
PY 2014
VL 101
IS 2
SU S
MA P-9
BP E11
EP E11
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AP8SX
UT WOS:000342350300018
ER

PT J
AU Cavallini, G
   Biagiotti, G
   Bolzon, E
AF Cavallini, Giorgio
   Biagiotti, Giulio
   Bolzon, Elisa
TI Multivariate analysis to predict letrozole efficacy in improving sperm
   count of non-obstructive azoospermic and cryptozoospermic patients: a
   pilot study
SO ASIAN JOURNAL OF ANDROLOGY
LA English
DT Article
DE cryptozoospermia; letrozole; male infertility; non-obstructive
   azoospermia
ID AROMATASE INHIBITORS; MALE-INFERTILITY; HORMONE-LEVELS; SEMEN QUALITY;
   MEN; SPERMATOGENESIS; TESTOSTERONE; POPULATION; PARAMETERS; MANAGEMENT
AB We tested the hypothesis that letrozole increases sperm count in non-obstructive azoospermic or cryptozoospermic patients with a testosterone (T)/17-beta-2-oestradiol (E2) ratio <10. Forty-six patients with no chromosomal aberrations were randomized into two groups: 22 received letrozole 2.5 mg per day for 6 months (Group 1: 6 azoospermic+16 cryptozoospermic patients), while 24 received a placebo (Group 2:5 azoospermic+19 cryptozoospermic patients). The following data were collected: two semen analyses, clinical history, scrotal Duplex scans, body mass index (BMI), Y microdeletion, karyotype and cystic fibrosis screens and follicle-stimulating hormone (FSH), luteinizing hormone (LH), E2, T and prolactin levels. Both before and after letrozole or placebo administration, the patients underwent two semen analyses and hormonal assessments. The differences were evaluated using the Mann-Whitney U test. The relationships between sperm concentration after letrozole administration with respect to FSH, T/E2 ratio, bilateral testicle volume and BMI before letrozole administration were assessed using multivariate analysis. The side effects were assessed using the chi-square test. Group 1 had sperm concentration (medians: 400-1.290x10(6) 6 ml(-1); P<0.01) and motility (medians: class A from 2% to 15%; P<0.01), FSH, LH and T significantly increased, while Group 2 did not. E2 levels diminished significantly in Group 1, but not in Group 2. Eight patients in Group 1 demonstrated side effects, whereas no patient side effects were observed in Group 2. The sperm concentration after letrozole administration is inversely related to T/E2, FSH and BMI; a direct relationship emerged between sperm concentration and testicular volume.
C1 [Cavallini, Giorgio; Bolzon, Elisa] Outpatient Clin Ferrara, Andros Italia, I-44121 Ferrara, Italy.
   [Biagiotti, Giulio] Outpatient Clin Perugia, Andros Italia, I-06128 Perugia, Italy.
RP Cavallini, G (reprint author), Outpatient Clin Ferrara, Andros Italia, I-44121 Ferrara, Italy.
EM giorgiocavallini@libero.it
CR Armitage P, 2002, STAT METHODS MED RES
   Beliveau ME, 2011, ASIAN J ANDROL, V13, P225, DOI 10.1038/aja.2010.178
   Biagiotti G, 2002, BJU INT, V90, P903, DOI 10.1046/j.1464-4096.2002.03033.x
   Carani C, 1999, CLIN ENDOCRINOL, V51, P517, DOI 10.1046/j.1365-2265.1999.00849.x
   Cavallini G, 2008, BIOL REPROD, V79, P667, DOI 10.1095/biolreprod.107.067330
   Cavallini G, 2011, ASIAN J ANDROL, V13, P312, DOI 10.1038/aja.2010.166
   Cavallini G, 2011, ASIAN J ANDROL, V13, P895, DOI 10.1038/aja.2011.44
   Chavarro JE, 2010, FERTIL STERIL, V93, P2222, DOI 10.1016/j.fertnstert.2009.01.100
   Donkol Ragab H, 2010, World J Radiol, V2, P172, DOI 10.4329/wjr.v2.i5.172
   Gennari L, 2004, J CLIN ENDOCR METAB, V89, P2803, DOI 10.1210/jc.2003-031342
   Gordetsky J, 2012, BJU INT, V110, P568, DOI 10.1111/j.1464-410X.2011.10783.x
   Gregoriou O, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.005
   Hammoud AO, 2010, HUM REPROD, V25, P3146, DOI 10.1093/humrep/deq255
   Jo B., 2007, J EDUC BEHAV STAT, V33, P158, DOI [10.3102/1076998607302635, DOI 10.3102/1076998607302635]
   Koscinski I, 2007, HUM REPROD, V22, P2679, DOI 10.1093/humrep/dem190
   La Sala GB, 2010, REPROD BIOMED ONLINE, V20, P2, DOI 10.1016/j.rbmo.2009.10.007
   Lotti F, 2012, HUM REPROD, V27, P3393, DOI 10.1093/humrep/des348
   Ma Y, 2011, HUM REPROD, V26, P294, DOI 10.1093/humrep/deq337
   Meeker JD, 2007, J ANDROL, V28, P397, DOI 10.2164/jandrol.106.001545
   Ombelet W, 1997, HUM REPROD, V12, P987
   Patry G, 2009, FERTIL STERIL, V92, P829
   Raman JD, 2002, J UROLOGY, V167, P624, DOI 10.1016/S0022-5347(01)69099-2
   Roy Kallol Kumar, 2012, J Hum Reprod Sci, V5, P20, DOI 10.4103/0974-1208.97789
   Saylam B, 2011, FERTIL STERIL, V95, P809, DOI 10.1016/j.fertnstert.2010.09.021
   Schlegel PN, 2012, FERTIL STERIL, V98, P1359, DOI 10.1016/j.fertnstert.2012.10.023
   Tamhane AC, 2010, BIOMETRICS, V66, P1174, DOI 10.1111/j.1541-0420.2010.01402.x
   Turkistani A, 2012, EXPERT OPIN PHARMACO, V13, P1299, DOI 10.1517/14656566.2012.687721
   Turner Lucy, 2012, Syst Rev, V1, P60, DOI 10.1186/2046-4053-1-60
   World Health Organization, 2010, WHO LAB EX PROC HUM
   Zanini G, 2011, REPROD BIOMED ONLINE, V23, P565, DOI 10.1016/j.rbmo.2011.08.007
   Zhang QF, 2010, J ANDROL, V31, P215, DOI 10.2164/jandrol.109.007609
NR 31
TC 3
Z9 4
U1 1
U2 4
PU ACTA PHARMACOLOGICA SINICA
PI SHANGHAI
PA 294 TAI-YUAN RD, SHANGHAI, 200031, PEOPLES R CHINA
SN 1008-682X
EI 1745-7262
J9 ASIAN J ANDROL
JI Asian J. Androl.
PD NOV
PY 2013
VL 15
IS 6
BP 806
EP 811
DI 10.1038/aja.2013.99
PG 6
WC Andrology; Urology & Nephrology
SC Endocrinology & Metabolism; Urology & Nephrology
GA 250TO
UT WOS:000326878200026
PM 24121976
ER

PT J
AU Gonzales, GF
   Gonzales-Castaneda, C
   Gasco, M
AF Gonzales, Gustavo F.
   Gonzales-Castaneda, Cynthia
   Gasco, Manuel
TI A mixture of extracts from Peruvian plants (black maca and yacon)
   improves sperm count and reduced glycemia in mice with
   streptozotocin-induced diabetes
SO TOXICOLOGY MECHANISMS AND METHODS
LA English
DT Article
DE Antioxidants; black maca; diabetes; Lepidium meyenii; polyphenols;
   Smallanthus sonchifolius; sperm count; yacon
ID LEPIDIUM-MEYENII MACA; SONCHIFOLIUS LEAF EXTRACTS; BETA-CELL DAMAGE;
   ADULT MALE RATS; SMALLANTHUS-SONCHIFOLIUS; ANTIOXIDANT ACTIVITY; SEXUAL
   DYSFUNCTION; OXIDATIVE STRESS; LIVER-INJURY; FLAVONOID ANTIOXIDANT
AB We investigated the effect of two extracts from Peruvian plants given alone or in a mixture on sperm count and glycemia in streptozotocin-diabetic mice. Normal or diabetic mice were divided in groups receiving vehicle, black maca (Lepidium meyenii), yacon (Smallanthus sonchifolius) or three mixtures of extracts black maca/yacon (90/10, 50/50 and 10/90%). Normal or diabetic mice were treated for 7 d with each extract, mixture or vehicle. Glycemia, daily sperm production (DSP), epididymal and vas deferens sperm counts in mice and polyphenol content, and antioxidant activity in each extract were assessed. Black maca (BM), yacon and the mixture of extracts reduced glucose levels in diabetic mice. Non-diabetic mice treated with BM and yacon showed higher DSP than those treated with vehicle (p<0.05). Diabetic mice treated with BM, yacon and the mixture maca/yacon increased DSP, and sperm count in vas deferens and epididymis with respect to non-diabetic and diabetic mice treated with vehicle (p<0.05). Yacon has 3.05 times higher polyphenol content than in maca, and this was associated with higher antioxidant activity. The combination of two extracts improved glycemic levels and male reproductive function in diabetic mice. Streptozotocin increased 1.43 times the liver weight that was reversed with the assessed plants extracts. In summary, streptozotocin-induced diabetes resulted in reduction in sperm counts and liver damage. These effects could be reduced with BM, yacon and the BM+yacon mixture.
C1 [Gonzales, Gustavo F.; Gonzales-Castaneda, Cynthia; Gasco, Manuel] Univ Peruana Cayetano Heredia, Fac Sci & Philosophy, Dept Biol & Physiol Sci, Lima 31, Peru.
   [Gonzales, Gustavo F.; Gonzales-Castaneda, Cynthia; Gasco, Manuel] Univ Peruana Cayetano Heredia, Fac Sci & Philosophy, LID, Lima 31, Peru.
   [Gonzales, Gustavo F.; Gonzales-Castaneda, Cynthia; Gasco, Manuel] Univ Peruana Cayetano Heredia, Inst Invest Altura, Lima 31, Peru.
RP Gonzales, GF (reprint author), Univ Peruana Cayetano Heredia, Av Honorio Delgado 430, Lima 31, Peru.
EM gustavo.gonzales@upch.pe
RI Gonzales , Gustavo/I-9153-2016
OI Gonzales , Gustavo/0000-0003-1611-2894
FU PROCOM; CONCYTEC (Consejo Nacional de Ciencia, Tecnologia e Innovacion),
   Lima-Peru
FX Dr Gustavo F. Gonzales is in charge of CAYENATUR EIRL. No other authors
   have conflict of interest. This study was supported by PROCOM 2007
   granted to Dr Gustavo F. Gonzales, by CONCYTEC (Consejo Nacional de
   Ciencia, Tecnologia e Innovacion), Lima-Peru.
CR Ahmed D, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-10
   Aladag I, 2009, J LARYNGOL OTOL, V9, P1
   Amaral Sandra, 2008, Curr Diabetes Rev, V4, P46
   Aquino R, 2001, J NAT PROD, V64, P1019, DOI 10.1021/np0101245
   Aybar MJ, 2001, J ETHNOPHARMACOL, V74, P125, DOI 10.1016/S0378-8741(00)00351-2
   Ballester J, 2004, J ANDROL, V25, P706
   Bener A, 2009, INT UROL NEPHROL, V41, P777, DOI 10.1007/s11255-009-9565-6
   Brooks NA, 2008, MENOPAUSE, V15, P1157, DOI [10.1097/gme.0b013e3181732953, 10.1097/01.gme.0b013e3181732953]
   Campos D, 2012, FOOD CHEM, V135, P1592, DOI 10.1016/j.foodchem.2012.05.088
   Chao CL, 2008, BR J NUTR, V14, P1
   Cobo Bernabe, 1956, HIST NUEVO MUNDO
   Coskun O, 2005, PHARMACOL RES, V51, P117, DOI 10.1016/j.phrs.2004.06.002
   Dandona P, 2009, POSTGRAD MED, V121, P45, DOI 10.3810/pgm.2009.05.2001
   Dandu AM, 2009, PAK J PHARM SCI, V22, P49
   Dekel Y, 2009, LAB ANIMAL, V38, P55, DOI 10.1038/laban0209-55
   Dording CM, 2008, CNS NEUROSCI THER, V14, P182, DOI 10.1111/j.1755-5949.2008.00052.x
   Enzlin P, 2002, DIABETES CARE, V25, P672, DOI 10.2337/diacare.25.4.672
   Fang XK, 2008, LIFE SCI, V82, P615, DOI 10.1016/j.lfs.2007.12.021
   Gasco M, 2007, ANDROLOGIA, V39, P151, DOI 10.1111/j.1439-0272.2007.00783.x
   Genta SB, 2010, CHEM-BIOL INTERACT, V185, P143, DOI 10.1016/j.cbi.2010.03.004
   Gezginci-Oktayoglu S, 2009, DIGEST DIS SCI, V54, P538, DOI 10.1007/s10620-008-0381-0
   Gonzales C, 2006, J ETHNOPHARMACOL, V103, P448, DOI 10.1016/j.jep.2005.08.035
   Gonzales GF, 2006, ANDROLOGIA, V38, P166, DOI 10.1111/j.1439-0272.2006.00733.x
   Gonzales GF, 2001, ASIAN J ANDROL, V3, P231
   Gonzales GF, 2006, RECENT PROGR MED PLA, V15, P217
   Gonzales GF, 2004, J ENDOCRINOL, V180, P87, DOI 10.1677/joe.0.1800087
   Gonzalez GF, 2001, ASIAN J ANDROL, V3, P301
   Guven A, 2006, ACTA HISTOCHEM, V108, P85, DOI 10.1016/j.acthis.2006.03.005
   Hamadi N, 2012, J BIOCHEM MOL TOXIC, V26, P384, DOI 10.1002/jbt.21432
   Hamden Khaled, 2010, Archives of Physiology and Biochemistry, V116, P146, DOI 10.3109/13813455.2010.486405
   Hisatomi A, 2008, TOXICOLOGY, V243, P23, DOI 10.1016/j.tox.2007.09.017
   Honore SM, 2012, FOOD CHEM TOXICOL, V50, P1704, DOI 10.1016/j.fct.2012.02.073
   Kahkonen MP, 1999, J AGR FOOD CHEM, V47, P3954, DOI 10.1021/jf990146l
   Kaleem M, 2008, SINGAP MED J, V49, P800
   Kim EK, 2008, INT J MOL MED, V22, P481, DOI 10.3892/ijmm_00000046
   Kishore A, 2008, CHEM-BIOL INTERACT, V177, P242
   Lee KJ, 2005, AQUACULTURE, V244, P293, DOI 10.1016/j.aquaculture.2004.12.006
   Lee W, 2013, BIOCH BIOPHYS RES CO
   Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7
   Lu CC, 2009, J SEX MED, V6, P1719, DOI 10.1111/j.1743-6109.2009.01219.x
   Machha A, 2007, NITRIC OXIDE-BIOL CH, V16, P442, DOI 10.1016/j.niox.2007.04.001
   Nabi SA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-37
   *NAT RES COUNC, 1996, GUID CAR US LAB AN
   Olubomehin OO, 2013, J ETHNOPHARMACOL, V146, P811, DOI 10.1016/j.jep.2013.02.007
   Panda S, 2007, BIOFACTORS, V31, P201, DOI 10.1002/biof.5520310307
   Rehman K, 2001, J SEX REPROD MED, V1, P29
   Rubinstein R, 2008, CLIN EXP IMMUNOL, V154, P235, DOI 10.1111/j.1365-2249.2008.03742.x
   Rubio J, 2007, FOOD CHEM TOXICOL, V45, P1882, DOI 10.1016/j.fct.2007.04.002
   Rubio J, 2006, FOOD CHEM TOXICOL, V44, P1114, DOI 10.1016/j.fct.2006.01.007
   Sandoval M, 2002, FOOD CHEM, V79, P207, DOI 10.1016/S0308-8146(02)00133-4
   Barcellona CS, 2012, J ETHNOPHARMACOL, V144, P362, DOI 10.1016/j.jep.2012.09.021
   Seven A, 2004, YONSEI MED J, V45, P703
   Shrilatha B, 2007, INT J ANDROL, V30, P508, DOI 10.1111/j.1365-2605.2007.00748.x
   Shrilatha B, 2007, REPROD TOXICOL, V23, P578, DOI 10.1016/j.reprotox.2007.02.001
   Sing S, 2005, ANAT REC PART A, V287, P1281
   Tabatabaei S R Fatemi, 2008, Pak J Biol Sci, V11, P633
   Takahashi O, 2003, FOOD CHEM TOXICOL, V41, P1035, DOI 10.1016/S0278-6915(03)00031-0
   Thayer KA, 2001, HUM REPROD, V16, P988, DOI 10.1093/humrep/16.5.988
   Valentova K, 2004, CELL BIOL TOXICOL, V20, P109, DOI 10.1023/B:CBTO.0000027931.88957.80
   Valentova K, 2003, EUR J NUTR, V42, P61, DOI 10.1007/s00394-003-0402-x
   Valentova K, 2006, CELL BIOL TOXICOL, V22, P91, DOI 10.1007/s10565-006-0033-0
   Valentova K, 2005, J AGR FOOD CHEM, V53, P5577, DOI 10.1021/jf050403o
   Valentova Katerina, 2003, Biomedical Papers (Olomouc), V147, P119
   Valerio Luis G Jr, 2005, Toxicol Rev, V24, P11, DOI 10.2165/00139709-200524010-00002
   Vecera R, 2007, PLANT FOOD HUM NUTR, V62, P59, DOI 10.1007/s11130-007-0042-z
   Xiang Z, 2010, NAT PROD COMMUN, V5, P95
   Xie W., 2008, J CHINESE MED MAT, V31, P1510
   Yadav D, 2012, PROTOPLASMA
   Yucra S, 2008, FERTIL STERIL, V89, P1461, DOI 10.1016/j.fertnstert.2007.04.052
   Zhao Hongguang, 2004, Zhonghua Nan Ke Xue, V10, P767
   Zheng BL, 2000, UROLOGY, V55, P598, DOI 10.1016/S0090-4295(99)00549-X
   Zivic Sasa, 2008, Med Pregl, V61, P458
   [Anonymous], 2013, TOXICOL MECH METHODS, V23, P509
NR 73
TC 1
Z9 3
U1 6
U2 50
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1537-6516
J9 TOXICOL MECH METHOD
JI Toxicol. Mech. Methods
PD SEP
PY 2013
VL 23
IS 7
BP 509
EP 518
DI 10.3109/15376516.2013.785656
PG 10
WC Toxicology
SC Toxicology
GA 211WU
UT WOS:000323943300005
PM 23489070
ER

PT J
AU Anderson, KS
   Miller, BT
   Wolf, LJ
   Shah, TA
AF Anderson, K. S.
   Miller, B. T.
   Wolf, L. J.
   Shah, T. A.
TI STRICT SPERM MORPHOLOGY IS PREDICTIVE OF INTRAUTERINE INSEMINATION
   SUCCESS IN CASES OF NORMAL INSEMINATING TOTAL MOTILE SPERM COUNT.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT International-Federation-of-Fertility-Societies 21st World Congress on
   Fertility and Sterility / 69th Annual Meeting of the
   American-Society-for-Reproductive-Medicine
CY OCT 12-17, 2013
CL Boston, MA
SP Int Federat Fertil Soc, Amer Soc Reprod Med
C1 [Anderson, K. S.] Oakland Univ, William Beaumont Sch Med, Dept Obstet & Gynecol, Royal Oak, MI USA.
   [Miller, B. T.; Wolf, L. J.; Shah, T. A.] Reprod Med Associates Michigan, Troy, MI USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2013
VL 100
IS 3
SU S
MA P-987
BP S433
EP S433
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AQ1PY
UT WOS:000342554502001
ER

PT J
AU Hammoud, AO
   VanDerslice, J
   Al-Temimi, MH
   Peterson, CM
   Blauer, K
   Carrell, D
AF Hammoud, A. O.
   VanDerslice, J.
   Al-Temimi, M. H.
   Peterson, C. M.
   Blauer, K.
   Carrell, D.
TI EVIDENCE OF A RECENT DECLINE IN SPERM COUNT IN A UNITED STATES
   POPULATION FROM 2002-2010
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT International-Federation-of-Fertility-Societies 21st World Congress on
   Fertility and Sterility / 69th Annual Meeting of the
   American-Society-for-Reproductive-Medicine
CY OCT 12-17, 2013
CL Boston, MA
SP Int Federat Fertil Soc, Amer Soc Reprod Med
C1 [Hammoud, A. O.; VanDerslice, J.; Al-Temimi, M. H.; Peterson, C. M.; Blauer, K.; Carrell, D.] Univ Utah, Salt Lake City, UT USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2013
VL 100
IS 3
SU S
MA O-41
BP S13
EP S13
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AQ1PY
UT WOS:000342554500042
ER

PT J
AU Kim, YY
   Lee, KH
   Park, IH
   Sun, HG
   Kim, SG
   Lee, JH
AF Kim, Y. Y.
   Lee, K. H.
   Park, I. H.
   Sun, H. G.
   Kim, S. G.
   Lee, J. H.
TI USE OF THE TOTAL MOTILE SPERM COUNT TO PREDICT PREGNANCY OUTCOMES IN IN
   VITRO FERTILIZATION.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT International-Federation-of-Fertility-Societies 21st World Congress on
   Fertility and Sterility / 69th Annual Meeting of the
   American-Society-for-Reproductive-Medicine
CY OCT 12-17, 2013
CL Boston, MA
SP Int Federat Fertil Soc, Amer Soc Reprod Med
C1 [Kim, Y. Y.; Lee, K. H.; Park, I. H.; Sun, H. G.; Kim, S. G.; Lee, J. H.] Mamapapa&Baby Obstet & Gynecol, Infertil Lab, Infertil Clin, Ulsan, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2013
VL 100
IS 3
SU S
MA P-1040
BP S448
EP S448
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AQ1PY
UT WOS:000342554502053
ER

PT J
AU Said, AH
   Reed, ML
   Thompson, DJ
   Caperton, CL
AF Said, A-H
   Reed, M. L.
   Thompson, D. J.
   Caperton, C. L.
TI COMPARING SPERM CHECK (R) FERTILITY KITS DESIGNED FOR SPERM COUNT
   SCREENING AT HOME, IN A CLINICAL ANDROLOGY LAB SETTING.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT International-Federation-of-Fertility-Societies 21st World Congress on
   Fertility and Sterility / 69th Annual Meeting of the
   American-Society-for-Reproductive-Medicine
CY OCT 12-17, 2013
CL Boston, MA
SP Int Federat Fertil Soc, Amer Soc Reprod Med
C1 [Said, A-H; Reed, M. L.; Thompson, D. J.; Caperton, C. L.] Ctr Reprod Med New Mexico, Albuquerque, NM USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2013
VL 100
IS 3
SU S
MA P-1028
BP S445
EP S445
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AQ1PY
UT WOS:000342554502041
ER

PT J
AU Patil, PS
   Humbarwadi, RS
   Patil, AD
   Gune, AR
AF Patil, Priya S.
   Humbarwadi, Rajendra S.
   Patil, Ashalata D.
   Gune, Anita R.
TI Immature germ cells in semen - Correlation with total sperm count and
   sperm motility
SO JOURNAL OF CYTOLOGY
LA English
DT Article
DE Immature germ cells; round cells; semen; total sperm count
ID WHITE BLOOD-CELLS; ROUND CELLS
AB Background: Current data regarding infertility suggests that male factor contributes up to 30% of the total cases of infertility. Semen analysis reveals the presence of spermatozoa as well as a number of non-sperm cells, presently being mentioned in routine semen report as "round cells" without further differentiating them into leucocytes or immature germ cells.
   Aim: The aim of this work was to study a simple, cost-effective, and convenient method for differentiating the round cells in semen into immature germ cells and leucocytes and correlating them with total sperm counts and motility.
   Materials and Methods: Semen samples from 120 males, who had come for investigation for infertility, were collected, semen parameters recorded, and stained smears studied for different round cells. Statistical analysis of the data was done to correlate total sperm counts and sperm motility with the occurrence of immature germ cells and leucocytes. The average shedding of immature germ cells in different groups with normal and low sperm counts was compared. The clinical significance of "round cells" in semen and their differentiation into leucocytes and immature germ cells are discussed.
   Conclusions: Round cells in semen can be differentiated into immature germ cells and leucocytes using simple staining methods. The differential counts mentioned in a semen report give valuable and clinically relevant information. In this study, we observed a negative correlation between total count and immature germ cells, as well as sperm motility and shedding of immature germ cells. The latter was statistically significant with a P value 0.000.
C1 [Patil, Priya S.] Dr DY Patil Med Coll, Dept Anat, Kolhapur 416006, Maharashtra, India.
   Univ Kolhapur, Kolhapur, Maharashtra, India.
RP Patil, PS (reprint author), Dr DY Patil Med Coll, Dept Anat, Kolhapur 416006, Maharashtra, India.
EM priyakolhapur@yahoo.co.in
CR Agarwal A, 2008, UROL CLIN N AM, V35, P157, DOI 10.1016/j.ucl.2008.01.012
   Ariagno J, 2002, ARCH ANDROLOGY, V48, P127
   AUROUX M, 1984, ARCH ANDROLOGY, V12, P197
   Cooper TG, 2002, MANUAL BASIC SEMEN A, P4
   FEDDER J, 1993, ARCH ANDROLOGY, V31, P95
   Gandini L, 1999, HUM REPROD, V14, P1022, DOI 10.1093/humrep/14.4.1022
   JASSIM A, 1987, J REPROD IMMUNOL, V11, P77, DOI 10.1016/0165-0378(87)90013-1
   Johanisson E, 2000, HUM REPROD UPDATE, V6, P404, DOI 10.1093/humupd/6.4.404
   Dacie John V, 1995, PRACTICAL HAEMATOLOG, P85
   Kahraman S, 1998, HUM REPROD, V13, P104, DOI 10.1093/humrep/13.1.104
   Phadke AM, 2007, CLIN ATLAS SPERM MOR
   POLITCH JA, 1993, FERTIL STERIL, V60, P372
   Roy S, 2001, ASIAN J ANDROL, P157
   TOMLINSON MJ, 1992, FERTIL STERIL, V58, P1257
   Cooper TG, 2010, WHO LAB MAN EX PROC
   Williams MA, 1996, BIOTECH HISTOCHEM, V71, P118, DOI 10.3109/10520299609117147
   WOLFF H, 1995, FERTIL STERIL, V63, P1143
NR 17
TC 3
Z9 3
U1 0
U2 2
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0970-9371
J9 J CYTOL
JI J. Cytol.
PD JUL-SEP
PY 2013
VL 30
IS 3
BP 185
EP 189
DI 10.4103/0970-9371.117682
PG 5
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA 223BK
UT WOS:000324778400008
PM 24130411
ER

PT J
AU Schwetz, V
   Gumpold, R
   Graupp, M
   Hacker, N
   Schweighofer, N
   Trummer, O
   Pieber, TR
   Ballon, M
   Lerchbaum, E
   Obermayer-Pietsch, B
AF Schwetz, V.
   Gumpold, R.
   Graupp, M.
   Hacker, N.
   Schweighofer, N.
   Trummer, O.
   Pieber, T. R.
   Ballon, M.
   Lerchbaum, E.
   Obermayer-Pietsch, B.
TI Osteocalcin is not a strong determinant of serum testosterone and sperm
   count in men from infertile couples
SO ANDROLOGY
LA English
DT Article
DE carboxylated osteocalcin; male fertility; osteocalcin; testosterone;
   undercarboxylated osteocalcin
ID HORMONE-BINDING GLOBULIN; BONE MASS; UNDERCARBOXYLATED OSTEOCALCIN;
   ENERGY-METABOLISM; OSTEOPOROSIS; GLUCOSE; PROTEIN; LEPTIN; ASSOCIATION;
   SKELETON
AB Osteocalcin (OC) - released by osteoblasts and known as a marker of bone turnover - has been suggested to influence male fertility in murine models by enhancing testosterone production and sperm count. Results from clinical studies are scarce, however. The aim of this cross-sectional study was to investigate the proposed association of OC, undercarboxylated osteocalcin (ucOC) or carboxylated osteocalcin (cOC) with testosterone and sperm count in a cohort of 159 young male adults from infertile couples. Semen analysis was performed. Testosterone, free testosterone, LH, OC and ucOC were measured in serum samples after an overnight fast. cOC and OC correlated weakly but significantly with testosterone (OC: r=0.165, p=0.040, cOC: r=0.193, p=0.017), but not after adjusting for age and body mass index (BMI) or waist-hip ratio (WHR). %ucOC (ucOC levels expressed as percentage of total OC) correlated inversely with LH (r=-0.184, p=0.023) and remained significant after the same adjustment. No significant correlations were observed between OC, cOC, ucOC, %ucOC and sperm count, semen volume and number of vital spermatozoa. In binary logistic regression analyses, none of the parameters of OC were predictors of oligozoospermia after adjusting for age and BMI or WHR. The weak association between %ucOC and LH has marginal clinical importance because of the lack of associations of parameters of OC with testosterone and sperm count. The current data thus cannot support the notion that OC is associated with male fertility in young men from infertile couples.
C1 [Schwetz, V.; Gumpold, R.; Hacker, N.; Schweighofer, N.; Trummer, O.; Pieber, T. R.; Lerchbaum, E.; Obermayer-Pietsch, B.] Med Univ Graz, Div Endocrinol & Metab, Dept Internal Med, A-8036 Graz, Austria.
   [Graupp, M.] Med Univ Graz, Dept Otorhinolaryngol, A-8036 Graz, Austria.
   [Ballon, M.] Med Univ Graz, Dept Obstet & Gynecol, A-8036 Graz, Austria.
RP Schwetz, V (reprint author), Med Univ Graz, Div Endocrinol & Metab, Dept Internal Med, Auenbruggerpl 15, A-8036 Graz, Austria.
EM verena.schwetz@medunigraz.at
FU BioPersMed (COMET K-project) [825329]; Federal Ministry of Transport,
   Innovation and Technology (BMVIT); Federal Ministry of Economics and
   Labour/the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ);
   Styrian Business Promotion Agency (SFG)
FX This work was supported by BioPersMed (COMET K-project 825329) which is
   funded by the Federal Ministry of Transport, Innovation and Technology
   (BMVIT) and the Federal Ministry of Economics and Labour/the Federal
   Ministry of Economy, Family and Youth (BMWA/BMWFJ) and the Styrian
   Business Promotion Agency (SFG).
CR Castilla JA, 2006, HUM REPROD, V21, P847, DOI 10.1093/humrep/dei423
   Clarke BL, 2009, STEROIDS, V74, P296, DOI 10.1016/j.steroids.2008.10.003
   Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5
   Falahati-Nini A, 2000, J CLIN INVEST, V106, P1553, DOI 10.1172/JCI10942
   Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003
   Gundberg CM, 1998, J CLIN ENDOCR METAB, V83, P3258, DOI 10.1210/jc.83.9.3258
   Hannemann A, 2013, ANDROLOGY-US, V1, P469, DOI 10.1111/j.2047-2927.2012.00044.x
   Hwang YC, 2012, DIABETES CARE, V35, P1919, DOI 10.2337/dc11-2471
   Kanazawa I, 2013, OSTEOPOROSIS INT, V24, P1115, DOI 10.1007/s00198-012-2017-7
   Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008
   Kindblom JM, 2009, J BONE MINER RES, V24, P785, DOI [10.1359/jbmr.081234, 10.1359/JBMR.081234]
   Kirmani S, 2011, J BONE MINER RES, V26, P2212, DOI 10.1002/jbmr.421
   Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006
   Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047
   Legrand E, 2001, BONE, V29, P90, DOI 10.1016/S8756-3282(01)00478-1
   Lerchbaum E, 2013, OSTEOPOROSIS INT, V24, P1321, DOI 10.1007/s00198-012-2076-9
   Lu CY, 2012, J CLIN ENDOCR METAB, V97, P4106, DOI 10.1210/jc.2012-2045
   MacLean C, 2008, ANN INTERN MED, V148, P197
   Motyl KJ, 2010, ARCH BIOCHEM BIOPHYS, V503, P2, DOI 10.1016/j.abb.2010.07.030
   Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004
   Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200
   PIETSCHMANN P, 1988, J CLIN ENDOCR METAB, V66, P1071
   Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422
   PRICE PA, 1981, J BIOL CHEM, V256, P2760
   PRICE PA, 1981, J BIOL CHEM, V256, P2754
   Sadeu JC, 2010, CRIT REV TOXICOL, V40, P633, DOI 10.3109/10408444.2010.493552
   Schwetz V, 2012, EUR J ENDOCRINOL, V166, P959, DOI 10.1530/EJE-12-0030
   Walimaki VV, 2004, J CLIN ENDOCR METAB, V89, P3785, DOI 10.1210/jc.2003-032187
   Watts NB, 2010, J CLIN ENDOCR METAB, V95, P1555, DOI 10.1210/jc.2009-1947
   Cooper TG, 2010, WHO LAB MAN EX PROC
NR 30
TC 7
Z9 7
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2047-2919
J9 ANDROLOGY-US
JI Andrology
PD JUL
PY 2013
VL 1
IS 4
BP 590
EP 594
DI 10.1111/j.2047-2927.2013.00095.x
PG 5
WC Andrology
SC Endocrinology & Metabolism
GA 167FZ
UT WOS:000320618100010
PM 23696116
ER

PT J
AU Sermondade, N
   Faure, C
   Fezeu, L
   Shayeb, AG
   Bonde, JP
   Jensen, TK
   Van Wely, M
   Cao, J
   Martini, AC
   Eskandar, M
   Chavarro, JE
   Koloszar, S
   Twigt, JM
   Ramlau-Hansen, CH
   Borges, E
   Lotti, F
   Steegers-Theunissen, RPM
   Zorn, B
   Polotsky, AJ
   La Vignera, S
   Eskenazi, B
   Tremellen, K
   Magnusdottir, EV
   Fejes, I
   Hercberg, S
   Levy, R
   Czernichow, S
AF Sermondade, N.
   Faure, C.
   Fezeu, L.
   Shayeb, A. G.
   Bonde, J. P.
   Jensen, T. K.
   Van Wely, M.
   Cao, J.
   Martini, A. C.
   Eskandar, M.
   Chavarro, J. E.
   Koloszar, S.
   Twigt, J. M.
   Ramlau-Hansen, C. H.
   Borges, E., Jr.
   Lotti, F.
   Steegers-Theunissen, R. P. M.
   Zorn, B.
   Polotsky, A. J.
   La Vignera, S.
   Eskenazi, B.
   Tremellen, K.
   Magnusdottir, E. V.
   Fejes, I.
   Hercberg, S.
   Levy, R.
   Czernichow, S.
TI BMI in relation to sperm count: an updated systematic review and
   collaborative meta-analysis
SO HUMAN REPRODUCTION UPDATE
LA English
DT Review
DE obesity; BMI; sperm concentration; total sperm count; meta-analysis
ID BODY-MASS INDEX; SEMEN QUALITY; REPRODUCTIVE HORMONES; OBESE MEN;
   INTERINDIVIDUAL VARIABILITY; SUBFERTILE COUPLES; DNA INTEGRITY;
   HEALTHY-MEN; INHIBIN-B; PARAMETERS
AB The global obesity epidemic has paralleled a decrease in semen quality. Yet, the association between obesity and sperm parameters remains controversial. The purpose of this report was to update the evidence on the association between BMI and sperm count through a systematic review with meta-analysis.
   A systematic review of available literature (with no language restriction) was performed to investigate the impact of BMI on sperm count. Relevant studies published until June 2012 were identified from a Pubmed and EMBASE search. We also included unpublished data (n 717 men) obtained from the Infertility Center of Bondy, France. Abstracts of relevant articles were examined and studies that could be included in this review were retrieved. Authors of relevant studies for the meta-analysis were contacted by email and asked to provide standardized data.
   A total of 21 studies were included in the meta-analysis, resulting in a sample of 13 077 men from the general population and attending fertility clinics. Data were stratified according to the total sperm count as normozoospermia, oligozoospermia and azoospermia. Standardized weighted mean differences in sperm concentration did not differ significantly across BMI categories. There was a J-shaped relationship between BMI categories and risk of oligozoospermia or azoospermia. Compared with men of normal weight, the odds ratio (95 confidence interval) for oligozoospermia or azoospermia was 1.15 (0.931.43) for underweight, 1.11 (1.011.21) for overweight, 1.28 (1.061.55) for obese and 2.04 (1.592.62) for morbidly obese men.
   Overweight and obesity were associated with an increased prevalence of azoospermia or oligozoospermia. The main limitation of this report is that studied populations varied, with men recruited from both the general population and infertile couples. Whether weight normalization could improve sperm parameters should be evaluated further.
C1 [Sermondade, N.; Faure, C.; Levy, R.] Hopl Jean Verdier, AP HP, Serv Histol Embryol Cytogenet CECOS, F-93143 Bondy, France.
   [Sermondade, N.; Faure, C.; Fezeu, L.; Hercberg, S.; Levy, R.] INSERM, Unite Rech Epidemiol Nutr, UMR U557, F-93017 Bobigny, France.
   [Sermondade, N.; Faure, C.; Fezeu, L.; Hercberg, S.; Levy, R.] INRA, U1125, F-93017 Bobigny, France.
   [Sermondade, N.; Faure, C.; Fezeu, L.; Hercberg, S.; Levy, R.] Cnam, F-93017 Bobigny, France.
   [Sermondade, N.; Faure, C.; Fezeu, L.; Hercberg, S.; Levy, R.] Univ Paris 13, CRNH IdF, F-93017 Bobigny, France.
   [Shayeb, A. G.] Univ Wales Hosp, Cardiff CF 14 4XW, S Glam, Wales.
   [Bonde, J. P.] Univ Copenhagen, Bispebjerg Hosp, Dept Occupat & Environm Med, DK-2400 Copenhagen NV, Denmark.
   [Jensen, T. K.] Rigshosp, Univ Dept Growth & Reprod, DK-2100 Copenhagen, Denmark.
   [Van Wely, M.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands.
   [Cao, J.] Third Mil Med Univ, Coll Prevent Med, Chongqing 400038, Peoples R China.
   [Martini, A. C.] Univ Nacl Cordoba, Fac Ciencias Med, Inst Fisiol, RA-5000 Cordoba, Argentina.
   [Eskandar, M.] King Khalid Univ, Coll Med, Dept Obstet & Gynaecol, Abha, Saudi Arabia.
   [Chavarro, J. E.] Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02115 USA.
   [Chavarro, J. E.] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA.
   [Chavarro, J. E.] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Koloszar, S.] Univ Szeged, Dept Obstet & Gynaecol, H-6725 Szeged, Hungary.
   [Twigt, J. M.; Steegers-Theunissen, R. P. M.] Univ Med Ctr, Erasmus MC, Dept Obstet, NL-3000 CA Rotterdam, Netherlands.
   [Twigt, J. M.; Steegers-Theunissen, R. P. M.] Univ Med Ctr, Erasmus MC, Dept Gynaecol, NL-3000 CA Rotterdam, Netherlands.
   [Ramlau-Hansen, C. H.] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, DK-8000 Aarhus C, Denmark.
   [Borges, E., Jr.] Ferti Assisted Fertilizat Ctr, BR-4545 Sao Paulo, Brazil.
   [Lotti, F.] Univ Florence, Dept Clin Physiopathol, Sexual Med & Androl Unit, I-50139 Florence, Italy.
   [Zorn, B.] Univ Med Ctr Ljubljana, Dept Obstet & Gynecol, Androl Ctr, Ljubljana, Slovenia.
   [Polotsky, A. J.] Univ Colorado Denver, Dept Obstet & Gynecol, Aurora, CO 80045 USA.
   [La Vignera, S.] Univ Catania, Sect Andro1 Endocrinol & Internal Med, Policlin G Rodolico, I-95123 Catania, Italy.
   [Eskenazi, B.] Univ Calif Berkeley, Ctr Environm Res & Childrens Hlth, Sch Publ Hlth, Berkeley, CA 94704 USA.
   [Tremellen, K.] Repromed, Adelaide, SA, Australia.
   [Tremellen, K.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.
   [Magnusdottir, E. V.] Univ Iceland, Dept Pharmacol & Toxicol, IS-107 Reykjavik, Iceland.
   [Fejes, I.] Univ Szeged, Dept Ophthalmol, H-6720 Szeged, Hungary.
   [Hercberg, S.] Hop Avicenne, AP HP, Dept Sante Publ, F-93017 Bobigny, France.
   [Czernichow, S.] Hop Ambroise Pare, AP HP, Dept Nutr, F-92100 Boulogne, France.
   [Czernichow, S.] Univ Versailles St Quentin Yvelines, F-92100 Boulogne, France.
   [Czernichow, S.] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France.
RP Czernichow, S (reprint author), Hop Ambroise Pare, AP HP, Dept Nutr, 9 Ave Charles de Gaulle, F-92100 Boulogne, France.
EM sebastien.czernichow@apr.aphp.fr
FU National Institute of Diabetes and Digestive and Kidney Diseases
   [5P30DK046200-19]; National Institutes of Health [P42ES04705]
FX J.E.C. was supported in part by National Institute of Diabetes and
   Digestive and Kidney Diseases grant 5P30DK046200-19 and B. E. was
   supported in part by National Institutes of Health grant P42ES04705.
CR Aggerholm AS, 2008, FERTIL STERIL, V90, P619, DOI 10.1016/j.fertnstert.2007.07.1292
   Akpinar E, 2007, COLLEGIUM ANTROPOL, V31, P387
   Auger J, 2000, HUM REPROD, V15, P2360, DOI 10.1093/humrep/15.11.2360
   Bak CW, 2010, INT J UROL, V17, P937, DOI 10.1111/j.1442-2042.2010.02628.x
   Bjorndahl L, 2011, HUM FERTIL, V14, P179, DOI 10.3109/14647273.2011.580823
   BLANK DM, 1994, BRAIN RES BULL, V34, P571, DOI 10.1016/0361-9230(94)90142-2
   CARLSEN E, 1992, BRIT MED J, V305, P609
   Chavarro JE, 2010, FERTIL STERIL, V93, P2222, DOI 10.1016/j.fertnstert.2009.01.100
   Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048
   Braga DPDF, 2012, FERTIL STERIL, V97, P53, DOI 10.1016/j.fertnstert.2011.10.011
   Duits FH, 2010, FERTIL STERIL, V94, P1356, DOI 10.1016/j.fertnstert.2009.05.075
   Egger M, 1997, BRIT MED J, V315, P629
   Egwurugwu J N, 2011, Niger J Physiol Sci, V26, P29
   Eskandar M, 2012, ADV UROL, V2012
   Eskenazi B, 2003, HUM REPROD, V18, P447, DOI 10.1093/humrep/deg107
   Eustache F, 2003, HUM REPROD, V18, P1018, DOI 10.1093/humrep/deg197
   Fariello RM, 2012, BJU INT, V110, P863, DOI 10.1111/j.1464-410X.2011.10813.x
   Fejes I, 2005, ANDROLOGIA, V37, P155, DOI 10.1111/j.1439-0272.2005.00671.x
   Fejes I, 2006, ARCH ANDROLOGY, V52, P97, DOI 10.1080/01485010500315479
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Gao J, 2007, HUM REPROD, V22, P477, DOI 10.1093/humrep/de1383
   Hakonsen LB, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-24
   Hammiche F, 2011, J ANDROL, V32, P70, DOI 10.2164/jandrol.109.009647
   Hammiche F, 2012, HUM REPROD, V27, P2365, DOI 10.1093/humrep/des177
   Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011
   Hammoud AO, 2010, HUM REPROD, V25, P3146, DOI 10.1093/humrep/deq255
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hofny ERM, 2010, FERTIL STERIL, V94, P581, DOI 10.1016/j.fertnstert.2009.03.085
   Jensen TK, 2004, FERTIL STERIL, V82, P863, DOI 10.1016/j.fertnstert.2004.03.056
   Jouannet P, 2001, APMIS, V109, P333, DOI 10.1034/j.1600-0463.2001.090502.x
   Keltz J, 2010, J ASSIST REPROD GEN, V27, P539, DOI 10.1007/s10815-010-9439-y
   Koloszar S, 2005, ARCH ANDROLOGY, V51, P299, DOI 10.1080/01485010590919701
   Kort HI, 2006, J ANDROL, V27, P450, DOI 10.2164/jandrol.05124
   La Vignera S, 2011, J ANDROL, V33, P53, DOI 10.2164/jandrol.110.012120
   Li YF, 2009, HUM REPROD, V24, P459, DOI 10.1093/humrep/den399
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   Lotti F, 2011, J ENDOCRINOL INVEST, V34, pE336, DOI 10.3275/7855
   MacDonald AA, 2010, HUM REPROD UPDATE, V16, P293, DOI 10.1093/humupd/dmp047
   Magnusdottir EV, 2005, HUM REPROD, V20, P208, DOI 10.1093/humrep/deh569
   Martini AC, 2010, FERTIL STERIL, V94, P1739, DOI 10.1016/j.fertnstert.2009.11.017
   Nguyen RHN, 2007, HUM REPROD, V22, P2488, DOI 10.1093/humrep/dem139
   Nicopoulou SC, 2009, FERTIL STERIL, V92, P1016, DOI 10.1016/j.fertnstert.2008.12.093
   Paasch U, 2010, FERTIL STERIL, V94, P2898, DOI 10.1016/j.fertnstert.2010.06.047
   PARAZZINI F, 1993, ARCH ANDROLOGY, V31, P105
   Pauli EM, 2008, FERTIL STERIL, V90, P346, DOI 10.1016/j.fertnstert.2007.06.046
   Prentice A M, 2001, Obes Rev, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x
   Qin DD, 2007, ASIAN J ANDROL, V9, P827, DOI 10.1111/j.1745-7262.2007.00268.x
   Ramlau-Hansen CH, 2007, HUM REPROD, V22, P1634, DOI 10.1093/humrep/dem035
   Ramlau-Hansen CH, 2010, FERTIL STERIL, V94, P610, DOI 10.1016/j.fertnstert.2009.01.142
   Relwani R, 2011, REPROD SCI, V18, P391, DOI 10.1177/1933719110385708
   Robeva R, 2008, Akush Ginekol (Sofiia), V47, P11
   Rybar R, 2011, ANDROLOGIA, V43, P286, DOI 10.1111/j.1439-0272.2010.01057.x
   Sallmen M, 2006, EPIDEMIOLOGY, V17, P520, DOI 10.1097/01.ede.0000229953.76862.e5
   SCHNEIDER G, 1979, J CLIN ENDOCR METAB, V48, P633
   Sekhavat L, 2010, AGING MALE, V13, P155, DOI 10.3109/13685530903536643
   Sermondade N, 2012, REPROD BIOMED ONLINE, V24, P206, DOI 10.1016/j.rbmo.2011.10.014
   Sermondade N, 2012, ARCH INTERN MED, V172, P440, DOI 10.1001/archinternmed.2011.1382
   SHAFIK A, 1981, BRIT J UROL, V53, P50, DOI 10.1111/j.1464-410X.1981.tb03128.x
   Shayeb AG, 2011, REPROD BIOMED ONLINE, V23, P717, DOI 10.1016/j.rbmo.2011.07.018
   Sifer C, 2005, HUM REPROD, V20, P2769, DOI 10.1093/humrep/dei118
   Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490
   Stewart TM, 2009, HUM REPROD, V24, P1561, DOI 10.1093/humrep/dep075
   STRAIN GW, 1982, METABOLISM, V31, P871, DOI 10.1016/0026-0495(82)90175-5
   Swan SH, 1999, BIOESSAYS, V21, P614
   THONNEAU P, 1991, HUM REPROD, V6, P811
   Tunc O, 2011, ANDROLOGIA, V43, P121, DOI 10.1111/j.1439-0272.2009.01032.x
   Vujkovic M, 2009, HUM REPROD, V24, P1304, DOI 10.1093/humrep/dep024
   Wegner CC, 2010, FERTIL STERIL, V93, P332, DOI 10.1016/j.fertnstert.2009.07.970
   WHO, 2010, LAB MAN EX HUM SEM S
   World Health Organisation, 2000, WHO TECH REP SER, V894
   WHO, 1999, LAB MAN EX HUM SEM S
   Winters SJ, 2006, J ANDROL, V27, P560, DOI 10.2164/jandrol.05193
   Woodward M., 2005, EPIDEMIOLOGY STUDY D
   Zorn B, 2007, INT J ANDROL, V30, P439, DOI 10.1111/j.1365-2605.2006.00728.x
   Zorn B, 2012, J ASSIST REPROD GEN, V29, P357, DOI 10.1007/s10815-012-9718-x
NR 76
TC 69
Z9 72
U1 5
U2 30
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1355-4786
J9 HUM REPROD UPDATE
JI Hum. Reprod. Update
PD MAY-JUN
PY 2013
VL 19
IS 3
BP 221
EP 231
DI 10.1093/humupd/dms050
PG 11
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 133AG
UT WOS:000318109200003
PM 23242914
ER

PT J
AU Ozcan, O
   Malkoc, E
   Cosar, A
   Ipcioglu, OM
   Gultepe, M
   Muftuoglu, T
   Hira, S
   Ates, F
AF Ozcan, Omer
   Malkoc, Ercan
   Cosar, Alpaslan
   Ipcioglu, Osman Metin
   Gultepe, Mustafa
   Muftuoglu, Tuba
   Hira, Serdar
   Ates, Ferhat
TI Prolidase enzyme activity in varicose venous walls related to sperm
   count in patients with varicocele
SO SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
LA English
DT Article
DE Prolidase; varicocele; sperm count; infertility; seminal fluid
ID HYPOXIA-INDUCIBLE FACTOR; HUMAN SKIN FIBROBLASTS; OXIDATIVE STRESS;
   COLLAGEN BIOSYNTHESIS; EXTRACELLULAR-MATRIX; MALE-INFERTILITY; POTENTIAL
   ROLE; LIVER-DISEASE; DEFICIENCY; VEINS
AB Objectives. To investigate peripheral, seminal and varicose venous wall prolidase enzyme activities and their relationships between sperm parameters in patients with varicocele. Design and methods. Prolidase enzyme activities were determined in blood, seminal fluid and varicose vein walls in patients with grade 3 varicocele. Sperm parameters were also measured and the relationships between prolidase enzyme and sperm parameters were assessed by statistical correlation analysis. Results. There was a significant and negative correlation between sperm counts and varicose venous wall prolidase enzyme activities (r = -0.618, p < 0.001) and a positive significant correlation between sperm counts and seminal fluid prolidase enzyme activities (r = -0.676, p < 0.001). None of the parameters were correlated with sperm motility indices. Conclusion. Varicose venous wall prolidase enzyme activity could be an important factor in progression of azoospermia and infertility in patients with varicocele.
C1 [Ozcan, Omer; Ipcioglu, Osman Metin; Gultepe, Mustafa; Muftuoglu, Tuba; Hira, Serdar] GATA Haydarpasa Training Hosp, Dept Clin Biochem, Istanbul, Turkey.
   [Malkoc, Ercan] Corlu Mil Hosp, Dept Urol, Corlu, Tekirdag, Turkey.
   [Cosar, Alpaslan] Van Mil Hosp, Dept Clin Biochem, Van, Turkey.
   [Ates, Ferhat] GATA Haydarpasa Training Hosp, Dept Urol, Istanbul, Turkey.
RP Ozcan, O (reprint author), GATA Haydarpasa Training Hosp, Dept Biochem, Istanbul, Turkey.
EM ozcanmd@yahoo.com
CR Agarwal A, 2008, AM J REPROD IMMUNOL, V59, P2, DOI 10.1111/j.1600-0897.2007.00559.x
   Aitken RJ, 2006, MOL CELL ENDOCRINOL, V250, P66, DOI 10.1016/j.mce.2005.12.026
   Blumer CG, 2008, FERTIL STERIL, V90, P1716, DOI 10.1016/j.fertnstert.2007.09.007
   Cayan S, 2009, J ANDROL, V30, P33, DOI 10.2164/jandrol.108.005967
   CHAMSON A, 1989, CLIN PHYSIOL BIOCH, V7, P128
   Chinard P, 1952, J BIOL CHEM, V199, P61
   CLARKE BG, 1966, J AMER MED ASSOC, V198, P1121, DOI 10.1001/jama.198.10.1121
   EMMERSON KS, 1993, J NUTR, V123, P909
   Erbagci AB, 2002, CLIN BIOCHEM, V35, P263, DOI 10.1016/S0009-9120(02)00305-3
   Falanga V, 2002, J CELL PHYSIOL, V191, P42, DOI 10.1002/jcp.10065
   Gecit I, 2012, J CANCER RES CLIN, V138, P739, DOI 10.1007/s00432-011-1136-4
   GEJYO F, 1983, NEPHRON, V35, P58, DOI 10.1159/000183046
   Gultepe M, 2006, FEBS J, V273, P75
   Iafrate M, 2009, WORLD J UROL, V27, P363, DOI 10.1007/s00345-008-0352-2
   JACKSON SH, 1975, CAN MED ASSOC J, V113, P759
   Kurien BT, 2006, ANAL BIOCHEM, V349, P165, DOI 10.1016/j.ab.2005.10.018
   Lee JD, 2006, J UROLOGY, V175, P1045, DOI 10.1016/S0022-5347(05)00417-9
   Lund L, 1998, SCAND J UROL NEPHROL, V32, P47
   Marmar JL, 2001, HUM REPROD UPDATE, V7, P461, DOI 10.1093/humupd/7.5.461
   Miltyk W, 2000, COMP BIOCHEM PHYS A, V125, P265, DOI 10.1016/S1095-6433(99)00181-6
   Miltyk Wojciech, 1996, Polish Journal of Pharmacology, V48, P609
   MOCK WL, 1990, J BIOL CHEM, V265, P19600
   Musalam AO, 2010, ULTRASTRUCT PATHOL, V34, P260, DOI 10.3109/01913121003793067
   Muszynska A, 2000, EXP TOXICOL PATHOL, V52, P149
   MYARA I, 1984, LIFE SCI, V34, P1985, DOI 10.1016/0024-3205(84)90363-1
   MYARA I, 1985, CLIN BIOCHEM, V18, P220, DOI 10.1016/S0009-9120(85)80043-6
   MYARA I, 1984, CLIN CHEM, V30, P211
   NAKADA T, 1994, J UROLOGY, V151, P1539
   O'Brien J, 2005, UROLOGY, V65, P16, DOI 10.1016/j.urology.2004.07.015
   Ohh M, 2000, NAT CELL BIOL, V2, P423
   OSTER J, 1971, Scandinavian Journal of Urology and Nephrology, V5, P27, DOI 10.3109/00365597109133569
   Palka JA, 1997, J CELL BIOCHEM, V67, P166, DOI 10.1002/(SICI)1097-4644(19971101)67:2<166::AID-JCB2>3.0.CO;2-V
   Palka Jerzy A., 1996, Tokai Journal of Experimental and Clinical Medicine, V21, P207
   Surazynski A, 2008, AMINO ACIDS, V35, P731, DOI 10.1007/s00726-008-0051-8
   Surazynski A, 2008, INT J CANCER, V122, P1435, DOI 10.1002/ije.23263
   Tanji N, 1999, INT J UROL, V6, P355, DOI 10.1046/j.1442-2042.1999.00076.x
   Tilki D, 2007, EUR UROL, V51, P1402, DOI 10.1016/j.eururo.2006.11.010
   Turner TT, 2008, J ANDROL, V29, P488, DOI 10.2164/jandrol.108.005132
   Vural M, 2012, J OBSTET GYNAECOL, V32, P68, DOI 10.3109/01443615.2011.633718
   World Health Organization WHO, 1992, LAB MAN EX HUM SEM S
   ZANABONI G, 1994, HAEMATOLOGICA, V79, P13
   Zimmer M, 2004, MOL CANCER RES, V2, P89
NR 42
TC 1
Z9 1
U1 1
U2 5
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0036-5513
J9 SCAND J CLIN LAB INV
JI Scand. J. Clin. Lab. Invest.
PD MAR
PY 2013
VL 73
IS 2
BP 97
EP 101
DI 10.3109/00365513.2012.743676
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 103DY
UT WOS:000315896000001
PM 23171426
ER

PT J
AU Lucio, RA
   Tlachi-Lopez, JL
   Eguibar, JR
   Agmo, A
AF Angelica Lucio, Rosa
   Tlachi-Lopez, Jose L.
   Eguibar, Jose R.
   Agmo, Anders
TI Sperm count and sperm motility decrease in old rats
SO PHYSIOLOGY & BEHAVIOR
LA English
DT Article
DE Copulatory parameters; Seminal parameters; Seminal plug; Sexual
   behavior; Sperm motility; Sperm count
ID BROWN-NORWAY RAT; BENIGN PROSTATIC HYPERPLASIA; SEXUAL-BEHAVIOR; MALE
   AGE; COPULATORY-BEHAVIOR; FEMALE RAT; AGING MEN; LIFE-SPAN; FERTILITY;
   SPERMATOZOA
AB Sexual behavior declines with age in male rats. The rate and magnitude of this decline may depend on the amount of prior sexual experience and a number of other, unidentified factors. Age-dependent changes in the characteristics of ejaculate quality in rats have not been described earlier, and the relationship between such changes and modifications of sexual behavior is likewise unknown. We have recently developed a technique for the detailed analysis of parameters of ejaculate in rats, and this technique was used for the determination of semen and seminal plug characteristics in rats of different ages. Sexually experienced Wistar rats were tested for sex behavior at the ages of 3, 12 and 24 months. Semen was obtained from the female partner immediately after ejaculation at these tests. Between tests, the males were offered the opportunity to copulate once every 3-4 weeks. The behavioral data showed that the latency to ejaculation was increased only at 24 months. Concerning the characteristics of semen, there was a substantial increase in the proportion of immobile spermatozoa and motility of those moving was much reduced, both at 12 and 24 months of age. There was no relationship between parameters of sexual behavior and those of the ejaculate. Likewise, the size of the seminal plug did not affect the amount of intrauterine spermatozoa. The reduced sperm number together with the increased sperm immobility diminishes the ejaculate quality of old males, which could influence fertility. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Angelica Lucio, Rosa; Tlachi-Lopez, Jose L.] Univ Autonoma Tlaxcala, Ctr Tlaxcala Biol Conducta, Tlaxcala 90062, Tlax, Mexico.
   [Eguibar, Jose R.] Benemerita Univ Autonoma Puebla, Inst Fisiol, Puebla 72430, Pue, Mexico.
   [Eguibar, Jose R.] Benemerita Univ Autonoma Puebla, Direcc Relac Int, Puebla 72430, Pue, Mexico.
   [Agmo, Anders] Univ Tromso, Inst Psychol, N-9037 Tromso, Norway.
RP Lucio, RA (reprint author), Univ Autonoma Tlaxcala, Ctr Tlaxcala Biol Conducta, Carretera Tlaxcala Puebla Km 1-5 S-N, Tlaxcala 90062, Tlax, Mexico.
EM lucioral@yahoo.com.mx
FU CONACYT [105502, 164340]; Red de Cuerpos Academicos UAM-UAT-UNAM
   "Fisiologia, Farmacologia y Biologia Molecular de la Conducta"
FX This research was supported by CONACYT grant 105502 to RAL, and
   partially supported by Red de Cuerpos Academicos UAM-UAT-UNAM
   "Fisiologia, Farmacologia y Biologia Molecular de la Conducta" 2012.
   JLTL received a fellowship from CONACYT 164340.
CR ADLER NT, 1969, J COMP PHYSIOL PSYCH, V69, P613, DOI 10.1037/h0028244
   Allen WE, 2001, FERTILIDAD OBSTET
   Lucio RA, 2009, VET MEXICO, V40, P405
   AUSTIN D, 1986, PHYSIOL BEHAV, V37, P627, DOI 10.1016/0031-9384(86)90297-0
   BLAZAK WF, 1985, FUND APPL TOXICOL, V5, P1097, DOI 10.1016/0272-0590(85)90145-9
   BOSTOFTE E, 1990, FERTIL STERIL, V54, P1100
   Bravo PW, 1997, BIOL REPROD, V57, P520, DOI 10.1095/biolreprod57.3.520
   BUJAN L, 1988, ANDROLOGIA, V20, P121
   CARBALLADA R, 1993, J EXP ZOOL, V265, P61, DOI 10.1002/jez.1402650109
   CHAMBERS KC, 1991, NEUROBIOL AGING, V12, P123, DOI 10.1016/0197-4580(91)90050-T
   Chen JC, 2007, BRAIN RES, V1184, P186, DOI 10.1016/j.brainres.2007.10.003
   CHOWDHURY AK, 1979, STEROIDS, V34, P151, DOI 10.1016/0039-128X(79)90044-8
   Chu X, 2008, PHARMACOL BIOCHEM BE, V89, P209, DOI 10.1016/j.pbb.2007.12.012
   CLARK JT, 1995, NEUROSCI BIOBEHAV R, V19, P279, DOI 10.1016/0149-7634(94)00058-9
   Claus S, 1997, J UROLOGY, V158, P217, DOI 10.1097/00005392-199707000-00074
   COOPERSMITH C, 1994, J REPROD FERTIL, V102, P451
   CUKIERSKI MA, 1991, REPROD TOXICOL, V5, P347, DOI 10.1016/0890-6238(91)90093-U
   Dain L, 2011, FERTIL STERIL, V95, P1
   Davidson J. M., 1969, Biology of Reproduction Suppl, VNo. 1, P67, DOI 10.1095/biolreprod1.Supplement_1.67
   DEWSBURY DA, 1984, BEHAV ECOL SOCIOBIOL, V16, P37, DOI 10.1007/BF00293102
   EDMONDS ES, 1980, PHYSIOL BEHAV, V24, P1139, DOI 10.1016/0031-9384(80)90060-8
   FLANNELLY KJ, 1985, J COMP PSYCHOL, V99, P87
   Haidl G, 1996, HUM REPROD, V11, P558
   HOWARTH B, 1978, POULTRY SCI, V57, P1751
   Hwang K, 2011, NAT REV UROL, V8, P86, DOI 10.1038/nrurol.2010.230
   Judd JE, 1997, J ANDROL, V18, P698
   Kidd SA, 2001, FERTIL STERIL, V75, P237, DOI 10.1016/S0015-0282(00)01679-4
   LARSSON K, 1962, GERONTOLOGY, V6, P133
   LARSSON K, 1958, J GERONTOL, V13, P136
   Lucio RA, 2008, ANALISIS COPULA EYAC
   MATTHEWS M, 1977, J COMP PHYSIOL PSYCH, V91, P727, DOI 10.1037/h0077364
   MATTHEWS MK, 1979, BIOL REPROD, V20, P540, DOI 10.1095/biolreprod20.3.540
   MATTHEWS MK, 1978, PHYSIOL BEHAV, V20, P303, DOI 10.1016/0031-9384(78)90224-X
   Meigs JB, 2001, J CLIN EPIDEMIOL, V54, P935, DOI 10.1016/S0895-4356(01)00351-1
   NEAVES WB, 1984, J CLIN ENDOCR METAB, V59, P756
   NIESCHLAG E, 1982, J CLIN ENDOCR METAB, V55, P676
   Nijs M, 2011, ANDROLOGIA, V43, P174, DOI 10.1111/j.1439-0272.2010.01040.x
   Oakes CC, 2003, P NATL ACAD SCI USA, V100, P1775, DOI 10.1073/pnas.0437971100
   Ollero M, 1996, INT J ANDROL, V19, P287, DOI 10.1111/j.1365-2605.1996.tb00477.x
   Orgebin-Cist MC, 1974, HDB PHYSL, V5, P319
   Paulson RJ, 2001, AM J OBSTET GYNECOL, V184, P818, DOI 10.1067/mob.2001.113852
   Pichardo A.I., 2011, ADV BIOSCIENCE BIOTE, V2, P75, DOI DOI 10.4236/ABB.2011.22012
   Prats RLP, 2009, REV INT ANDROL, V7, P222
   QUEEN K, 1981, J REPROD FERTIL, V62, P423
   SAKSENA SK, 1979, EXP AGING RES, V5, P373, DOI 10.1080/03610737908257211
   Sanchez HL, 2008, NEUROSCIENCE, V154, P1598, DOI 10.1016/j.neuroscience.2008.04.016
   SASANO N, 1969, TOHOKU J EXP MED, V99, P269
   Serre V, 1998, FERTIL STERIL, V70, P625, DOI 10.1016/S0015-0282(98)00259-3
   SERVADIO C, 1986, EUR UROL, V12, P195
   SMITH ER, 1992, HORM BEHAV, V26, P110, DOI 10.1016/0018-506X(92)90035-T
   SPRUIJT BM, 1989, BEHAV BRAIN RES, V32, P51, DOI 10.1016/S0166-4328(89)80071-3
   Syntin P, 2001, J ANDROL, V22, P235
   TAYLOR GT, 1987, EXPERIENTIA, V43, P311, DOI 10.1007/BF01945563
   TAYLOR GT, 1986, J REPROD FERTIL, V77, P419
   Tlachi-Lopez JL, 2012, PHYSIOL BEHAV, V106, P626, DOI 10.1016/j.physbeh.2012.04.020
   Tlachi-Lopez JL, 2011, BIOL RES, V44, P259, DOI [/S0716-97602011000300007, 10.4067/S0716-97602011000300007]
   TONER JP, 1985, PHYSIOL BEHAV, V35, P113, DOI 10.1016/0031-9384(85)90181-7
   TSAI YF, 1994, ZOOL STUD, V33, P232
   VERMEULEN A, 1995, HORM RES, V43, P25, DOI 10.1159/000184233
   WALLACE JE, 1980, J GERONTOL, V35, P364
   WANG C, 1993, ENDOCRINOLOGY, V133, P2773, DOI 10.1210/en.133.6.2773
   Weir CP, 2007, J ANDROL, V28, P229, DOI 10.2164/jandrol.106.001362
   WORKING PK, 1988, ENVIRON HEALTH PERSP, V77, P37, DOI 10.2307/3430627
NR 63
TC 4
Z9 4
U1 1
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0031-9384
J9 PHYSIOL BEHAV
JI Physiol. Behav.
PD FEB 17
PY 2013
VL 110
BP 73
EP 79
DI 10.1016/j.physbeh.2012.12.015
PG 7
WC Psychology, Biological; Behavioral Sciences
SC Psychology; Behavioral Sciences
GA 133IM
UT WOS:000318132100012
PM 23296084
ER

PT J
AU Wirleitner, B
   Vanderzwalmen, P
   Stecher, A
   Spitzer, D
   Schiff, M
   Schwerda, D
   Bach, M
   Schechinger, B
   Zech, NH
AF Wirleitner, Barbara
   Vanderzwalmen, Pierre
   Stecher, Astrid
   Spitzer, Dietmar
   Schuff, Maximilian
   Schwerda, Delf
   Bach, Magnus
   Schechinger, Birgit
   Zech, Nicolas Herbert
TI Dietary Supplementation of Antioxidants Improves Semen Quality of IVF
   Patients in Terms of Motility, Sperm Count, and Nuclear Vacuolization
SO INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
LA English
DT Article
DE IVF; sperm quality; IMSI; MSOME; nuclear vacuoles;
   oligoasthenoteratozoospermia; oxidative stress; antioxidative
   supplementation
ID ASSISTED REPRODUCTION; OXIDATIVE STRESS; INFERTILE MEN;
   HIGH-MAGNIFICATION; HUMAN SPERMATOZOA; RANDOMIZED-TRIAL; INJECTION;
   ICSI; VACUOLES; ABNORMALITIES
AB Background: This study aimed to investigate the influence of an oral antioxidative supplementation on sperm quality of in vitro fertilization (IVF) patients, as analyzed by sperm motility according to the WHO criteria and motile sperm organelle morphology examination (MSOME). Methods: Semen samples were collected from 147 patients before undergoing an IVF/intracytoplasmic morphologically-selected sperm injection (IMSI) cycle and 2-12 months after an antioxidative supplementation. Semen analysis was evaluated according to WHO and MSOME criteria. Spermatozoa were grouped according to the size of nuclear vacuoles within the sperm's heads. Patients were divided into oligoasthenoteratozoospermic (OAT) and non-OAT men. Between first and second semen analysis, patients were supplemented orally with an antioxidative preparation. Results: After the antioxidative therapy we observed a significant reduction in the percentage of immotile sperm cells in the patients. Additionally, the percentage of class I spermatozoa according to MSOME criteria was significantly higher after antioxidative supplementation. In OAT patients the percentage of class I sperm was found to be increased, although not significantly. However, we observed a drastic improvement in sperm motility as well as in total sperm count in this group. Conclusion: The results demonstrated a considerable improvement in semen quality, notably in OAT patients. Considering the putative relationship between semen quality on the one hand and reactive oxygen species on the other, the observed changes in the sperm parameters indicate that a decline in semen quality, and even subtle morphological changes, might be associated with oxidative stress. Our findings suggest that an antioxidative and micronutrient supplementation has a remarkable benefit for IVF patients having restricted sperm parameters, in particular.
C1 [Wirleitner, Barbara; Vanderzwalmen, Pierre; Stecher, Astrid; Schuff, Maximilian; Schwerda, Delf; Bach, Magnus; Schechinger, Birgit; Zech, Nicolas Herbert] IVF Ctr Prof Zech, Bregenz, Austria.
   [Spitzer, Dietmar] IVF Ctr Prof Zech, Salzburg, Austria.
RP Zech, NH (reprint author), Roemerstr 2, A-6900 Bregenz, Austria.
EM n.zech@ivf.at
CR Agarwal A, 2008, BIOMED PHARMACOTHER, V62, P550, DOI 10.1016/j.biopha.2008.07.052
   Agarwal Ashok, 2011, J Indian Med Assoc, V109, P184
   Akmal M, 2006, J MED FOOD, V9, P440, DOI 10.1089/jmf.2006.9.440
   Alukal JP, 2008, UROL CLIN N AM, V35, P277, DOI 10.1016/j.ucl.2008.01.004
   Antinori M, 2008, REPROD BIOMED ONLINE, V16, P835
   Appleton Jeremy, 2002, Altern Med Rev, V7, P512
   Balercia G, 2009, FERTIL STERIL, V91, P1785, DOI 10.1016/j.fertnstert.2008.02.119
   Bartoov B, 2002, J ANDROL, V23, P1
   Bartoov B, 2003, FERTIL STERIL, V80, P1413, DOI 10.1016/j.fertnstert.2003.05.016
   Berkovitz A, 2006, HUM REPROD, V21, P1787, DOI 10.1093/humrep/del049
   Ciftci H, 2009, UROLOGY, V74, P73, DOI 10.1016/j.urology.2009.02.034
   Cocuzza M, 2008, UROLOGY, V71, P490, DOI 10.1016/j.urology.2007.11.041
   Colagar AH, 2009, NUTR RES, V29, P82, DOI 10.1016/j.nutres.2008.11.007
   Comhaire F, 2010, ANDROLOGIA, V42, P331, DOI 10.1111/j.1439-0272.2009.01025.x
   Braga DPDF, 2012, FERTIL STERIL, V97, P53, DOI 10.1016/j.fertnstert.2011.10.011
   Braga DPDF, 2011, UROLOGY, V78, P786, DOI 10.1016/j.urology.2011.06.018
   El-Melegy NT, 2011, INT BRAZ J UROL, V37, P495, DOI 10.1590/S1677-55382011000400009
   Franco JIG, 2008, REPROD BIOMED ONLINE, V17, P42, DOI 10.1016/S1472-6483(10)60291-X
   Funke S, 2010, EARLY HUM DEV, V86, P547, DOI 10.1016/j.earlhumdev.2010.06.015
   Garolla A, 2008, REPROD BIOMED ONLINE, V17, P610
   Gharagozloo P, 2011, HUM REPROD, V26, P1628, DOI 10.1093/humrep/der132
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Gupta Narmada P., 2002, International Urology and Nephrology, V34, P369, DOI 10.1023/A:1024483520560
   Hazout A, 2006, REPROD BIOMED ONLINE, V12, P19
   Maher ER, 2003, J MED GENET, V40, P62, DOI 10.1136/jmg.40.1.62
   Moslemi Mohammad K, 2011, Int J Gen Med, V4, P99, DOI 10.2147/IJGM.S16275
   Nadalini M, 2009, REPROD BIOMED ONLINE, V19, P45
   Perdrix A, 2011, HUM REPROD, V26, P47, DOI 10.1093/humrep/deq297
   Reddy PS, 2011, J TRACE ELEM MED BIO, V25, P247, DOI 10.1016/j.jtemb.2011.08.145
   Ross C, 2010, REPROD BIOMED ONLINE, V20, P711, DOI 10.1016/j.rbmo.2010.03.008
   Setti AS, 2010, REPROD BIOMED ONLINE, V21, P450, DOI 10.1016/j.rbmo.2010.05.017
   Silva LFI, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-19
   Simon L, 2010, HUM REPROD, V25, P1594, DOI 10.1093/humrep/deq103
   Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004
   Tunc O, 2011, ANDROLOGIA, V43, P121, DOI 10.1111/j.1439-0272.2009.01032.x
   Vanderzwalmen P., 2010, GYNECOL OBSTET BIO S, V39, P22
   Vanderzwalmen P, 2008, REPROD BIOMED ONLINE, V17, P617
   Varghese AC, 2008, REPROD BIOMED ONLINE, V17, P866
   Wen SW, 2010, EUR J OBSTET GYN R B, V150, P160, DOI 10.1016/j.ejogrb.2010.02.028
   Wogatzky J., REPROD BIOL IN PRESS
   Young SS, 2008, HUM REPROD, V23, P1014, DOI 10.1093/humrep/den036
   Zini A, 2006, CAN MED ASSOC J, V175, P495, DOI 10.1503/cmaj.060218
NR 42
TC 5
Z9 5
U1 0
U2 6
PU VERLAG HANS HUBER
PI BERN 9
PA LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND
SN 0300-9831
J9 INT J VITAM NUTR RES
JI Int. J. Vitam. Nutr. Res.
PD DEC
PY 2012
VL 82
IS 6
BP 391
EP 398
DI 10.1024/0300-9831/a000136
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 185TY
UT WOS:000321994400004
PM 23823924
ER

PT J
AU Capucho, C
   Sette, R
   Predes, FD
   Monteiro, JD
   Pigoso, AA
   Barbieri, R
   Dolder, MAH
   Severi-Aguiar, GDC
AF Capucho, Cristina
   Sette, Rayra
   Predes, Fabricia de Souza
   Monteiro, Juliana de Castro
   Pigoso, Acacio A.
   Barbieri, Renata
   Heidi Dolder, Mary Anne
   Severi-Aguiar, Grasiela D. C.
TI Green Brazilian propolis effects on sperm count and epididymis
   morphology and oxidative stress
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Green Brazilian propolis; Epididymis; Sperm production; Morphometry;
   Stereology; Oxidative stress
ID MALE RATS; MALE-INFERTILITY; SUPPLEMENTATION; FINASTERIDE; TOXICITY;
   EXTRACTS; PERIOD
AB Basal generation of reactive oxygen species (ROS) is essential for male reproductive function, whereas high ROS levels may be linked to low quality of sperm and male infertility. The number of antioxidants known to inflict damage is growing, and it will be of interest to study natural products, which may have this activity. Since the epididymis is known to play an important role in providing the microenvironment for sperm maturation and storage of sperm, this study was undertaken to evaluate the morphometric-stereological and functional alterations in the epididymis after chronic treatment with low doses of Brazilian green propolis, which is known for its antioxidant properties. For this purpose, forty-eight adult male Wistar rats were treated with 3, 6 and 10 mg/kg/day of aqueous extract of Brazilian green propolis during 56 days and morphological parameters, sperm production and number of sperm in rat epididymis and oxidative stress levels were analyzed. The results showed higher sperm production and greater epithelium height of the epididymis initial segment and no induction of oxidative stress in treated animals. Further studies are needed to fully understand the effects of propolis on the reproductive system but our results showed that it could alter male reproductive function. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Capucho, Cristina; Sette, Rayra; Pigoso, Acacio A.; Barbieri, Renata; Severi-Aguiar, Grasiela D. C.] UNIARARAS, Ctr Univ Herminio Ometto, Programa Posgrad Ciencias Biomed, BR-13607339 Araras, SP, Brazil.
   [Predes, Fabricia de Souza] Univ Estadual Parana, Paranagua, PR, Brazil.
   [Monteiro, Juliana de Castro] Univ Fed Espirito Santo UFES, Ctr Univ Norte Espirito Santo, Dept Ciencias Saude Biol & Agr, Sao Mateus, ES, Brazil.
   [Heidi Dolder, Mary Anne] Univ Estadual Campinas UNICAMP, Dept Biol Estrut & Func, Lab Biol Reprod, Campinas, SP, Brazil.
RP Severi-Aguiar, GDC (reprint author), UNIARARAS, Ctr Univ Herminio Ometto, Programa Posgrad Ciencias Biomed, Av Maximiliano Barutto 500, BR-13607339 Araras, SP, Brazil.
EM grasielaguiar@uniararas.br
RI 6, INCT/H-4795-2013; Infabic, Inct/I-2128-2013
FU Fundacao Herminio Ometto
FX The authors thank to Fundacao Herminio Ometto by financial support and
   to Profa. Dra. Fernanda O. G. de Gaspi and PIBIC/CNPq for providing the
   extract of Brazilian green propolis.
CR Abdallah F. B, 2011, TOXICOL IND HLTH
   Aebi H., 1974, METHOD ENZYMAT AN, V2, P674
   AITKEN R.J., 2002, ACTIVE OXYGEN SPERMA, P435
   Allameh A, 1997, MECH AGEING DEV, V95, P71, DOI 10.1016/S0047-6374(97)01862-9
   Aly HAA, 2012, TOXICOL APPL PHARM, V261, P134, DOI 10.1016/j.taap.2012.02.015
   Arivarasu N. A., 2012, BIOL TRACE ELEM RES
   Buege J A, 1978, Methods Enzymol, V52, P302
   Burdock GA, 1998, FOOD CHEM TOXICOL, V36, P347, DOI 10.1016/S0278-6915(97)00145-2
   Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055
   Dada R, 2012, J ASSIST REPROD GEN, V29, P213, DOI 10.1007/s10815-012-9715-0
   Alencar Severino Matias de, 2005, Cienc. Rural, V35, P909, DOI 10.1590/S0103-84782005000400025
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   ElMazoudy RH, 2011, PESTIC BIOCHEM PHYS, V101, P175, DOI 10.1016/j.pestbp.2011.09.003
   Garcia PV, 2012, FERTIL STERIL, V97, P1444, DOI 10.1016/j.fertnstert.2012.03.025
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   Goyal A, 2007, BJU INT, V99, P1456, DOI 10.1111/j.1464-410X.2007.06804.x
   Hermo L, 2002, EPIDIDYMIS MOL CLIN, P81
   Jarvi K, 2012, FERTIL STERIL, V97, P1298, DOI 10.1016/j.fertnstert.2012.04.016
   Jasprica I, 2007, J ETHNOPHARMACOL, V110, P548, DOI 10.1016/j.jep.2006.10.023
   Kempinas WD, 1998, BIOL REPROD, V59, P890, DOI 10.1095/biolreprod59.4.890
   Mani F, 2006, J ETHNOPHARMACOL, V105, P95, DOI 10.1016/j.jep.2005.10.011
   Mbongue G. Y. F., 2011, ANDROLOGIA, V44, P53, DOI [10.1111/j.1439-0272.2010.01102.x, DOI 10.1111/J.1439-0272.2010.01102.X]
   Medic-Saric M, 2009, NUTR J, V8
   Morakinyo AO, 2011, ADV MED SCI-POLAND, V56, P95, DOI 10.2478/v10039-011-0018-y
   Moura S. A. L, 2011, E CAM, DOI 10.1093/ecam/nep112
   Cabral SRP, 2011, ANAT REC, V294, P145, DOI 10.1002/ar.21302
   Pagliarone AC, 2009, INT IMMUNOPHARMACOL, V9, P1352, DOI 10.1016/j.intimp.2009.08.005
   Quintar AA, 2011, CELLS TISSUES ORGANS, V193, P170, DOI 10.1159/000317127
   ROBB GW, 1978, J REPROD FERTIL, V54, P103
   Russell LD, 1990, HISTOLOGICAL HISTOPA, P1
   Russo A, 2006, LIFE SCI, V78, P1401, DOI 10.1016/j.lfs.2004.10.085
   Sforcin JM, 2000, J ETHNOPHARMACOL, V73, P243, DOI 10.1016/S0378-8741(00)00320-2
   Sharma RK, 1996, UROLOGY, V48, P835, DOI 10.1016/S0090-4295(96)00313-5
   Sikka SC, 1995, J ANDROL, V16, P464
   Soliman GA, 2012, PHARM BIOL, V50, P105, DOI 10.3109/13880209.2011.601465
   Sousa J. P. B, 2009, ECAM, P2011, DOI [10.1093/ecam/nep077, DOI 10.1093/ECAM/NEP077]
   Sprando RL, 1990, HISTOLOGICAL HISTOPA, P277
   Tavares DC, 2007, PLANTA MED, V73, P1531, DOI 10.1055/s-2007-993737
   Teixeira EW, 2010, EVID-BASED COMPL ALT, V7, P307, DOI 10.1093/ecam/nem177
   Yousef M. I., 2010, FOOD CHEM TOXICOL, V47, P1646
   Yousef MI, 2009, FOOD CHEM TOXICOL, V47, P1168, DOI 10.1016/j.fct.2009.02.006
NR 41
TC 10
Z9 11
U1 0
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD NOV
PY 2012
VL 50
IS 11
BP 3956
EP 3962
DI 10.1016/j.fct.2012.08.027
PG 7
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA 031PL
UT WOS:000310654300011
PM 22951362
ER

PT J
AU Swayne, BG
   Kawata, A
   Behan, NA
   Williams, A
   Wade, MG
   MacFarlane, AJ
   Yauk, CL
AF Swayne, Breanne G.
   Kawata, Alice
   Behan, Nathalie A.
   Williams, Andrew
   Wade, Mike G.
   MacFarlane, Amanda J.
   Yauk, Carole L.
TI Investigating the effects of dietary folic acid on sperm count, DNA
   damage and mutation in Balb/c mice
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article
DE Heritable mutations; Sperm chromatin structure assay; Folic acid; ESTR;
   Sperm
ID RADIATION-INDUCED MUTATION; TANDEM REPEAT INSTABILITY; HEALTH MEASURES
   SURVEY; ONE-CARBON METABOLISM; GERM-CELL MUTAGENS; URACIL
   MISINCORPORATION; AIR-POLLUTION; S-ADENOSYLMETHIONINE; ESTIMATING
   EQUATIONS; ANTICANCER DRUGS
AB To date, fewer than 50 mutagens have been studied for their ability to cause heritable mutations. The majority of those studied are classical mutagens like radiation and anti-cancer drugs. Very little is known about the dietary variables influencing germline mutation rates. Folate is essential for DNA synthesis and methylation and can impact chromatin structure. We therefore determined the effects of folic acid-deficient (0 mg/kg), control (2 mg/kg) and supplemented (6 mg/kg) diets in early development and during lactation or post-weaning on mutation rates and chromatin quality in sperm of adult male Balb/c mice. The sperm chromatin structure assay and mutation frequencies at expanded simple tandem repeats (ESTRs) were used to evaluate germline DNA integrity. Treatment of a subset of mice fed the control diet with the mutagen ethylnitrosourea (ENU) at 8 weeks of age was included as a positive control. ENU treated mice exhibited decreased cauda sperm counts, increased DNA fragmentation and increased ESTR mutation frequencies relative to non-ENU treated mice fed the control diet. Male mice weaned to the folic acid deficient diet had decreased cauda sperm numbers, increased DNA fragmentation index, and increased ESTR mutation frequency. Folic acid deficiency in early development did not lead to changes in sperm counts or chromatin integrity in adult mice. Folic acid supplementation in early development or post-weaning did not affect germ cell measures. Therefore, adequate folic acid intake in adulthood is important for preventing chromatin damage and mutation in the male germline. Folic acid supplementation at the level achieved in this study does not improve nor is it detrimental to male germline chromatin integrity. Crown Copyright (C) 2012 Published by Elsevier B.V. All rights reserved.
C1 [Behan, Nathalie A.; MacFarlane, Amanda J.] Hlth Canada, Hlth Prod & Food Branch, Nutr Res Div, Food Directorate, Ottawa, ON K1A 0K9, Canada.
   [Swayne, Breanne G.; Kawata, Alice; Williams, Andrew; Wade, Mike G.; Yauk, Carole L.] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0K9, Canada.
RP MacFarlane, AJ (reprint author), Hlth Canada, Hlth Prod & Food Branch, Nutr Res Div, Food Directorate, Ottawa, ON K1A 0K9, Canada.
EM carole.yauk@hc-sc.ga.ca
OI Yauk, Carole/0000-0003-4919-876X
FU Health Canada A-base; Canadian Regulatory Systems for Biotechnology;
   Canadian Institute of Health Research
FX Funding for this project provided by Health Canada A-base and the
   Canadian Regulatory Systems for Biotechnology. Financial support for
   B.S. provided by the Canadian Institute of Health Research training
   program in Reproduction, Early Development and the Impact on Health. The
   funding sources had no involvement in study design; collection, analysis
   and interpretation of the data; in the writing of the report or in the
   decision to submit the article for publication.
CR Aziz AHA, 1997, PHARMACOL RES, V35, P457
   Bailey RL, 2010, AM J CLIN NUTR, V92, P383, DOI 10.3945/ajcn.2010.29499
   BARAM J, 1988, J BIOL CHEM, V263, P7105
   Beetstra S, 2005, MUTAT RES-FUND MOL M, V578, P317, DOI 10.1016/j.mrfmmm.2005.05.012
   Bistulfi G, 2010, BMC BIOL, V8, DOI [10.1186/1741-7007-8-6, 10.1186/1741-7007/8/6]
   Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290
   Boxmeer JC, 2009, FERTIL STERIL, V92, P548, DOI 10.1016/j.fertnstert.2008.06.010
   Bungum M, 2011, ASIAN J ANDROL, V13, P69, DOI 10.1038/aja.2010.73
   Carrell DT, 2007, HUM REPROD UPDATE, V13, P313, DOI 10.1093/humupd/dm1057
   Chan D, 2010, ENDOCRINOLOGY, V151, P3363, DOI 10.1210/en.2009-1340
   Colapinto CK, 2011, CAN MED ASSOC J, V183, pE100, DOI 10.1503/cmaj.100568
   De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103
   DeMarini DM, 2012, ENVIRON MOL MUTAGEN, V53, P166, DOI 10.1002/em.21685
   Dubrova YE, 2005, RADIAT RES, V163, P200, DOI 10.1667/RR3296
   Duthie SJ, 1998, FASEB J, V12, P1491
   Duthie SJ, 2011, J INHERIT METAB DIS, V34, P101, DOI 10.1007/s10545-010-9128-0
   Efron B, 1993, INTRO BOOTSTRAP
   EVENSON DP, 1980, SCIENCE, V210, P1131, DOI 10.1126/science.7444440
   Evenson DP, 2002, J ANDROL, V23, P25
   Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9
   Glen CD, 2008, CANCER RES, V68, P3630, DOI 10.1158/0008-5472.CAN-08-0484
   Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162
   Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200
   Higgins J. J., 2003, INTRO MODERN NONPARA
   Hojsgaard S, 2005, J STAT SOFTW, V15, P1
   Kelly P, 1997, AM J CLIN NUTR, V65, P1790
   LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13
   Linhart HG, 2009, GASTROENTEROLOGY, V136, P227, DOI 10.1053/j.gastro.2008.10.016
   MacFarlane AJ, 2009, J BIOL CHEM, V284, P1533, DOI 10.1074/jbc.M808281200
   MacFarlane AJ, 2011, AM J CLIN NUTR, V94, P1079, DOI 10.3945/ajcn.111.020230
   Marchetti F, 2005, EMBRYO TODAY REV, V75, P112
   Marchetti F, 2011, P NATL ACAD SCI USA, V108, P12811, DOI 10.1073/pnas.1106896108
   Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev
   MATTHEWS RG, 1982, ADV ENZYME REGUL, V20, P123, DOI 10.1016/0065-2571(82)90012-7
   Olfert ED, 1993, GUIDE CARE USE EXPT
   Padmanabhan S, 2009, MUTAT RES-GEN TOX EN, V673, P43, DOI 10.1016/j.mrgentox.2008.11.011
   Padmanabhan S, 2008, MUTAT RES-GEN TOX EN, V655, P59, DOI 10.1016/j.mrgentox.2008.07.003
   PRENTICE RL, 1991, BIOMETRICS, V47, P825, DOI 10.2307/2532642
   R Development Core Team, 2009, R LANG ENV STAT COMP, Patent No. R Foundation for Statistical Computing
   REEVES PG, 1993, J NUTR, V123, P1939
   Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802
   Russell LB, 2004, GENETICA, V122, P25, DOI 10.1007/s10709-004-1443-7
   Sauer J, 2009, CURR OPIN CLIN NUTR, V12, P30, DOI 10.1097/MCO.0b013e32831cec62
   Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2
   Shakur YA, 2010, AM J CLIN NUTR, V92, P818, DOI 10.3945/ajcn.2010.29696
   Singer TM, 2006, MUTAT RES-FUND MOL M, V598, P164, DOI 10.1016/j.mrfmmm.2006.01.017
   Singer TM, 2010, ENVIRON MOL MUTAGEN, V51, P919, DOI 10.1002/em.20613
   Somers CM, 2011, SYST BIOL REPROD MEC, V57, P63, DOI 10.3109/19396368.2010.500440
   Somers CM, 2002, P NATL ACAD SCI USA, V99, P15904, DOI 10.1073/pnas.252499499
   Stover P. J., 2004, NUTR REV, V62, pS13
   Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1301/nr.2004.jun.S3-S12
   Vilarino-Guell C, 2003, MUTAT RES-FUND MOL M, V526, P63, DOI 10.1016/S0027-5107(03)00016-2
   Voutounou M, 2012, MUTAT RES-FUND MOL M, V734, P1, DOI 10.1016/j.mrfmmm.2012.04.009
   Wallock LM, 2001, FERTIL STERIL, V75, P252, DOI 10.1016/S0015-0282(00)01697-6
   Witt KL, 1996, MUTAT RES-FUND MOL M, V355, P209, DOI 10.1016/0027-5107(96)00029-2
   Yan J, 2002, R NEWS, P12
   Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650
   Yang QH, 2010, AM J CLIN NUTR, V91, P64, DOI 10.3945/ajcn.2009.28401
   Yauk C, 2008, P NATL ACAD SCI USA, V105, P605, DOI 10.1073/pnas.0705896105
   Yauk CL, 2008, ENVIRON MOL MUTAGEN, V49, P26, DOI 10.1002/em.20359
   Yauk CL, 2004, MUTAT RES-REV MUTAT, V566, P169, DOI 10.1016/j.mrrev.2003.08.001
   Yauk CL, 2002, MUTAT RES-FUND MOL M, V500, P147, DOI 10.1016/S0027-5107(02)00005-2
   Young SS, 2008, HUM REPROD, V23, P1014, DOI 10.1093/humrep/den036
NR 63
TC 10
Z9 11
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0027-5107
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD SEP 1
PY 2012
VL 737
IS 1-2
BP 1
EP 7
DI 10.1016/j.mrfmmm.2012.07.002
PG 7
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 018CF
UT WOS:000309636900001
PM 22824165
ER

PT J
AU Villaverde, AISB
   Fioratti, EG
   Ramos, RS
   Neves, RCF
   Padilha, PM
   Lopes, MD
AF Villaverde, A. I. S. B.
   Fioratti, E. G.
   Ramos, R. S.
   Neves, R. C. F.
   Padilha, P. M.
   Lopes, M. D.
TI Correlations of zinc and selenium concentrations in seminal plasma and
   serum with sperm count and morphology in domestic cats
SO REPRODUCTION IN DOMESTIC ANIMALS
LA English
DT Meeting Abstract
CT 17th International Congress on Animal Reproduction (ICAR)
CY JUL 29-AUG 02, 2012
CL Vancouver, CANADA
SP Bioniche, Merial, Sanofi Co, Pfizer Anim Hlth, MSD Anim Hlth, Imv Technol, Minitube, Semex, Canadian Food Inspect Agcy
DE Sperm quality; zinc; selenium; seminal plasma; serum
C1 [Villaverde, A. I. S. B.; Fioratti, E. G.; Ramos, R. S.; Lopes, M. D.] Sao Paulo State Univ, FMVZ, Dept Anim Reprod & Vet Radiol, Botucatu, SP, Brazil.
   [Neves, R. C. F.; Padilha, P. M.] Sao Paulo State Univ, IB, Dept Chem & Biochem, Botucatu, SP, Brazil.
RI Padilha, Pedro/C-1377-2012
OI Padilha, Pedro/0000-0003-4179-0574
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0936-6768
J9 REPROD DOMEST ANIM
JI Reprod. Domest. Anim.
PD AUG
PY 2012
VL 47
SU 4
SI SI
BP 525
EP 525
PG 1
WC Agriculture, Dairy & Animal Science; Reproductive Biology; Veterinary
   Sciences
SC Agriculture; Reproductive Biology; Veterinary Sciences
GA 980UG
UT WOS:000306918700359
ER

PT J
AU Bonde, JP
   Jensen, MS
   Ramlau-Hansen, CH
   Toft, GV
   Thulstrup, AM
   Olsen, J
AF Bonde, Jens Peter
   Jensen, Morten Sondergaard
   Ramlau-Hansen, Cecilia Host
   Toft, Gunnar Vase
   Thulstrup, Ane Marie
   Olsen, Jorn
TI Trends in sperm count in Finnish men
SO INTERNATIONAL JOURNAL OF ANDROLOGY
LA English
DT Letter
ID RELAXED REPRODUCTIVE SELECTION; DECLINE
C1 [Bonde, Jens Peter] Bispebjerg Hosp, DK-2400 Copenhagen, Denmark.
   [Jensen, Morten Sondergaard; Ramlau-Hansen, Cecilia Host; Toft, Gunnar Vase; Thulstrup, Ane Marie] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark.
   [Olsen, Jorn] Aarhus Univ, Aarhus, Denmark.
RP Bonde, JP (reprint author), Bispebjerg Hosp, DK-2400 Copenhagen, Denmark.
EM jbon0004@bbh.regionh.dk
RI Lindhard, Morten/B-1963-2008; 
OI Lindhard, Morten/0000-0002-5685-8845; Sondergaard Jensen,
   Morten/0000-0003-4225-1388
CR Czeizel AE, 2002, EPIDEMIOLOGY, V13, P113, DOI 10.1097/00001648-200201000-00020
   Fisch H, 2008, UROL CLIN N AM, V35, P137, DOI 10.1016/j.ucl.2008.01.001
   Handelsman DJ, 2001, REPROD FERT DEVELOP, V13, P317, DOI 10.1071/RD00103
   Joffe M, 2010, HUM REPROD, V25, P295, DOI 10.1093/humrep/dep390
   Jorgensen N, 2011, INT J ANDROL, V34, pE37, DOI 10.1111/j.1365-2605.2010.01133.x
   Sharpe R. M., 1994, PHYSL REPROD, P1
   Slama R, 2002, EPIDEMIOLOGY, V13, P613, DOI 10.1097/01.EDE.0000024141.36696.68
   Walport M, 2011, LANCET, V377, P537, DOI 10.1016/S0140-6736(10)62234-9
NR 8
TC 2
Z9 2
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0105-6263
J9 INT J ANDROL
JI Int. J. Androl.
PD AUG
PY 2012
VL 35
IS 4
BP 626
EP 626
DI 10.1111/j.1365-2605.2011.01214.x
PG 1
WC Andrology
SC Endocrinology & Metabolism
GA 972VL
UT WOS:000306309100017
PM 21875429
ER

PT J
AU Ghirelli, M
   Peluso, C
   Christofolini, DM
   Gava, MM
   Glina, S
   Barbosa, CP
   Bianco, B
AF Ghirelli-Filho, Milton
   Peluso, Carla
   Christofolini, Denise M.
   Gava, Marcello M.
   Glina, Sidney
   Barbosa, Caio P.
   Bianco, Bianca
TI Variants in Follicle-Stimulating Hormone Receptor Gene in Infertile
   Brazilian Men and the Correlation to FSH Serum Levels and Sperm Count
SO REPRODUCTIVE SCIENCES
LA English
DT Article
DE FSHR gene; follicle-stimulating hormone; male infertility; sperm count
ID SINGLE-NUCLEOTIDE POLYMORPHISMS; IDENTIFICATION; ASSOCIATION; ISOFORMS;
   FERTILE; DEPENDS
AB The aim of the study was to analyze the distribution of the follicle-stimulating hormone (FSH) receptor (FSHR) Ala307Thr and Asn680Ser polymorphisms in infertile Brazilian men and evaluate the possible role of these polymorphisms on the serum levels of FSH and in sperm count. A case-control study was performed comprising138 infertile men with nonobstructive azoospermia (n = 53) or severe oligozoospermia (n = 85), and 217 fertile men as controls. Genotyping of FSHR polymorphisms was performed by real-time polymerase chain reaction (PCR). The results were analyzed statistically and a P value <.05 was considered significant. According to the sperm count, relatively similar FSHR polymorphisms genotype and allele frequencies were found among the groups, and combined genotypes of 2 polymorphisms did not identify a haplotype associated with sperm count. Considering FSH serum level according to genotypes of the Ala307Thr and Asn680Ser polymorphisms individually, statistical analysis showed no difference among the groups. When the combined genotypes of the FSHR polymorphisms were compared to FSH serum levels, no difference was also found among the groups. In conclusion, the findings demonstrate that, in Brazilian population studied, genetic variations, Asn680Ser and Thr307Ala, of the FSHR gene are not correlated with serum FSH levels or sperm count in male infertility.
C1 [Ghirelli-Filho, Milton; Peluso, Carla; Christofolini, Denise M.; Gava, Marcello M.; Barbosa, Caio P.; Bianco, Bianca] Fac Med ABC, Div Human Reprod & Genet, Dept Gynecol & Obstet, Santo Andre, SP, Brazil.
   [Ghirelli-Filho, Milton; Gava, Marcello M.; Glina, Sidney] Dept Surg, Div Urol, Tucson, AZ USA.
RP Bianco, B (reprint author), Ave Principe Gales 821, BR-09060650 Santo Andre, SP, Brazil.
EM bianca.bianco@hotmail.com
RI Bianco, Bianca/C-2488-2012
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)
   [2011/08681-1]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by grants from FAPESP (Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo) #2011/08681-1.
CR Ahda Y, 2005, J ANDROL, V26, P494, DOI 10.2164/jandrol.04186
   AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9
   Balkan M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/640318
   de Castro F, 2003, FERTIL STERIL, V80, P571, DOI 10.1016/S0015-0282(03)00795-7
   Ferlin A, 2006, REPROD TOXICOL, V22, P133, DOI 10.1016/j.reprotox.2006.04.016
   Foresta C, 2007, REPROD BIOMED ONLINE, V15, P666
   Foresta C, 2008, CURR OPIN UROL, V18, P602, DOI 10.1097/MOU.0b013e328313647d
   Greb RR, 2005, J CLIN ENDOCR METAB, V90, P4866, DOI 10.1210/jc.2004-2268
   Grigorova M, 2010, J CLIN ENDOCR METAB, V95, P100, DOI 10.1210/jc.2009-1010
   Gromoll J, 2005, TRENDS ENDOCRIN MET, V16, P368, DOI 10.1016/j.tem.2005.05.011
   Grover A, 2004, BIOL REPROD, V71, P117, DOI 10.1095/biolreprod.103.027003
   Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e181569d0
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   Lend AK, 2010, SYST BIOL REPROD MEC, V56, P84, DOI 10.3109/19396360903456676
   Li YC, 2011, CLIN CHIM ACTA, V412, P1048, DOI 10.1016/j.cca.2011.02.016
   Mayorga MP, 2000, J CLIN ENDOCR METAB, V85, P3365, DOI 10.1210/jc.85.9.3365
   Meduri G, 2008, MOL CELL ENDOCRINOL, V282, P130, DOI 10.1016/j.mce.2007.11.027
   Nieschlag E, 1999, CLIN ENDOCRINOL, V51, P139, DOI 10.1046/j.1365-2265.1999.00846.x
   O'Flynn O'Brien KL, 2010, FERTIL STERIL, V93, P1, DOI DOI 10.1016/J.FERTNSTERT.2009.10.045
   Pengo M, 2006, REPROD BIOMED ONLINE, V13, P795
   Poongothai J, 2009, SINGAP MED J, V50, P336
   Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149
   Rao AJ, 2004, REPROD BIOMED ONLINE, V8, P385
   Safarinejad MR, 2011, BJU INT, V108, pE117, DOI 10.1111/j.1464-410X.2010.09890.x
   Selice R, 2011, INT J ANDROL, V34, P306, DOI 10.1111/j.1365-2605.2010.01086.x
   Shimoda C, 2009, ENDOCR J, V56, P859
   Simoni M, 1999, J CLIN ENDOCR METAB, V84, P751, DOI 10.1210/jc.84.2.751
   Simoni M, 2002, HUM REPROD UPDATE, V8, P413, DOI 10.1093/humupd/8.5.413
   Tuerlings JHAM, 1998, HUM REPROD, V13, P2098, DOI 10.1093/humrep/13.8.2098
   WHO, 1999, WHO LAB MAN EX HUM S
   Wunsch A, 2005, FERTIL STERIL, V84, P446, DOI 10.1016/j.fertnstert.2005.02.031
   Zalata AA, 2008, ANDROLOGIA, V40, P392, DOI 10.1111/j.1439-0272.2008.00877.x
NR 32
TC 4
Z9 5
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
J9 REPROD SCI
JI Reprod. Sci.
PD JUL
PY 2012
VL 19
IS 7
BP 733
EP 739
DI 10.1177/1933719111432872
PG 7
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 968HX
UT WOS:000305969600009
PM 22421444
ER

PT J
AU Vogel, L
AF Vogel, Lauren
TI Age, sex, location . . . sperm count?
SO CANADIAN MEDICAL ASSOCIATION JOURNAL
LA English
DT News Item
NR 0
TC 1
Z9 1
U1 0
U2 1
PU CMA-CANADIAN MEDICAL ASSOC
PI OTTAWA
PA 1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA
SN 0820-3946
J9 CAN MED ASSOC J
JI Can. Med. Assoc. J.
PD APR 17
PY 2012
VL 184
IS 7
BP E347
EP E348
DI 10.1503/cmaj.109-4156
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA 007RO
UT WOS:000308906000006
PM 22451687
ER

PT J
AU McGill, J
   Baker, K
   Sharma, R
   Agarwal, A
   Sabanegh, E
AF McGill, John
   Baker, Karen
   Sharma, Rakesh
   Agarwal, Ashok
   Sabanegh, Edmund
TI EFFECT OF MICROSURGICAL VARICOCELE LIGATION ON SPERM DNA FRAGMENTATION,
   SPERM CONCENTRATION, AND TOTAL MOTILE SPERM COUNT IN SUBFERTILE MEN.
SO JOURNAL OF UROLOGY
LA English
DT Meeting Abstract
CT AUA Annual Meeting
CY MAY 19-23, 2012
CL Atlanta, GA
SP AUA
RI Agarwal, Ashok/B-1689-2013
OI Agarwal, Ashok/0000-0003-0585-1026
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2012
VL 187
IS 4
SU S
MA 1991
BP E803
EP E803
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA 927MT
UT WOS:000302912503287
ER

PT J
AU Hamilton, JCM
   Braam, SC
   Brandes, M
   Smeenk, JMJ
   de Bruin, JP
   Nelen, WLDM
   Kremer, JAM
AF Hamilton, J. C. M.
   Braam, S. C.
   Brandes, M.
   Smeenk, J. M. J.
   de Bruin, J. P.
   Nelen, W. L. D. M.
   Kremer, J. A. M.
TI Total motile sperm count as an alternative for the WHO classification of
   male infertility
SO HUMAN REPRODUCTION
LA English
DT Meeting Abstract
CT 28th Annual Meeting of the
   European-Society-of-Human-Reproduction-and-Embryology (ESHRE)
CY JUL 01-04, 2012
CL Istanbul, TURKEY
SP European Soc Human Reprod & Embryol
C1 [Hamilton, J. C. M.; Braam, S. C.; Brandes, M.; de Bruin, J. P.] Jeroen Bosch Hosp, sHertogenbosch, Netherlands.
   [Smeenk, J. M. J.] St Elizabeth Hosp, Tilburg, Netherlands.
   [Nelen, W. L. D. M.; Kremer, J. A. M.] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands.
RI Nelen, Willianne/N-4239-2013; Kremer, J.A.M./H-8063-2014
CR Brandes, 2011, INT J ANDROL, P614
NR 1
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
J9 HUM REPROD
JI Hum. Reprod.
PY 2012
VL 27
SU 2
MA O-123
PG 3
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 229WW
UT WOS:000325299600120
ER

EF